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MOUSE DEVELOPMENT
Bonnie Lynn Reinhart, PhD
University of Pittsburgh, 2003
DNA methylation in mammals is involved in several essential processes including X
chromosome inactivation, genomic imprinting, and host defense against mobile genetic
elements. How methylation is targeted to specific sequences in the germ line and how specific
methylation patterns are maintained during development is not fully understood.  Genomic
methylation is established in the gamete, decreases dramatically during preimplantation
development, and is re-established after implantation of the blastocyst.  However, the
methylation present at imprinted loci is specifically maintained during preimplantation
development.  Imprinted genes are located in clusters, and within each gene cluster parent-of-
origin specific expression is governed by an imprinting center (IC). The ICs of the maternally
imprinted murine Snrpn, Kcnq1, and Igf2r gene clusters coincide with their differentially
methylated domains (DMDs). We have shown that specific DMD sequences are required to
establish differential methylation at an imprinted locus. Hybrid transgenes were generated using
a non-imprinted derivative of the imprinted RSVIgmyc mouse transgene, Ig/myc, and sequences
from endogenous imprinted gene DMDs.  Addition of specific DMD sequences to the Ig/myc
transgene restored its imprinting. Only the tandem repeats found within the Snrpn, Kcnq1, and
Igf2r DMDs were capable of establishing maternal-specific transgene methylation.  These
experiments have also shown that the methylation on imprinted gene DMD sequences is
specifically maintained during the early stages of preimplantation development.  These results
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clearly demonstrate the importance of tandem repeats in the process of genomic imprinting.
DNA methylation is also critical for silencing intracisternal A particle (IAP) transposition within
the genome. It is thought that maintenance of IAP element methylation during preimplantation is
critical to repress IAP element transcription and transposition.  The methylation of IAP element
long terminal repeat (LTR) sequences was analyzed at the blastocyst stage of preimplantation
development using the bisulfite genomic sequencing technique. These experiments have shown
that methylation is maintained on the majority of IAP elements at the blastocyst stage of
preimplantation development.  However, the methylation on specific IAP elements is completely
lost at this time, including the methylation of single IAP element LTRs.
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1Chapter 1: Introduction
1.1. Functions of DNA methylation in mammals
DNA methylation in mammals has several properties that make it essential for distinct
processes in the genome.  Methylation patterns on genomic DNA are heritable, erasable, and the
presence of DNA methylation is associated with transcriptional activation or transcriptional
repression (Bestor 2000; Wigler 1981; Prendergast and Ziff 1991).  For these reasons DNA
methylation is required for the processes of X chromosome inactivation, genomic imprinting,
and host defense against mobile genetic elements (Swain et al. 1987; Goto and Monk 1998;
Walsh et al. 1998).  Each process requires the ability to establish heritable methylation patterns
within the genome that are easily reversible and have the ability to control gene expression.  X
chromosome inactivation silences genes specifically on one X chromosome.  Genomic
imprinting establishes reversible patterns of DNA methylation in the gametes that are maintained
during development and translate into tight transcriptional control.  The methylation of mobile
genetic elements inhibits their transposition via silencing active transcription, and is an essential
mechanism to restrain aberrant insertional mutations in the genome.  Methylation is a critical
component of each process, and each process is essential for normal mammalian development.
While proper targeting of methylation to specific regions of the genome is essential for
normal development, aberrant targeting of sequences for methylation can have adverse effects on
development.  It is now well established that aberrant methylation of tumor suppressor genes can
lead to alterations in gene expression that ultimately result in the development of cancer (Lee
2003).  Similarly, at certain disease loci aberrant promoter methylation can lead to silencing of
normal gene expression and the development of disease (Pieretti et al. 1991).  For example,
2abnormal methylation of the expanded CGG repeat tract at the FMR1 locus leads to loss of gene
expression and development of the fragile X syndrome.  For these reasons it is essential to
further our understanding of genomic methylation.
1.2. Establishment and maintenance of DNA methylation patterns
DNA methylation in mammals occurs at the 5-position of cytosine in the context of a
CpG dinucleotide (Figure 1) (Bestor 2000).  Cytosine methylation is established on both strands
of the DNA duplex through a process termed de novo methylation.  A DNA duplex containing
symmetrical methylation of the CpG dinucleotide on both strands of the DNA is referred to as
fully methylated. Following semi-conservative DNA replication the parent strand of each duplex
is methylated and the corresponding daughter strand is unmethylated.  This state is referred to as
hemimethylated.  The pattern of methylation on the parent DNA strand is faithfully copied to the
corresponding unmethylated daughter strand through a process termed maintenance methylation
(Wigler 1981).  DNA methylation can be erased by two possible mechanisms.  Passive
demethylation of DNA occurs simply by lack of maintenance methylation over successive cell
divisions.  Active DNA demethylation describes the removal of the methyl group from cytosine
by the action of an enzyme termed a demethylase.  However, there is currently no known DNA
demethylase.
3Figure 1. Establishment and maintenance of DNA methylation
DNA methylation is established on an unmethylated DNA duplex (top left) through a process
termed de novo methylation.  De novo methylation of DNA in mammals occurs at the 5-position
of cytosine in the context of a CpG dinucleotide. The result is a fully methylated DNA duplex on
which both cytosines are methylated (top right).  Following DNA replication, the parent strand of
DNA is methylated and the newly synthesized daughter strand is unmethylated.  This is referred
to as a hemimethylated CpG dinucleotide (bottom right).  The pattern of methylation present on
the parent strand of DNA is copied to the daughter strand of DNA through a process termed
maintenance methylation.  A fully methylated DNA duplex is once again established (bottom
left).
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5Methylation patterns on genomic DNA are dynamic throughout development, exhibiting
periods of methylation gain and loss (Figure 2) (Monk et al. 1987; Kafri et al. 1992).  Global
genomic methylation is erased during the formation of primordial germ cells, the precursors to
the gametes.  Gamete-specific methylation is then established during spermatogenesis and
oogenesis.  After fertilization, during preimplantation development, global genomic methylation
levels decrease dramatically. Interestingly, the rate of demethylation differs between the
maternal and paternal genomes (Oswald et al. 2000).  The paternal genome is rapidly
demethylated, in a replication-independent fashion, while the maternal genome is slowly
demethylated over several cell divisions.  The maternal and paternal genomes reach equivalent
levels of methylation around the 8-cell stage; however, this timing varies in different mammals.
After implantation of the blastocyst stage embryo, high levels of methylation are once again
established.  The complex patterns of methylation gain and loss are controlled by a group of
proteins termed DNA methyltransferases.
6Figure 2. Changes in DNA methylation levels throughout development
The graph depicts the increases and decreases in DNA methylation (y-axis) that the genome
undergoes throughout various stages of development (x-axis).  Methylation is low in primordial
germ cells (PGC), the precursors to the gametes.  De novo methylation occurs during
gametogenesis, and high levels of methylation are established in mature sperm and oocytes.
Following fertilization and formation of the zygote methylation levels fall dramatically.  The
majority of the genome is unmethylated by the blastocyst stage of preimplantation development.
De novo methylation occurs following implantation of the blastocyst stage embryo, and high
levels of methylation are once again established.  DNA methylation levels are maintained during
embryogenesis and in adult somatic cells.
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81.3. The mammalian DNA methyltransferases
There are several known mammalian DNA methyltransferase (Dnmt) proteins (Figure
3A).  Many of these proteins have been shown to be enzymatically active.  Each protein contains
a conserved catalytic domain at its C-terminus that is similar to the prokaryotic DNA
methyltransferase catalytic domain.  The N-terminal domain of each methyltransferase is
variable and is thought to be involved in regulating specific protein functions (reviewed by
Bestor 2000).   The first mammalian DNA methyltransferase to be identified was Dnmt1. The
Dnmt2, Dnmt3A, and Dnmt3B proteins were identified by similarity to the catalytic domain of
Dnmt1 (Van den Wyngaert et al. 1998; Aapola et al. 2000; Okano et al. 1998).  Certain Dnmt
proteins are present in multiple isoforms, generated by alternative splicing or use of tissue
specific promoters (Weisenberger et al. 2002; Mertineit et al. 1998; Chen et al. 2002).  The
requirement for many different methyltransferases in mammals suggests that each
methyltransferase may have a specific function during development.
1.3.1. DNA methyltransferase 1 activity
Dnmt1 is the predominant mammalian methyltransferase (Bestor 1988). It has been
shown that the Dnmt1 protein is present in at least two isoforms, generated by expression from
alternative first exons at the Dnmt1 locus  (Figure 3B) (Mertineit et al. 1998). The Dnmt1
genomic locus contains three alternative first exons whose expression is driven by tissue specific
promoters. The expression of the two Dnmt1 isoforms is tightly regulated at the level of
transcription of specific mRNAs from each promoter, and at the level of translation of protein
from these mRNAs at specific times during development. The 1o promoter expresses an mRNA
9Figure 3. The mammalian DNA methyltransferase proteins
A, Schematic representation of the mammalian DNA methyltransferase (Dnmt) proteins
identified to date.  The name of each protein is shown on the far left, and the length of each
protein in amino acid number is shown in parentheses on the far right. Black boxes represent
conserved motifs within the C-terminal catalytic domain. The C-terminus of the Dnmt3L protein
is similar to the Dnmt3A and Dnmt3B proteins; however, it does not contain the conserved
motifs required for methyltransferase activity.  Each protein, except Dnmt2, contains a conserved
cysteine-rich region (gray box) near its amino terminus. B, Schematic of the two isoforms of the
Dnmt1 methyltransferase.  The somatic isoform (Dnmt1s) is 118 amino acids longer at the amino
terminus than the oocyte-specific isoform (Dnmt1o). The length of each isoform in amino acid
number is shown in parenthesis to the right. Black boxes represent the catalytic motifs in the C-
terminus, and gray boxes indicate regions identified by function, or by homology to other
proteins. Figure adapted from figures 2 and 3 (Bestor 2000).
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 transcript in the oocyte. The 1s promoter expresses an mRNA transcript during preimplantation
development and in somatic cells. Another alternative first exon found at the Dnmt1 locus,
designated 1p, is expressed in pachytene spermatocytes and does not encode a protein. Evidence
for the presence of other isoforms of the Dnmt1 protein, generated by alternative splicing within
the body of the gene, has also been suggested (Hsu et al. 1999; Bonfils et al. 2000; Aguirre-
Arteta 2000).
The Dnmt1o and Dnmt1s proteins have very distinct expression and localization patterns.
Dnmt1o protein is synthesized in the oocyte, and this protein store is stable during
preimplantation development (Mertineit et al. 1998; Howell et al. 2001).  Dnmt1o is
predominantly localized in the cytoplasm of preimplantation stage embryos except in the
growing oocyte and at the 8-cell stage when it is translocated into the nucleus. The Dnmt1o
isoform is replaced by the Dnmt1s isoform after implantation of the blastocyst stage embryo.
Dnmt1s is then found in the nucleus of all somatic cells in the developing embryo and in the
adult.  The precise expression and localization patterns of the Dnmt1 isoforms suggest that they
have specific functions.
The Dnmt1s and Dnmt1o isoforms are essentially identical, with their only known
variation occurring at the amino terminus. The Dnmt1s isoform of the protein contains 118
amino acids at its N-terminus that are not present in the Dnmt1o isoform.  The 1s first exon
contains an in-frame AUG codon that encodes the 1620 amino acid long Dnmt1s protein.  The
1o first exon does not contain an in-frame AUG codon, and translation of the Dnmt1o protein
begins in exon 4, generating a protein 1502 amino acids long.  Both proteins contain a C-
terminal catalytic domain and an N-terminal region that is thought to modulate protein function.
Domains for protein-protein interactions, nuclear localization, and targeting to replication foci
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have all been identified in the N-terminus (Bestor et al. 1988; Araujo et al. 2001; Fatemi et al.
2001). The Dnmt1o and Dnmt1s proteins have similar enzymatic activities, indicated by the
ability of Dnmt1o to functionally substitute for Dnmt1s in somatic cells (Ding et al. 2002).
However, the Dnmt1o isoform is 5 times more stable than the Dnmt1s isoform (Ding et al.
2002). This suggests that one primary difference between the two proteins lies in this difference
in stability.
Dnmt1 co-localizes with replication foci in vivo and has a preference for hemimethylated
DNA over unmethylated DNA in in vitro (Leonhardt 1992, Bestor and Ingram 1983). This
suggests that Dnmt1 travels with the replication fork to maintain methylation following DNA
synthesis. It has therefore been proposed that Dnmt1 is primarily a maintenance
methyltransferase.  Heterozygous mutant mice carrying a hypomorphic Dnmt1 allele (Dnmt1c)
are viable and fertile (Li et al. 1992).  Homozygous embryos generated by mating two
heterozygous Dnmt1c/+ animals die by E 9.5 (days post-coitum) of gestation.  These homozygous
embryos have drastically reduced levels of methylation over the entire genome (Li et al. 1993).
The widespread loss of methylation seen with the loss of Dnmt1 activity suggests that this
protein is nonspecific, required to maintain methylation everywhere on the genome.  ES cells
homozygous for the null Dnmt1c/c allele still contain a low level of methylation on genomic
DNA (Lei et al. 1996).  Interestingly, these ES cells still possess the ability to de novo methylate
newly integrated proviral DNA.  At the time these experiments were conducted Dnmt1 was the
only known DNA methyltransferase, and these data clearly indicated that other
methyltransferases remained to be identified.
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1.3.2. Activity of the Dnmt3 family of methyltransferases
The Dnmt3A and Dnmt3B methyltransferases were identified by similarity to the Dnmt1
methyltransferase in its catalytic domain.   Both proteins contain the conserved methyltransferase
motifs, and are enzymatically active in vitro and in vivo (Okano, et al. 1998; Hsieh 1999).
Dnmt3A and Dnmt3B are expressed at lower levels than Dnmt1 in adult somatic tissues (Okano
et al. 1998; Xie et al. 1999). It has been suggested that the Dnmt3A and Dnmt3B
methyltransferases are strictly de novo methyltransferases. ES cells homozygous for both
Dnmt3a-/- and Dnmt3b-/- null alleles completely lacked the ability to de novo methylate newly
integrated proviral DNA (Okano et al. 1999).  Also, the Dnmt3A protein shows a preference for
unmethylated DNA over hemimethylated DNA in vitro supporting the notion that it is strictly a
de novo methyltransferase (Yokochi and Robertson 2002).
Mice heterozygous for individual Dnmt3a-/+ or Dnmt3b-/+ mutations are viable (Okano et
al. 1999). Dnmt3a-/- homozygous mutant mice die at around 4 weeks of age, and Dnmt3b-/-
homozygous mutant mice die before birth.  Mice homozygous for both mutations die during
early embryogenesis, and have a more severe phenotype than either individual mutant.  These
data suggest that Dnmt3A and Dnmt3B have distinct but slightly overlapping functions. Unlike
Dnmt1c/c mutant embryos, a significant amount of methylation remains on the DNA of embryos
lacking both Dnmt3A and Dnmt3B enzymes.  Decreases in methylation on specific types of
sequences were identified.  For example repetitive sequences such as C-type retroviral DNA
were undermethylated in Dnmt3b-/- embryos, and were even less methylated in Dnmt3a-/-,
Dnmt3b-/- embryos.  The loss of both proteins also led to the loss of methylation from the 5’
region of the Xist gene.  Distinct functions of the two methyltransferases are indicated by the
specific loss of methylation on minor satellite repeats in the Dnmt3b-/- embryos.
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Clues to the function of the Dnmt3B protein have come from its human homologue.  In
humans, mutations in DNMT3B are associated with ICF syndrome (immunodeficiency,
centromeric region instability, and facial abnormalities) (Hansen et al. 1999).  ICF syndrome is
associated with hypomethylation of specific satellite repeats leading to chromosomal instability.
This correlates well with the loss of minor satellite repeat methylation specific to Dnmt3b-/-
embryos.  Null mutations in the human DNMT3B protein have never been observed in ICF
patients, suggesting that DNMT3B is essential for viability in humans as well as in mice.
The Dnmt3L protein was identified by similarity to the Dnmt3A and Dnmt3B
methyltransferases  (Aapola et al. 2001).  However, Dnmt3L does not possess methyltransferase
activity due to amino acid changes in its catalytic domain motifs. Dnmt3L is expressed in
oocytes and spermatocytes, and heterozygous Dnmt3l-/+ mice are viable and fertile (Yoder et al.
2001; Aapola et al. 2001).  Homozygous Dnmt3l-/- mutant mice are also viable, but males are
infertile, suggesting that Dnmt3L is required for spermatogenesis.  Dnmt3L co-localizes with
Dnmt3A and Dnmt3B in transfected cells (Hata et al. 2002).  Additionally, over-expression of
Dnmt3L stimulates the activity of Dnmt3A for nonspecific target sequences in a cell culture
system (Chedin et al. 2002). These data suggest that Dnmt3A and Dnmt3L interact to regulate de
novo methylation of DNA target sites.
1.3.3. Possible involvement of Dnmt2 in DNA methylation
Like the Dnmt3 family of methyltransferases the Dnmt2 protein was identified due to its
homology with the active Dnmt1 methyltransferase (Yoder and Bestor 1998).  Dnmt2 is
homologous to the pmt1 protein, a non-essential protein identified in S. Pombe (Wilkinson et al.
1995).  Fission yeast are not known to methylate their genome and pmt1 shows no in vitro
activity.  Dnmt2 has an intact catalytic domain. However, evidence is equivocal as to whether the
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protein possesses methyltransferase activity.  It was initially shown that Dnmt2 was not
enzymatically active in vitro (Van den Wyngaert, et al. 1998).  In agreement with these data,
Dnmt2 homozygous mutant embryonic stem cells showed no defects in methylation (Okano et al.
1998).  Still, recent studies suggest that Dnmt2 may possess minimal methyltransferase activity
(Tang et al. 2003; Hermann et al. 2003; Liu et al. 2003).  Therefore, the involvement of Dnmt2
in the process of genomic methylation remains a possibility, and further investigation into this
issue is required.
1.3.4. Interactions between the DNA methyltransferase proteins
Studies with the human DNMT1 protein have implicated the methyltransferase in several
protein-protein interactions.  Human DNMT3A and DNMT3B have been shown to interact with
the N-terminus of DNMT1 (Kim et al. 2002). Physical interactions among the DNA
methyltransferase proteins would suggest that along with individual functions in establishment
and maintenance of genomic methylation, the proteins cooperate to coordinate methylation of the
genome.  Indeed, functional interactions among these proteins have also been demonstrated
(Liang et al. 2002; Fatemi et al. 2002; Rhee et al. 2002).  These studies described cooperation
among the methyltransferases to maintain methylation in human cancer cells, and in mouse
embryonic stem cells.  Also, recent studies suggest that the Dnmt3A and Dnmt3L proteins
interact to establish methylation at imprinted loci (Hata et al. 2002).
1.3.5. Other proteins required for genomic DNA methylation
Proteins other than methyltransferases are associated with regulation of genomic
methylation. The CpG binding protein (CGBP) binds specifically to unmethylated CpGs in vitro
(Voo et al. 2000; Lee et al. 2001). Targeted mutation of CGBP in the mouse led to homozygous
lethality immediately following implantation of the blastocyst stage embryo (Carlone and
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Skalnik 2001).  Additionally, ES cells generated from homozygous mutant blastocysts show
severe defects in genomic methylation (David Skalnik, personal communication).  This
observation suggests a possible role for CGBP in regulating genomic methylation during early
development. The CGBP protein was also shown to act as a methylation-sensitive transcriptional
activator, and the possibility exists that CGBP is indirectly involved in regulating methylation
during early development (Voo et al. 2000).
ATRX and Lsh, Snf2-like ATP-dependent chromatin remodeling proteins, are both
required for maintenance of methylation on genomic DNA (Gibbons et al. 2000; Dennis et al.
2001). ATRX is required for proper methylation of highly repetitive sequences such as rRNA
genes, Y specific repeats, and subtelomeric repeats. Lsh is required for methylation of repetitive
elements such as IAPs, SINES, LINES, and telomeres.  Not unexpectedly, these results
demonstrate a requirement for chromatin remodeling proteins in the process of global DNA
methylation.
1.4. DNA methylation and the regulation of gene transcription
Many of the functions of DNA methylation require that the methylation mark directly
affect the expression of nearby genes. In line with this function, a number of proteins have been
described that are able to interact specifically with methylated or unmethylated DNA sequences
as a part of their transcriptional regulatory activity.  This feature allows the presence of DNA
methylation in the promoter region of a gene to affect its ultimate level of expression.  These
proteins include those that bind specifically to DNA sequences containing methylated CpGs and
those that bind specifically to DNA sequences containing unmethylated CpGs.  In some cases
proteins that interact with the DNA methyltransferases are associated with transcriptional
activation or repression.
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1.4.1. Methyl-binding domain proteins and transcriptional control
Many proteins have been identified that specifically bind to methylated CpG
dinucleotides. These proteins are termed MeCP proteins for methyl-CpG binding protein, and
they all contain a conserved DNA binding domain, termed a methyl-binding domain (MBD).
The MeCP2 protein was identified biochemically by its ability to bind methylated CpGs, and
other members of the family (MBD1-MBD4) were identified by sequence similarity to the
methyl-binding domain of MeCP2. Many of these proteins are involved in transcription
regulation, either alone or in large transcription regulatory complexes (reviewed by Jorgensen
and Bird 2002).
MeCP2 possesses transcriptional repression activity in in vitro assays and is a component
of the histone deacetylase complex, Sin3a/HDAC (Jones et al. 1998; Nan et al. 1998).
Additionally, MeCP2 has a transcription repression domain and the ability to interact with
histone methyltransferases, also associated with transcriptional repression (Nan et al. 1997; Fuks
et al. 2003).  Interactions between methyl-binding domain proteins and histone modifying
enzymes may provide a link between DNA methylation and histone modifications to establish
transcriptional repression.
Like MeCP2, MBD1 binds methyl-CpGs and contains a transcriptional repression
domain (Cross et al. 1997).  MBD1 is also involved in repression via association with histone
deacetylases and the Suv39h1-HP1 heterochromatic complex (Ng et al. 2000; Fujita et al. 2003).
MBD1 contains CXXC domains of unknown function that vary in number in different MBD1
isoforms (produced from different splice variants) (Nakao et al. 2001). The CXXC domain is
also found in the Dnmt1 methyltransferase and the CGBP protein and its exact function is
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MBD2 binds methylated CpGs as a part of the MeCP1/NuRD complex that has been
shown to remodel and deacetylate chromatin templates (Ng et al. 1999; Feng-Zhang 2001).
MBD3, though it contains a methyl-binding domain, is unable to bind methylated CpGs (Wade
2001). However, MBD3 shows an association with the NuRD nucleosome remodeling complex
as a co-repressor, and shows a genetic interaction with MBD2 (Zhang et al. 1999). MBD3 is the
only MBD protein that is essential for early development (Hendrich et al. 2001).
1.4.2. Methylation-sensitive DNA binding factors
Just as specific proteins are able to bind methylated CpG sequences, binding of certain
proteins is inhibited by DNA methylation.  Examples of such proteins include YY1, CTCF, SP1,
MTF-1, Krox-20 and, c-myc, all of which have effects on gene expression (Prendergast and Ziff
1991; Radtke et al. 1996; Hark et al. 2000; Kim et al. 2003).  For example, inhibition of YY1
binding by methylation leads to repression of Peg3 gene transcription (Kim et al. 2003).  As a
general trend, methylation of a gene’s promoter leads to repression of transcription.
1.4.3. DNA methyltransferase interacting factors
Human DMAP1 was identified by interaction with the human DNMT1 amino terminus
(Rountree et al. 2000). The human DMAP1 protein possesses transcriptional repressor activity
and also associates with the TSG101 co-repressor.  The same study implicated DNMT1 in
interactions with the human HDAC2 protein. Similar studies suggest that DNMT1 interacts with
E2F1, HDAC1, and the tumor suppressor protein Rb to repress transcription from E2F-
responsive promoters (Robertson et al. 2000). Together these results suggest that the
methyltransferase may be directly involved in transcriptional repression.
The Dnmt3 family of methyltransferases has also been associated with transcriptional
control. In one study the Dnmt3L protein was shown to repress transcription and to co-purify
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with HDAC1 (Aapola et al. 2002; Deplus et al. 2002).  Both of these activities required the PHD-
like motif found within the Dnmt3L protein. Recently, both Dnmt3A and Dnmt3L were shown to
interact with SUV39H1 and HP1 b, once again implicating the methyltransferase proteins in the
establishment of chromatin (Fuks et al. 2003).  All of these interactions increase the types of
transcriptional control possible by the establishment and maintenance of a methylated region of
DNA.
1.5. Genomic imprinting and DNA methylation
1.5.1. Genomic imprinting
Normal mammalian development requires fertilization of an oocyte by a sperm to form a
zygote, with each haploid gamete contributing half of the genetic information to the developing
organism. This process suggests that the two parental genomes are equivalent, providing
essentially identical information to their offspring.  This is the case for most genes; the alleles
from each parent contribute equally to the phenotype of their offspring. For example, in humans
the allele for brown eye color is dominant to the allele for blue eye color (Eiberg and Mohr
1996).  Therefore, a heterozygous child receiving one allele for blue eyes and one allele for
brown eyes will have brown eyes, regardless of which parent contributes the allele for brown
eyes.  This is an example of the simple genetic inheritance described by Mendel. However, many
genes have a more complex system of regulation.
Expression of a subset of genes in the mammalian genome is governed by the process of
genomic imprinting.  Genomic imprinting is defined by the differential expression of a gene
depending upon its parental origin.  For example, the mouse Snrpn gene is expressed when
inherited through the paternal germ line, and silent when inherited through the maternal germ
line (Leff et al. 1992).  Imprinted genes demonstrate consistent parent-specific expression over
successive generations, regardless of the sex of the offspring.  The Snrpn gene is expressed when
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passed from a father to his daughter, and the identical allele is silenced when passed from his
daughter to his grandson. The opposite is true for the mouse Igf2r gene.  Igf2r is expressed when
inherited through the maternal germ line and silenced when inherited through the paternal germ
line (Stoger et al. 1993).  Due to the parent-specific expression of imprinted genes, the maternal
and paternal genomes are not equivalent, even if the DNA sequences of the parental autosomal
genes are the same.
1.5.2. Importance of genomic imprinting
Understanding the inheritance of imprinted genes is critical to our understanding of
various disease mutations. The occurrence of visible phenotypes from mutations at imprinted
loci is altered by the parent-specific expression of the gene involved. Deletion mutations that
lead to loss of gene expression are detrimental only when inherited on the normally expressed
parental chromosome (Ledbetter et al. 1982).  Inheritance of both copies of a chromosomal
region from one parent is known as a uniparental disomy (UPD). UPD can have adverse effects
due to the loss of expression or overexpression of imprinted genes.  For example, the Prader-
Willi syndrome results when both copies of human chromosome 15 are maternally inherited, due
to loss of expression of paternally expressed imprinted genes found in this region (Nicholls et al.
1989; Glenn et al. 1997).  Mutations at imprinted genes are involved in a number of human
syndromes including the Prader-Willi syndrome, Angelman’s syndrome, and the Beckwith-
Weidemann syndrome.
The extent of analysis possible through the study of families with imprinting disorders is
limited. Using the mouse model system to study genomic imprinting offers numerous
advantages.   The process of genomic imprinting is conserved between humans and mice, and
many human imprinted genes have mouse homologues that are also imprinted (Leff et al. 1992;
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Rachmilewitz et al. 1992).  The genetics of inbred mouse strains has been well characterized, and
the ability to generate transgenic or knockout animals is a powerful tool.  Additionally, the
ability to study germ line inheritance, and the short generation time of the mouse makes the
system ideal.  The large amount of sequence information available for various laboratory mouse
strains adds the advantage of using single nucleotide polymorphisms to closely follow the
inheritance of imprinted genes.  The mouse model has provided an excellent system to study the
mechanism of genomic imprinting over the last 20 years.
1.5.3. Genomic imprinting in the mouse
Maternal and paternal genome non-equivalence was first demonstrated in 1984 by
pronuclear transfer experiments in the mouse (McGrath and Solter 1984; Surani et al. 1984).
Pronuclear transfer between recently fertilized mouse eggs allows the generation of zygotes
containing both sets of chromosomes from one parent.  Zygotes containing two maternal
pronuclei are referred to as gynogenotes, and those containing two paternal pronuclei are referred
to as androgenotes.  Both gynogenotes and androgenotes were not viable, dying by mid-
gestation.  Gynogenotes were characterized by fair embryonic tissue development and poor
extraembryonic tissue development.  Androgenotes were characterized by poor embryonic
development and fair extraembryonic tissue development.  These experiments clearly illustrated
that an embryo must contain information from both parents in order to be viable.
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Table 1. Imprinted loci in the mouse
Description of imprinted loci identified in the mouse. Data obtained from
http://www.mgu.har.mrc.ac.uk/imprinting/imprinting.html.  The abbreviations for imprinted loci
are listed along with their chromosomal locations and gene names.  The repressed parental allele
at each locus is also listed.  Repressed maternal allele (M). Repressed paternal allele (P).
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Imprinted loci Chromosome Chromosomal Region Repressed
parental allele;
Maternal (M)/
Paternal (P)
Name
Gatm 2 central 2 P L-arginine: Glucine amidino-
transferase
Nnat 2 distal 2 M neuronatin
Gnas 2 distal 2 P guanine nucleotide binding
protein, alpha stimulating
Gnasxl 2 distal 2 M guanine nucleotide binding
protein, alpha stimulating, extra
large
Nesp 2 distal 2 P neuroendocrine secretory protein
Nespas 2 distal 2 M neuroendocrine secretory protein
antisense
Dlx5 6 centromere to T77H
(A3.2)
P Distal-less homeobox 5
Calcr 6 centromere to T77H
(A3.2)
P Calcitorin receptor
Sgce 6 centromere to T77H
(A3.2)
M sarcoglycan, epsilon
Asb4 6 centromere to T77H
(A3.2)
P Ankyrin repeat and suppressor of
cytokine signaling
Peg1/Mest 6 proximal 6 (distal to
A3.2)
M mesoderm specific transcript
Copg2 6 proximal 6 (distal to
A3.2)
P coatomer protein complex
subunit gamma 2
Copg2as 6 proximal 6 (distal to
A3.2)
M antisense to Copg2
Mit1/lb9 6 proximal 6 (distal to
A3.2)
M mest linked imprinted transcript 1
Nap1l5 6 proximal 6 (distal to
A3.2)
M Nucleosome assemble protein 1,
like 5.
Zim1 7 proximal 7 P imprinted zinc-finger gene 1
Peg3/Pw1 7 proximal 7 M paternally expressed gene 3
Usp29 7 proximal 7 M ubiquitin specific processing
protease 29
Zim3 7 proximal 7 P Zinc Finger Gene 3 from
Imprinted domain
Zpf264 7 proximal 7 M Zinc Finger gene 264
Snrpn 7 central 7 M small nuclear ribonucleoprotein
polypeptide N
Snurf 7 central 7 M Snrpn upstream reading frame
Pwcr1 7 central 7 M Prader-Willi chromosome region
1
Magel2 7 central 7 M Magel2
Ndn 7 central 7 M necdin
Zfp127/Mkrn3 7 central 7 M ring zinc-finger encoding gene
Zfp127as/Mkrn3as 7 central 7 M ring zinc-finger encoding gene
antisense
Frat3 7 central 7 M Frequently rearranged in
advanced T-cell lymphomas.
Ipw 7 central 7 M imprinted in Prader-Willi
Syndrome
Atp10c/Atp10a 7 central 7 P Aminophospholipid translocase
Ube3a 7 central 7 P E6-AP ubiquitin protein ligase
3A
Ube3aas 7 central 7 M Ube3a antisense
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Imprinted loci Chromosome Chromosomal Region Repressed
parental allele;
Maternal (M)/
Paternal (P)
Name
Nap1l4/Nap2 7 central 7 P
H19 7 distal 7 P A cDNA clone isolated from a
fetal hepatic library
Igf2 7 distal 7 M insulin-like growth factor type 2
Igf2as 7 distal 7 M insulin-like growth factor type 2,
antisense
Ins2 7 distal 7 M insulin 2
Mash2 7 distal 7 P Mus musculus achaete-scute
homologue 2
Kcnq1 7 distal 7 P -
Kcnq1ot1 7 distal 7 M Kvlqt1 antisense
Tapa1/Cd81 7 distal 7 P Cd 81 antigen
p57KIP2 / Cdkn1c 7 distal 7 P cyclin-dependent kinase inhibitor
1C
Msuit 7 distal 7 P mouse specific ubiquitously
expressed imprinted transcript 1
Slc221l 7 distal 7 P Solute carrier family 22 (organic
cation transporter member-1 like)
Ipl/Tssc3 7 distal 7 P imprinted in placenta and liver
(Tdag51?)
Tssc4 7 distal 7 P
Obph1 7 distal 7 P oxysterol-binding protein 1
A19 9 9 M
Rasgrf1 9 9 M Ras protein specific guanine
nucleotide-releasing factor 1
Zac1 10 10 M Zinc finger DNA binding protein
Dcn 10 Distal 10 P Decorin
Meg1/Grb10 11 proximal 11 (A1-A4) P growth factor receptor bound
protein 10
U2af1- rs1 11 Proximal 11 (A3.2-4) M U 2  s m a l l  n u c l e a r
ribonucleoprotein auxiliary factor
related sequence 1
Dlk/Pref1 12 distal 12 (E-F) M delta like 1
Meg3/Gtl2 12 distal 12 (E-F) P gene trap locus 2
Dio3 12 distal 12 (E-F) M Deiodinase Iodothyronine Type 3
Rian 12 distal 12 (E-F) P RNA imprinted and accumulated
in the nucleus.
Htr2a 14 distal 14 P 5-hydroxytryptamine (serotonin)
receptor 2 A
Slc38a4/Ata3 15 distal 15 M Solute carrier family 38, member
4/Amino acid transport system
A3
Peg13 15 distal 15 M Paternally expressed gene 13
Slc22a2 17 proximal 17 P Membrane spanning transporter
protein
Slc22a3 17 proximal 17 P Membrane spanning transporter
protein
Igf2r 17 proximal 17 P insulin-like growth factor type 2
receptor
Igf2ras/Air 17 proximal 17 M insulin-like growth factor type 2
receptor antisense RNA
Impact 18 proximal 18 (A2-B2) M Homology with yeast & bacterial
protein family YCR59c/yigZ
Ins1 19 19 M insulin 1
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Experiments later showed that inheriting two copies of certain subchromosomal regions
from only one parent resulted in abnormal phenotypes in the embryo including embryonic
lethality (Cattanach and Kirk 1985).  These data further supported the idea that the two parental
genomes were not equivalent, and narrowed the focus from entire chromosomes to smaller
chromosomal regions.  These chromosomal regions were later shown to contain imprinted genes
(Kaneko-Ishino 1995; Cattanach et al. 1992; Bartolomei et al. 1991).  To date more than 50
genes have been identified in the mouse that are preferentially maternally expressed or
preferentially paternally expressed (Table 1).  Recent experiments, aimed at identifying novel
imprinted genes, indicate that many more imprinted genes remain to be found (Smith et al. 2003;
Strichman-Almashanu et al. 2002).
1.5.4. DNA methylation and genomic imprinting
The differential expression of genes based on parental inheritance indicates that both
alleles are capable of remembering their parental origin.  The reversibility of the process in the
gamete suggests that the two alleles are distinguished without altering DNA sequence
information.  Epigenetic modifications of DNA are defined as heritable changes in gene function
that are not due to changes in DNA sequence.  These types of modifications can include DNA
cytosine methylation, and histone modifications such as acetylation, phosphorylation,
methylation, ubiquitination, and ADP-ribosylation.  An epigenetic mark capable of
distinguishing the alleles of an imprinted gene must be heritable through cell divisions,
removable during gametogenesis, and ultimately have an effect on gene expression.  DNA
methylation makes an excellent candidate for such a mark.
As described above, the cytosine methylation pattern found on genomic DNA is heritable
through successive cell divisions.  Methylation is established and maintained by a group of
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proteins termed DNA methyltransferases (Figure 3A).  DNA methylation can also be erased by
lack of maintenance methylation over successive cell divisions, or by removal of the methyl
group from cytosine by a demethylase. Importantly, DNA methylation has been shown to affect
gene expression by inhibiting the binding of transcription factors, or by recruiting methyl-CpG
binding proteins (Kim et al. 2003; Hark et al. 2000; Nan and Bird 2001).  These characteristics
make DNA methylation a suitable epigenetic mark to distinguish the alleles of an imprinted
gene.
Many lines of evidence support the prediction that DNA methylation plays an important
role in regulating imprinted gene expression.  The first genes identified with the differential
expression characteristic of imprinted genes were mouse transgenes (Swain et al. 1987; Chaillet
1991).  Transgenes have since provided useful tools with which to study the distinguishing
features of imprinted genes.  The paternally expressed RSVIgmyc transgene was shown to
contain high levels of CpG methylation on each silent maternal allele, while the active paternal
allele was undermethylated (Chaillet 1994).  Since, it has been shown that many endogenous
imprinted genes contain regions of parent-specific methylation termed differentially methylated
domains (DMDs) or differentially methylated regions (DMRs) (Tremblay et al. 1995; Shemer et
al. 1997; Stoger et al. 1993).  In order for the methylation present on imprinted gene DMDs to be
an effective epigenetic mark it must be present at all stages of development, from the gamete to
the adult.
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Figure 4. Establishment and maintenance of DNA methylation at imprinted loci
A, The graph depicts the increases and decreases in genomic methylation (y axis) that occur at
various stages of development (x axis).  Methylation on the bulk of the genome (red line) is
compared to the methylated alleles (solid blue line) and the unmethylated alleles (dashed blue
line) of imprinted gene differentially methylated domains (DMD).  All methylation is erased in
primordial germ cells, including the methylated allele of an imprinted gene (PGC).  Erasure of
methylation in PGCs allows new patterns of gamete-specific methylation to be reset.  During
gametogenesis methylation differences are established on the methylated and unmethylated
alleles of imprinted gene DMDs.  During preimplantation development methylation levels
decrease throughout the genome, including the unmethylated alleles of imprinted genes.  In
contrast, methylation on the methylated alleles of imprinted genes is maintained during
preimplantation and into the adult.  Genomic methylation is established following implantation
of the blastocyst stage embryo.  However, the unmethylated alleles of imprinted genes remain
relatively unmethylated. B, Summary of the stages of development (top) and the
methyltransferase proteins that are known to act at specific stages (bottom). Maintenance of
methylation at imprinted gene DMDs during preimplantation development requires the activity
of methyltransferase proteins.  Dnmt3A and Dnmt3L are required to establish maternal-specific
methylation at imprinted loci in the oocyte.  Dnmt1o is required to maintain maternal- and
paternal-specific methylation at imprinted loci in the 8-cell stage embryo.  It is not known what
methyltransferases are active at the other stages of preimplantation development.  Dnmt1s is
required for the maintenance of the majority of genomic DNA methylation after implantation of
the blastocyst.
28
R
el
at
iv
e 
D
N
A 
M
et
hy
la
tio
n 
 
PGC Gametes Zygote Blastocyst Adult
DMD - methylated allele 
DMD - unmethylated allele
genomic DNA
Zygote Blastocyst AdultSperm Oocyte 2- cell 4- cell 8- cell Morula
Dnmt1o
Dnmt3A
Dnmt3L
Dnmt1s
Preimplantation
A
B
low
high
29
Methylation patterns on global genomic DNA are extremely dynamic during mouse
development.  Importantly, global genomic methylation levels decrease dramatically after
fertilization, and remain low during preimplantation development (Monk et al. 1987; Kafri et al.
1992).  In contrast to the methylation gain and loss experienced throughout the genome,
imprinted gene DMDs exhibit consistent levels of methylation throughout development (Figure
4A).  The maternal and paternal contributions of imprinted genes are physically separated in the
gametes, and it is at this time that the differential methylation on imprinted genes is established.
It has been demonstrated for some maternally methylated imprinted genes that their DMDs are
highly methylated in the mature oocyte and unmethylated in the sperm (Chaillet et al. 1991;
Lucifero et al. 2002).  It has also been shown that the paternally methylated imprinted gene H19
is highly methylated in sperm and unmethylated in the oocyte (Lucifero et al. 2002; Tremblay et
al. 1995).  Interestingly, the gametic methylation present on the paternally methylated H19 gene
and the maternally methylated RSVIgmyc transgene is also present during certain stages of
preimplantation development.  This pattern of methylation is likely to be maintained at all stages
of preimplantation development (Chaillet et al. 1994; Tremblay et al. 1997; Warnecke et al.
1998).  Specific maintenance of imprinted gene methylation during preimplantation
development, a time when most other genomic methylation is lost, suggests that DMD
methylation is critical for the perpetuation of an imprint.
The association between DMD methylation and imprinted gene expression is
strengthened by the effect of DNA methylation loss on the expression of imprinted genes. A
hypomorphic mutation in the Dnmt1 DNA methyltransferase drastically reduces genomic DNA
methylation in homozygous embryos (Li et al. 1992).  The loss of methylation is widespread,
including the DMDs of imprinted genes.  Loss of methylation on imprinted genes in these mutant
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embryos abolishes differential gene expression (Li et al. 1993).  Together these data suggest that
methylation of imprinted gene DMDs is involved in the regulation of imprinted gene expression.
The specificity involved in the acquisition of methylation on imprinted genes in the
gamete, and the maintenance of imprinted gene methylation during preimplantation development
makes DNA methylation an ideal way to distinguish the alleles of imprinted genes.
Unfortunately, little is known about how this specificity is achieved.  Presumably the DMD
sequences that are targeted for methylation are also involved in directing the process, as well as a
number of known and unknown protein factors.  Several DNA methyltransferase proteins have
clearly been implicated in the regulation of imprinted gene methylation.  Other factors have been
identified that may be involved in the methylation-dependent expression of imprinted genes.
However, it is clear that many factors remain to be identified.
1.5.5. Specific methyltransferases establish and maintain imprinted gene methylation
The Dnmt1s isoform of the Dnmt1 methyltransferase is required for the maintenance of
genomic methylation in somatic cells, including the methylation present on imprinted genes (Li
et al. 1993).  The expression of the Dnmt1o specific isoform during preimplantation
development makes it a candidate for a role in maintenance of methylation specific to imprinted
genes (Carlson et al. 1992).  The Dnmt1c mutation eliminates the Dnmt1s form of the protein in
homozygous embryos.  However, because Dnmt1o is present as an oocyte store, the function of
this isoform cannot be assessed by this method.  Therefore, the Dnmt1o specific first exon was
targeted for deletion to test its function directly (Dnmt1D1o) (Howell, et al. 2001).  Dnmt1D1o/+
heterozygous mutant mice were viable and fertile, and mating two heterozygous mice generated
homozygous wild type, heterozygous mutant, and homozygous mutant mice at expected
frequencies.  Immunostaining with a Dnmt1 specific antibody showed that oocytes and
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preimplantation embryos from homozygous female mice contain no Dnmt1o protein.
Interestingly, embryos derived from Dnmt1o-deficient oocytes typically died during the last third
of gestation with variable phenotypes and the occasional surviving mouse.  This phenotype
makes Dnmt1o one of the few maternal effect proteins described in the mouse.
Heterozygous embryos generated from Dnmt1o-deficient oocytes showed no difference
in the level of global genomic methylation compared to wild type embryos, however, loss of
methylation was seen at imprinted loci.  Half of the normally methylated alleles of maternally
and paternally imprinted genes were completely unmethylated.  This loss of methylation
correlated with loss of imprinting.  The loss of methylation appeared to be post-zygotic due to
the fact that methylation at certain imprinted loci was established normally in Dnmt1o-deficient
oocytes. Together these data suggest that Dnmt1o is essential for the maintenance of imprinted
gene methylation during preimplantation development.  The unique pattern of methylation loss
seen in these embryos, and the 8-cell stage nuclear localization of Dnmt1o, suggest that Dnmt1o
is only active during the 8-cell stage of preimplantation development.  These data also suggest
that unknown methyltransferases are still functional at other stages of preimplantation
development, resulting in a partial loss of methylation.
Recent experiments suggest that the Dnmt3A methyltransferase is also involved in the
process of genomic imprinting.  Homozygous Dnmt3a-/- mice die at approximately 4 weeks of
age, making a detailed analysis of imprinting defects in these mice difficult.  However, embryos
have been derived from the ovaries of a Dnmt3a-/- homozygous mutant female mouse
transplanted into a wild type recipient (Hata et al. 2002).  These embryos showed a complete loss
of methylation at normally maternally methylated imprinted genes.  These data suggest that
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Dnmt3A is involved in the establishment of methylation on maternally methylated imprinted
genes in oocytes.
Although Dnmt3L does not possess methyltransferase activity, many lines of evidence
suggest that it also plays a role in controlling imprinted gene methylation.  Embryos derived
from Dnmt3l-/- homozygous oocytes die at approximately E10.5 (Hata et al. 2002).  Maternal
imprints are not established in these embryos, however paternal imprints are normal.  This
phenotype is identical to that seen in embryos generated from Dnmt3A-deficient oocytes.  This
suggests that Dnmt3A and Dnmt3L interact to establish methylation at imprinted genes.
The absolute requirement of DNA methylation to distinguish the parental alleles of
imprinted genes is demonstrated by the complete loss of imprinted expression with complete loss
of methylation.  The need to maintain the identity of each parental allele at all stages of
preimplantation development suggests that a methylation dependent step is required at each
preimplantation stage (Figure 4B).  This model is supported by the unique pattern of methylation
loss seen in Dnmt1o-deficient embryos, proposed to miss maintenance methylation specifically
at the 8-cell stage (Howell et al. 2001).  Moreover, the Dnmt3A and Dnmt3L proteins are
specifically required to establish imprinted gene methylation specifically in the oocyte (Hata et
al. 2001)).  The presence of methylation in the oocyte and at the 8-cell stage suggests that other,
unknown methyltransferase proteins are required in sperm and at the other preimplantation
stages to coordinate the process.
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Figure 5. DMD methylation at the H19 locus
A, The imprinted H19 gene has two differentially methylated domains (DMDs) (designated by
rectangles).  The primary DMD is methylated in the sperm (filled blue rectangle) and
unmethylated in the oocyte (open blue rectangle).  Paternal-specific methylation of the primary
DMD is inherited through all stages of development (bottom).  The secondary DMD is
equivalently methylated in the gametes, and acquires differential methylation later in
development.  The paternal-specific methylation at the H19 locus is associated with maternal-
specific expression of H19 (bent arrow).  B, Paternal-specific methylation of the H19 DMD is
required for maternal-specific expression of H19 and the paternal-specific expression of Igf2.
Bent arrows indicate active transcription.  The methylated DMD is indicated by a filled blue
rectangle, and the unmethylated DMD is indicated by an open blue rectangle.  Expression of H19
and Igf2 requires common enhancer elements located downstream of H19 (black circles). CTCF
(red oval) binds sites in the unmethylated maternal DMD and acts as a boundary element to
repress Igf2 expression (by blocking access to the enhancers), and activate H19 expression.
DMD methylation on the paternal allele inhibits CTCF binding and leads to Igf2 expression and
H19 repression.
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1.5.6. Characteristics of imprinted gene differentially methylated domains
The requirement for gamete specific methylation would suggest that distinct processes
operate in oocytes and in sperm to target methylation to the appropriate allele of imprinted genes.
A high level of methylation is established on one allele while the other allele is protected from
methylation.  Subsequently, gamete specific methylation marks are recognized during
preimplantation development and maintained during a period of widespread genomic
methylation loss.  Targeting methylation to the correct sequences requires the action of
methyltransferases and other protein factors.  It must also require cis-acting sequences in the
genome to direct the process.  Presumably sequences within the differentially methylated
domains themselves are required.
Methylation analyses at many imprinted loci have delineated imprinted gene regions that
are differentially methylated in adult tissues (Thorvaldsen et al. 1998; Bressler et al. 2001;
Shemer et al. 1997; Tremblay et al. 1997; Yatsuki et al. 2002).  Importantly, deletion analyses
have shown that at certain loci the regions required for imprinted gene expression overlap those
that carry the differential methylation mark.  The paternally methylated gene H19 has made an
excellent model for such studies.
A region of differential methylation at an imprinted locus is termed a differentially
methylated domain.  An essential requirement of a DMD is that it must be established in the
gamete and maintained at all stages of development.  In order for an imprinted gene to show
strict parent-specific expression it is important that differential methylation be established in the
gamete, while the parental genomes are separated.  Certain DMDs show allele-specific
methylation in adult tissues and in the gametes (primary DMDs), while others acquire their
methylation post-fertilization (secondary DMDs) (Figure 5A).  This suggests that not all
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differential methylation found in the adult is necessary to transmit an imprint from the germ line
(Hanel and Wevrick 2001; Tremblay et al. 1997).
The CpG methylation patterns at the mouse H19 locus have been extensively examined.
H19 is paternally methylated and expresses an untranslated RNA specifically from the maternal
allele (Tremblay et al. 1997; Bartolomei et al. 1991).  Methylation analyses of the H19 genomic
region have shown that it is differentially methylated in the 5' region of the gene, spanning -2 kb
to -4 kb from the transcription start site (Figure 5A).  Paternal-specific methylation in this region
is established in the germ line and is present during many stages of preimplantation
development.  The promoter region of H19 is also differentially methylated, however this
methylation is acquired after fertilization.  These data indicate that the 2 kb region, 5' of H19, is
its primary DMD.
Targeted deletion studies have demonstrated that H19’s DMD is required for maternal-
specific H19 expression.  The same region is also required for paternal-specific expression of the
Igf2 gene located 60 kb upstream (Figure 5B) (Thorvaldsen et al. 1998).  Both genes are
expressed in mesoderm and endoderm tissues and they have been shown to share enhancers
located downstream of H19 (Leighton et al. 1995).  Inheritance of a DMD deletion on the
normally methylated paternal allele led to paternal activation of H19 expression and paternal
repression of Igf2 expression.  Inheritance of the same deletion on the maternal, unmethylated
allele led to repression of maternal H19 expression and activation of maternal Igf2 expression.  It
has recently been shown that the H19 DMD contains binding sites for the methylation-sensitive
boundary element CTCF.  CTCF is normally bound at the unmethylated maternal sequences and
is necessary for H19 activation and Igf2 repression (Hark et al. 2000).  CTCF binding is inhibited
by methylation of the paternal allele, leading to activation of Igf2 and repression of H19.  These
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data demonstrate that methylation is important for the maintenance of imprinted Igf2 and H19
expression.
Over fifty imprinted genes have been identified in the mouse, and are distributed on 12
different autosomes (Table 1).  Many of these imprinted genes are arranged in clusters of two or
more imprinted genes.  Similar to the coordinate regulation of H19 and Igf2 imprinted gene
expression, these genes may be coordinately regulated.  Interestingly, genes that do not show
parent-specific gene expression are interspersed among the imprinted genes at each cluster.  This
observation suggests that although coordinate gene regulation in the cluster is widespread it is
also very specific within the large chromosomal domain.
Examples of coordinate regulation are found at the mouse Snrpn, Kcnq1, and Igf2r loci
(Figure 6).  Three paternally expressed genes Snrpn, Zfp127, and Ndn are all located in the same
region of chromosome 7.  The Snrpn imprinted gene contains a maternally methylated DMD that
is methylated in the oocyte and in the adult (Shemer et al. 1997).  This DMD is involved in the
coordinate regulation of each imprinted gene in the cluster.  Deletion of the Snrpn gene's DMD
affected not only Snrpn expression, but also affected the expression of other paternally expressed
imprinted genes within the Snrpn gene cluster (Figure 6A) (Bressler et al. 2001).  Inheritance of
a DMD deletion through the paternal germ line (normally unmethylated) led to loss of expression
of each gene, while inheritance of a DMD deletion through the maternal germ line (normally
methylated) had no effect (Figure 6B).  This suggests that the unmethylated, paternal DMD is
normally involved in gene activation and that methylation or deletion abolishes this activity.
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Figure 6. Maternally methylated imprinted gene clusters in the mouse
Diagrams of three maternally methylated imprinted gene clusters in the mouse (not to scale). In
each panel the wild type pattern of expression is depicted on the top line.  Thin lines represent
the genomic DNA, and the location of the DMD in each cluster is shown as a green rectangle.  A
red arrow indicates maternal-specific expression and a blue arrow indicates paternal-specific
expression.  The bottom line in each panel shows the effect of a DMD deletion on gene
expression on the deleted paternal chromosome.  Lack of an arrow indicates a loss of paternal
expression.  Gain of a blue arrow indicates a gain of paternal expression. At each cluster the
pattern of gene expression on the deleted paternal chromosome is identical to that of the
methylated maternal chromosome. Biallelically expressed genes are not pictured.  A, Expression
of imprinted genes in the Snprn gene cluster on chromosome 7.  The Snrpn gene cluster covers a
2 mb region of chromosome 7 (Gabriel et al. 1998). The DMD of this gene cluster is located
within the Snrpn gene.  B, Expression of imprinted genes in the Igf2r gene cluster on
chromosome 17. The Igf2r gene cluster covers a 400 kb region of chromosome 17 (Sleutels et al.
2002).  The DMD of this gene cluster is located within the Igf2r gene and contains the promoter
for the oppositely imprinted Air untranslated RNA.  C, Expression of imprinted genes in the
Kcnq1 gene cluster on chromosome 7.  The Kcnq1 gene cluster covers a 600 kb region of
chromosome 7 (Fitzpatrick et al. 2002).  The DMD of this gene cluster is located within the
Kcnq1 gene and contains the promoter for the oppositely imprinted Kcnq1ot1 untranslated RNA.
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The Snrpn gene cluster on mouse chromosome 7 is syntenic to a 2 mb region of human
chromosome 15 that contains the human SNRPN, IPW, and NDN genes.  The human SNRPN
gene also contains a maternally methylated DMD (Glenn et al. 1996).  Loss of expression of
genes in this imprinted gene cluster results in the Prader-Willi syndrome (PWS).  Loss of gene
expression can be brought about in several ways, including maternal uniparental disomy of
chromosome 15, or paternal deletions on chromosome 15.  Comparisons of PWS patients with
deletions on chromosome 15 have illustrated that a 4.3 kb region is essential for the proper
expression of genes within this region (Ohta et al. 1999).  The 4.3 kb region deleted in each of
these PWS patients includes the promoter and first exon of the SNRPN gene, and has been
termed the Prader-Willi syndrome-imprinting center (IC).  Remarkably, these data suggest that
regulation of gene expression in the PWS region is coordinated over a distance of up to 2 mb by
the small IC.  The PWS-IC overlaps with the DMD located within the SNRPN gene.  This would
suggest that the differential methylation present within this region is involved in the long-range
regulation of gene expression.  This idea is supported by the fact that certain PWS patients
exhibit abnormal methylation at the imprinting center without having identifiable deletions or
mutations (Buiting et al. 2003).
The mouse Igf2r gene is located within an imprinted gene cluster on chromosome 17
(Figure 6B) (Zwart et al. 2001).  Deletion studies at the Igf2r locus have shown that its DMD is
essential for imprinted expression of multiple genes within the cluster (Wutz et al. 2001).  The
Igf2r gene contains a maternally methylated DMD within its 2nd intron. The DMD houses the
promoter for the untranslated Air (antisense Igf2r RNA) RNA that drives transcription in the
opposite direction of Igf2r transcription.  Air shows paternal-specific gene expression, while
Igf2r and the other genes in the cluster show maternal-specific gene expression (Zwart et al.
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2001; Wutz et al. 1997).  A DMD deletion on the normally methylated maternal chromosome
had no effect on gene expression, while inheritance of a DMD deletion on the normally
unmethylated paternal chromosome abolished imprinted expression (Figure 6B).  Paternal
deletion of the DMD led to loss of Air transcription and biallelic expression of the other genes
within the cluster.
The Kcnq1 gene is located within an imprinted gene cluster on chromosome 7, and
contains a maternally methylated DMD within intron 10 (Figure 6C).  The Kcnq1 DMD harbors
a promoter driving transcription of the paternally expressed Kcnq1ot1 RNA in the opposite
direction of Kcnq1 transcription (Smilinich et al. 1999).  Deletion of the DMD on the normally
methylated maternal chromosome had no effect on gene expression, while deletion of the DMD
on the normally unmethylated paternal chromosome abolished imprinted expression of multiple
genes in the imprinted gene cluster (Fitzpatrick et al. 2002).  Paternal inheritance of the DMD
deletion led to loss of Kcnq1ot1 expression and resulted in biallelic expression of the other genes
within the cluster (Figure 6C).
The above data point to a requirement for DMD sequences in the appropriate expression
of imprinted genes over a long distance.  They also suggest that methylation of the sequences is a
critical component of the gene regulatory function. Identical patterns of expression are
established on the methylated maternal allele and the deleted paternal allele.  This suggests that
methylation of the maternal allele is functioning to abrogate a gene regulatory activity of the
unmethylated DMD sequences.
1.6. Silencing of intracisternal A particles in the mouse genome
1.6.1. Mobile genetic elements
The genomes of both prokaryotic and eukaryotic organisms contain a large number of
transposable genetic elements.  The presence of transposable elements in the genome was first
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suggested by Barbara McClintock in 1951 (reviewed in Barahona 1997).  While studying the
inheritance of color and the distribution of pigment in maize, McClintock observed that
particular genes could be turned on and off at abnormal times, consequently creating variegation
in pigmentation.  This was suggested to be due to the action of distinct mobile genetic units
referred to as "controlling elements" (reviewed by Amariglio and Rechavo 1993).  Such genetic
elements have since been observed in many organisms including, bacteria (transposons), yeast
(Ty elements), Drosophila (copia and copia-like elements), and mammals (retrotransposons).  In
each organism transposition of mobile genetic elements from one location to another in the host
genome can cause heritable genetic changes.
Several types of mobile genetic elements have been found in the eukaryotic genome.
These elements can be roughly divided into two main groups based on the organization of their
genome.  The first class includes retrovirus-like elements that contain symmetrical termini,
termed long terminal repeats (LTRs).  This class of retroelements includes the Ty elements of
yeast and the intracisternal A particles (IAPs) of mice.  The second class of elements includes
those without symmetrical termini, such as short interspersed Alu like repeats (SINEs) and long
interspersed repeated elements (LINEs or L1 elements).  This second class of elements
constitutes the majority of middle repetitive DNA in the mammalian genome. In fact, in humans
it has been estimated that approximately 45% of the genome is composed of transposon DNA,
while a mere 5% of the genome is made up by cellular genes (Deininger and Batzer 2002). The
great abundance of both classes of mobile genetic elements in the genome, in relation to the
coding region of the genome, makes them highly significant.
All retrovirus-like elements have a genome organization similar to that of retroviruses
such as the HIV virus.  The primary distinction between retrovirus-like elements and retroviruses
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is that while infective retroviruses are capable of horizontal transmission to other cells,
retrovirus-like elements are not able to leave the cell.  However, they are capable of replicating
their genome and moving to another location within their current host genome, via a mechanism
termed retrotransposition.  For this reason IAP elements have been termed retrotransposons.
Retrotransposition involves transcription of an RNA copy of the retroelement genome by the
host RNA polymerase II enzyme.  The RNA intermediate is then copied into DNA by a RNA-
dependent DNA polymerase encoded by the virus (Review Urnovitz and Murphy 1996).  The
new DNA copy of the genome can then be integrated into a new location in the host genome.
This is a replicative process, the original retrotransposon remains in the same location and a new
copy of the retrotransposon is present in another.
The IAP element is a common type of retrovirus-like element that has been well
characterized in the mouse.  There are approximately 1000 IAP elements per haploid mouse
genome (Review Kuff and Lueders 1988).  IAP elements derive their name from the phenotype
seen by electron microscopy in cells with actively transcribing IAPs.  Retrovirus particles
assemble on the golgi aparatus and bud into the cisternae.  IAP elements have also been found in
the Syrian hamster genome, and it has been suggested that IAP elements may also be found in
the human genome (Aota et al. 1987; Garry et al. 1990).  IAP elements, in both the mouse and
hamster, share a well conserved genome structure (Aota et al. 1987).
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Figure 7. Structure of intracisternal A particles in the mouse genome
Top, Schematic of a full length type I intracisternal a particle (IAP).  The full length type I IAP is
approximately 7.2 kb in size and has long terminal repeats (LTRs) on its 5’ and 3’ ends (black
boxes).  Conserved HpaII sites (H) are indicated above the IAP element. The IAP genome (white
rectangle) contains regions similar to the gag and pol regions of functional retroviruses.  The env
region contains multiple stop codons and is not functional.  Bottom, IAP elements are divided
into classes based on common internal deletions of the IAP element genome.  The locations of
deletions are shown by blank spaces within the IAP element genome and deletion sizes are
indicated (D kb).  The type II classes of IAP elements all include a 0.5-kb insertion in the gag
region (gray box), along with characteristic deletions.  Adapted from figure 1 (Kuff and Leuders
1988).
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The IAP element genome is flanked by LTRs at its 5’ and 3’ termini (Kuff and Lueders et
al. 1988) (Figure 7).  The 5’ and 3’ LTRs of an individual IAP element are essentially identical
in sequence.  Each LTR is divided into distinct regions termed U3, R, and U5.  The U5 region of
an IAP LTR is relatively short (50 to 60 bp) and fairly well conserved.  The R region, or
repetitive region, of an LTR is variable in size, and is composed almost entirely of C and T
nucleotides.  The U3 region is the most highly conserved region within an LTR and contains the
promoter and enhancer elements necessary for transcription of the IAP genome.  Transcription of
the body of the IAP genome begins at the 3' end of the R region in the 5’ LTR and continues
until the polyadenylation signal located just following the R region in the 3' LTR.  Transcription
of the IAP genome is necessary for IAP particle formation and active IAP transposition.
The genome of an IAP element is similar to that of a retrovirus.  The body of an IAP
element contains three gene regions, termed gag, pol, and env that are found among all
retroviruses.  The gag and pol regions of the IAP element are similar to those of the B-type and
D-type retroviruses (Fehrmann et al. 2003).  The gag region encodes a large polyprotein that is
cleaved into several structural proteins, and a viral proteinase.  These components are necessary
for particle formation and budding into the cisternae.  The pol region encodes a reverse
transcriptase and endonuclease, both required for retrotransposition.  The env region of all
known IAP elements contains multiple, conserved stop codons that make this region
nonfunctional.
The large number of IAPs in the mouse has been divided into distinct classes, defined by
the arrangement of their genome (Figure 7).  Type I elements are the major class of IAPs and are
approximately 7.2 kb in size when full length.  Further subdivisions of the type I elements are
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characterized by specific deletions within the IAP gene coding region. Type II elements are
classified by an insertion of 500 bp in the gag region of the genome.  Similar to type I elements,
type II elements are further subdivided based on internal genomic deletions. Each IAP element
subtype produces a transcript of a unique size.  Although many IAP elements contain large gene
deletions, IAP elements are still capable of transposition.  The largest class of IAP elements are
the type IDI elements, which contain a fusion of the gag and pol gene regions.  This class of IAPs
is known to be capable of transposition within the mouse genome.
1.6.2. Methylation and control of IAP element transcription
IAP insertions into various genomic locations can affect gene activity in a number of
ways.  Often IAPs alter transcription levels from the endogenous gene promoter, or interrupt the
coding region of a gene.  Such IAP element insertional mutations are capable of creating
heritable genetic changes that may be deleterious to their host.  Unchecked IAP element
transposition in the germ line, or even in somatic cells could be detrimental to normal
development of the mouse.  Therefore, it is thought that the host has developed a defense
mechanism to cope with retrotransposon activity.  IAP element transposition is dependent upon
active IAP element transcription and it has been suggested that transcription from the IAP
promoter, and therefore transposition of the IAP genome, is constrained by cytosine methylation
of the IAP LTR.
IAP element retrotransposition is dependent upon active transcription of the IAP genome.
Therefore restriction of IAP element transcription should be an effective host defense mechanism
against unwanted IAP element retrotransposition.  IAP element transcription is thought to be
inhibited by cytosine methylation within the LTR (Walsh et al. 1998).  Many lines of evidence
support this hypothesis. It has been shown that in vitro methylation of an IAP element LTR is
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able to inhibit transcription of a linked reporter construct (Feenstra et al. 1986).  Regulation of
transcription by methylation is often accomplished by inhibiting the binding of transcription
factors to their binding sites.  Consistent with this mechanism, the transcription factors EBP-80
and YY1 show methylation sensitive binding to enhancer sequences within the IAP LTR (Falzon
and Kuff 1991; Satyamoorthy et al. 1993).  Inhibition of enhancer binding activity by
methylation alters the level of transcription from the LTR promoter in vitro.  These data
strengthen the connection between IAP element methylation and repression of transcription.
If the ability of methylation to inhibit IAP element transcription in vitro correlates with
its ability to do so in vivo, the level of LTR methylation in various tissues should correlate with
the level of IAP element transcription detected in the tissue, and the amount of IAP particles
detected in the cell.  It has been shown for a number of different tissues and cell lines that the
extent of IAP element LTR methylation correlates with the amount of IAP element transcription
detected.  For example, in normal liver tissue IAP elements are methylated, however, in MOPC-
315 myeloma cells IAP sequences are demethylated (Wujcik et al. 1984).  These methylation
levels correspond to the level of IAP mRNA detected and the number of IAP particles seen in the
cells.  Moreover, many transformed cells and tumor cell lines show a correlation between IAP
LTR demethylation and activation of IAP element transcription (Feenstra et al. 1986; Morgan
and Hwang 1984).  These data suggest that high levels of methylation are correlated with
inactivation of IAP element transcription in vivo.
The involvement of DNA methylation in protection of the host genome is also suggested
by the effect of loss of global genomic methylation on the transcription of IAPs.  Embryos
lacking Dnmt1 methyltransferase activity lose methylation on the bulk of their genomic DNA,
ultimately resulting in embryonic lethality at E9.5.  This loss of methylation is accompanied by a
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dramatic increase in IAP element transcription in all regions of E9.5 embryos (Walsh et al.
1998).  These data strongly support a role for methylation in controlling IAP element
transcription and transposition.
1.6.3. IAP element methylation during development
During the life of the mouse IAP transposition would be most detrimental during
gametogenesis and preimplantation development.  In order for methylation to make an effective
host defense mechanism it should be present on IAP elements at these times in development.
Normal levels of genomic methylation are dynamic; methylation is erased in primordial germ
cells, established in the gametes, and decrease again after fertilization, falling dramatically by the
blastocyst stage (Figure 2).  Adult methylation patterns are established after implantation of the
blastocyst stage embryo.  This pattern of methylation gain and loss is seen over the bulk of the
genome; however, there are a few DNA regions that are exceptions to this general trend.  One
exception is the differentially methylated regions of imprinted genes, which maintain their
parent-specific methylation marks throughout preimplantation development (Figure 4).  Current
data indicate that IAP elements are also an exception to this general trend. 
Comparable to the majority of genomic DNA, IAP elements are unmethylated in the
primordial germ cells and heavily methylated in the mature oocytes and sperm, limiting the time
of demethylation to a few cell divisions.  Methylation is also present on the majority of IAP
elements at the zygote and preimplantation blastocyst stages (Lane et al. 2003).  This indicates
that the methylation established on IAP element LTRs in the gametes is maintained throughout
preimplantation development.  However, recent evidence indicates that the methylation of IAPs
at the blastocyst stage is incomplete (Walsh et al. 1998; Lane et al. 2003).  Southern blot and
bisulfite genomic sequencing data suggest that a portion of the IAP element population is
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unmethylated at the blastocyst stage. The incomplete silencing of IAP element transcription
during preimplantation development is supported by the fact that IAP element transcripts and
IAP particles can be detected in preimplantation embryos.  This suggests that some IAP elements
are unmethylated and active during preimplantation, or that methylation alone is not fully
capable of silencing IAPs.
Maintenance of a silent state for IAP elements is essential even in the somatic tissues. It
has been demonstrated that IAP elements are methylated in normal somatic tissues (Mietz and
Kuff 1990; Walsh et al. 1998).  However, some studies indicate that a small portion of the IAP
element population is unmethylated in somatic cells (Mietz and Kuff 1990).  Moreover, low
levels of IAP transcripts and IAP particles have been detected in some somatic tissues (Mietz et
al. 1992; Kuff and Fewell 1985).  These data suggest that methylation is a key regulator of IAP
transcription, but that some IAP elements escape this inactivation.
1.6.4. IAP element insertions
Many IAP insertion sites have been identified by their effect on gene expression.
However, not all IAP insertions are readily detected by easily visible phenotypes.  From the
C57BL/6J mouse genome sequence it is obvious that many IAP insertion sites are found on
every mouse chromosome (UCSC Genome Browser (http://genome.ucsc.edu/)).  IAP insertions
can act in several ways to influence the expression of mRNA from their target genes.  An IAP
element insertion in the 5' region of a gene can cause ectopic gene expression from the IAP LTR
promoter.  Alternatively, an IAP insertion 5' of a gene can alter transcription by interfering with
endogenous promoter or enhancer elements, or providing enhancer elements from within the IAP
LTR itself.  An IAP insertion in the coding region of a gene can lead to the production of a
truncated or aberrantly spliced mRNA.  Along with direct effects, by insertional mutagenesis,
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IAP elements can influence gene expression by changing the methylation pattern of the
surrounding DNA.  Changes in DNA methylation can then lead to changes in neighboring gene
expression.
Recent IAP insertions have been found at many loci that have severe effects on normal
development. For example, an insertion into the Ap3d locus was recently identified in the
C3H/HeJ strain of mice (Kantheti et al. 2003). These mice show phenotypes similar to known
deletions of the protein, which are a model for human storage pool deficiency (SPD).  An IAP
element insertion was found 5 basepairs downstream of the start of intron 21.  This IAP insertion
resulted in expression of an mRNA that was 2 kb larger than the wild type transcript, and
produced a C-terminally truncated protein.   Interestingly, the IAP insertion in this mouse line is
of type IDI, a class of IAP elements commonly associated with active IAP retrotransposition.
Along with disrupting the protein coding region of a gene IAP insertions are able to
disrupt normal gene transcription.  An example of this type of insertion is seen at the tyrosinase
(Tyr) locus.  An IAP insertion at the 5' end of the gene led to decreased gene transcription (Wu et
al. 1997).  The IAP involved was of type IDI and was inserted in the opposite orientation with
respect to the gene.  Expression still occurred normally from the Tyr promoter, however, it
occurred at a lower level.  This decrease in expression was attributed to the placement of the IAP
between the promoter and necessary enhancer elements located upstream.
1.6.5. Variable methylation within IAP insertions
The most well characterized examples of IAP element insertions are found at the agouti
locus (a).  In wild-type mice the pigmentation pattern of the fur is referred to as agouti, meaning
a brown-black pigmented hair with a ring of yellow pigmentation just before the tip.  Alternating
production of eumelanin, brown-black pigments, and pheomelanin, yellow pigments, is normally
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regulated by the a locus.  The production of agouti protein down-regulates synthesis of
eumelanin in favor of the production of pheomelanin.  Mutations leading to a high level of
expression from the a locus result in a mouse with a yellow coat color, and mutations leading to
a low level of expression, or no expression, from the a locus result in a mouse with agouti coat
coloring.  Mutations resulting from IAP insertions into the a locus are typically dominant
mutations, leading to the mis-expression, or overexpression, of the agouti protein and a resultant
yellow coat color in carrier animals.  Four known insertions, Aiapy, Avy, Aivy, and Ahvy have similar
dominant effects on agouti expression (Figure 8).
The Aiapy allele was identified in a cross of a C3H (A/A) male to a C57BL/6J (a/a) female,
which resulted in a spontaneous mutation at the agouti locus in a female offspring.  This
mutation was shown to be due to an IAP insertion located just prior to the first coding exon of
the agouti locus (exon 2).  The inserted IAP element is located in a head to head orientation with
the exon (the 5' LTR of the IAP is located adjacent to the 5' end of the exon).  IAP promoters are
known to be active in both directions.  In this case the agouti protein was shown to be produced
from a transcript originating in the IAP 5' LTR.  Expression from this promoter leads to ectopic
expression of the agouti protein in nonexpressing tissues and at abnormal times.
The ectopic expression of agouti protein results in a yellow coat color in carrier animals.
Interestingly, all carriers of the Aiapy allele did not shown a solid yellow coat color, the coat
colors ranged from solid yellow to pseudoagouti coat coloring (completely agouti coloring).
This range of phenotypes was associated with a corresponding range in expression levels of the a
mRNA.  The expression level of the agouti mRNA was shown to correlate with the methylation
level of the IAP LTR.  Increased methylation led to decreased expression and a pseudoagouti
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Figure 8. IAP insertions at the agouti locus
Schematic of the agouti locus (not drawn to scale) (Miltenberger et al. 2002). Dark lines indicate
the genomic DNA and open boxes indicate exons (exon numbers are indicated above each box).
Arrows above exons indicate transcription start sites. Translation of the agouti protein begins in
exon 2 (shaded boxes).  The locations of IAP element insertions are shown below the genomic
locus (agouti allele names are shown above the IAP). Each IAP insertion is of type IDI.  Arrows
above each IAP indicate the orientation of the IAP element (pointing 5’ to 3’). Promoter activity
in the IAP 5’ LTR alters expression from the agouti locus (bent arrows). (References: Argeson et
al. 1996, Michaud et al. 1994, Morgan et al. 1999)
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coat coloring.  Likewise, decreased methylation led to increased expression and a solid yellow
coat coloring.  Other variations in coat color arose from intermediate levels of methylation,
possibly suggesting mosaicism in the carrier animal.  Interestingly, the variation in methylation
seen at the a locus was parent-specific.  Inheritance of the Aiapy allele from the female parent led
to 2.5% pseudoagoui coloring, and inheritance of the Aiapy allele from the male parent led to
40.6% pseudoagouti coloring.  This correlated with a high levels of agouti expression in
offspring inheriting the Aiapy allele from the female parent, and a low level of expression in
offspring inheriting the Aiapy allele from the male parent.
Interestingly, the phenotype of the Aiapy allele is almost identical to the Ahvy allele.  The
Ahvy allele contains an IAP element inserted in the agouti 5' untranslated region in a different
location from that of the Aiapy allele.  The only difference in the phenotype generated from these
two alleles is the extent of variation seen among the progeny of a specific cross.  This similarity
suggests that an IAP element present in the context of the agouti 5' region is subject to
differential regulation of methylation.  This supports the notion that the methylation at IAPs is
malleable, changing dramatically with the time in development and the location of the IAP.
Changes in DNA methylation are also seen within the vicinity of an IAP insertion near
the Nocturnin (mNoc) promoter (Wang et al. 2001).  The IAP insertion present at this locus is
found in some inbred mouse strains but absent in others.  The IAP insertion is located in the first
intron of the mNoc gene in DBA/2, BALB/c, C57BL/6J, and C57BL/10 mice.  In all tested
strains of mice mNoc was rhythmically expressed in various tissues, with the pattern of mRNA
expression being circadian in nature.  The IAP promoter was also active, and produced a hybrid
transcript with the mNoc open reading frame.  Interestingly, the activity of the mNoc promoter
had an effect on methylation of the IAP element.  As the carrier mouse aged IAP transcription
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levels increased (Barbot et al. 2002).  The increase in mRNA levels was correlated with gradual
demethylation of the LTR.  This illustrates that surrounding genomic sequence can also exert an
effect on the IAP element.
1.7. DNA methylation and the stability of trinucleotide repeats
1.7.1. Dynamic mutations in human disease
A class of mutations, termed dynamic mutations, is occasionally found at human disease
loci.  Dynamic mutations derive their name from the characteristic large expansion of
trinucleotide repeats seen at each locus.  At least 14 examples of trinucleotide repeat expansions
have been characterized at human disease loci (Reviewed by Cummings and Zoghbi 2000)
(Table 2). The Huntington's disease (HD) locus contains a CAG trinucleotide repeat within the
coding region of the gene.  Expansions of this repeat tract lead to expansion of a corresponding
polyglutamine tract in the protein.  Presence of the expanded polyglutamine tract in Huntington's
disease patients results in protein misfolding and abnormal cytoplasmic protein aggregation
(Zoghbi and Orr 1999).  Trinucleotide repeat tract expansions have also been observed in the 5’
UTR (fragile X syndrome), promoter (progressive myoclonus epilepsy type 1), intron (friedreich
ataxia), and 3' UTR (myotonic dystrophy) gene regions.  Trinucleotide repeats such as CGG,
CAG, GAA, and CTG have all been associated with dynamic mutations.  The molecular
mechanism involved in these trinucleotide repeat expansion disorders is currently not fully
understood.
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Table 2. Dynamic mutations in human disease
Characteristics of the dynamic mutations known to be associated with human diseases.  Data are
obtained from Sinden et al. (2002, Review).  This is not an all-inclusive list.  The disease and
associated human locus are listed.  For each locus the trinucleotide repeat tract involved is
described.  The length of the trinucleotide repeat is described for normal individuals (normal),
premutation carriers (premutation), or for individuals with the disease (full mutation). Length is
shown in number of triplets. Not all trinucleotide repeat expansion disorders are associated with
a premutation size range (- or NA), or one may not be known (?).
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Disease Gene Repeat Normal Premutation Full Mutation
Repeat Length
Fragile X syndrome
Spinobulbar muscular 
atrophy (SMBA)
Myotonic dystrophy 
type I (DM1)
Huntington disease (HD)
Spinocerebellar ataxia 1
Spinocerebellar ataxia 3
Spinocerebellar ataxia 2
Spinocerebellar ataxia 6
Spinocerebellar ataxia 7
Spinocerebellar ataxia 12
Dentatorubral-pallidoluysian 
atrophy
Friedreich ataxia (FRDA)
SCA1
FMR1
AR
DMPK
HD
SCA2
SCA3
SCA6
SCA7
SCA12
DRPLA
X25
(CGG)n
(CTG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(CAG)n
(GAA)n
30-60 60-200 200-5000
14-32 40-55?
5-37 50-80 80-1000
10-34 36-39  40-121
-
-
?
?
?
6-44 39-82 (pure)
34-59 (pure)14-31
13-44 NA
4-18
4-34
7-28
7-25
6-29
NA
NA
200-900
49-75
66-78
21-33
37-306
55-84
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1.7.2. CGG trinucleotide repeat expansion at the human FMR1 locus
Fragile X syndrome is a common form of mental retardation, affecting approximately 1
in 4000 males and 1 in 8000 females (Jin and Warren 2000 review).  Patients with fragile X
syndrome are characterized by moderate to severe mental retardation, and have several
distinguishing physical characteristics including a large head, long face, prominent ears, and
machro-orchidism (Turner et al. 1980; Opitz et al. 1984; Hagerman et al. 1984; Merenstein et al.
1996).  Patients are also subject to behavioral abnormalities including poor eye contact, anxiety,
and hyperactivity.  The mechanism of mutation in fragile X syndrome has been well studied over
the years due to its prevalence in the population and the interesting features seen in pedigrees of
fragile X families.  The inheritance of the disease is similar to that of an ordinary X-linked
disease, however, the chance of inheriting the fragile X syndrome varies with an individual’s
position in the pedigree.  For example, a second-generation male had a 9% likelihood of
developing the disease, while a fourth-generation male had a 40% chance (Figure 9).  This was
observed by Sherman in 1985 and has been termed “Sherman’s Paradox”.
Fragile X syndrome was identified in 1943 by Martin and Bell and was originally termed
Martin-Bell syndrome.  The disease was later renamed fragile X syndrome when it was found to
be strongly associated with a fragile site at the tip of the long arm of the X chromosome (Lubs
1969).  Interestingly, the fragile site was shown to correlate with an unstable region of DNA that
increased in size following passage through a fragile X pedigree (Yu et al. 1991; Oberle et al.
1991).  The fragile site was eventually mapped to the FMR1 locus (Fragile X Mental Retardation
1) (Verkerk et al. 1991).  The association between the FMR1 locus and fragile X syndrome was
strengthened by the presence of FMR1 deletion mutations in several fragile X patients (Gedeon
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Figure 9. Inheritance of fragile X syndrome and “Sherman’s Paradox”
Inheritance of the fragile X syndrome in a representative family.  Symbols: unaffected females
(open circles), carrier females (partially filled circles), unaffected males (open squares), fragile X
syndrome males (filled squares), and fragile X syndrome females (filled circles). Roman
numerals indicate generation number.  Percentages located below each symbol indicate the
likelihood of acquiring fragile X syndrome.  Numbers located above each symbol indicate the
number of CGG repeats present at the FMR1 locus (described in figure 10). The likelihood of an
individual acquiring fragile X syndrome increases through successive generations in the
pedigree.
(http://www.ikm.jmu.edu/Buttsjl/ISAT493/Fragile%20X%20Syndrome/fragilexincidence.html.)
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et al. 1992).  Eventually, these observations were tied together by experiments demonstrating
that the unstable region of the chromosome, and the X chromosome break point, map to a CGG
repeat in the 5’ untranslated region (UTR) of the FMR1 locus (Figure 10A). (Kremer et al. 1991;
Verkerk et al. 1991).  Interestingly, extensive research since this time has shown that the size of
the CGG repeat tract is variable among members of the general population, and can expand when
inherited through the maternal germ line.
The organization of the CGG repeat tract present at the FMR1 locus has been well
characterized within the population (Figure 10B).  The appearance of fragile X syndrome is
associated with large expansions of the CGG repeat tract (Fu et al. 1991). The number of CGG
repeats within this region is variable, and it has been clearly shown that the number of CGG
repeats correlates with the repeat tracts tendency to expand (Yu et al. 1992; Snow et al. 1993).
The number of CGG repeats at the FMR1 locus in normal individuals can range from 30 to 60
CGGs.  These relatively short alleles are thought to be stable and have not been associated with
expansions.  CGG repeat tracts that range from 60 to 200 CGGs have been termed premutation
alleles, due to the fact that they are capable of large expansions.  Premutation alleles expand to
form full mutation alleles, which generally contain 200 to 5000 repeats.  Premutation carriers can
pass expanded full mutation alleles to their offspring.
How does CGG repeat tract expansion lead to the development of fragile X syndrome?
The symptoms of fragile X syndrome are caused by loss of expression from the FMR1 locus
(Pieretti et al. 1991).  Initial characterization of the fragile X breakpoint showed that the region
of the X chromosome containing the breakpoint was highly methylated in fragile X patients, and
unmethylated in unaffected individuals (Vincent et al. 1991; Bell et al. 1991).  These data
correlate well with data demonstrating that in fragile X patients the CGG repeat tracts are highly
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Figure 10. CGG repeat expansion at the human FMR1 locus
A, Schematic of the human FMR1 locus (not drawn to scale).  Genomic DNA is shown as a
black line, exons are depicted as open boxes (exon numbers are indicated below each box).  The
initiation codon for translation of the FMR1 protein is shown as an ATG.  The location of the
CGG repeat tract in the 5’ untranslated region is indicated by a filled box.  B, The CGG repeat
region described in panel A is divided into three categories based on its length.  Each category is
characterized by the number of CGG triplets present at the FMR1 locus, the presence or absence
of expansions, and the presence or absence of methylation at the CGG repeat and associated CpG
island.  The presence of methylation correlates with an absence of FMR1 expression.
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methylated and the FMR1 gene is silent (Pieretti et al. 1991; Sutcliffe et al. 1992). Methylation at
the expanded CGG repeat tract, and a neighboring CpG island, leads to aberrant silencing of
FMR1 transcription, and loss of the FMR1 protein (FMRP) (Pieretti et al. 1991; Sutcliff et al.
1992; Hornstra et al. 1993; Genc et al. 2000).  This characteristic expansion and methylation
provides an explanation for “Sherman’s Paradox”.  Gradual expansion of a premutation allele
through the germ line would increase the likelihood of inheriting the fragile X syndrome as you
move down in position through the pedigree.
The most interesting aspect of the trinucleotide repeat expansion associated with the
FMR1 locus is its parent-specific mode of inheritance (Malter et al. 1997).  The CGG repeat
region only expands when a premutation allele is inherited through the female germ line.
Because of this, female and male carriers of identical premutation alleles show different
frequencies of repeat tract expansions (Nolin et al. 1996).  A father carrying a premutation allele
will never pass an expanded, full mutation allele to his daughter; however, a mother carrying a
premutation allele can pass a full mutation allele to her sons or daughters.  Because the FMR1
gene is located on the X chromosome hemizygous male carriers of a full mutation allele always
show symptoms of fragile X syndrome, while heterozygous female carriers can have variable
phenotypes due to random X-chromosome inactivation (Abrams et al. 1994).  This mode of
inheritance suggests that an event specific to the female germ line triggers repeat expansion.
The CGG repeat tract is not completely composed of CGG triplets; it is occasionally
interrupted by AGG triplets (Verkerk et al. 1991; Kunst and Warren 1994).  The typical
sequence of the repeat tract is (CGG)8-15 AGG (CGG)9-13  AGG (CGG)x.  Periodic AGG
interruptions are thought to increase the stability of the repeat region (Gacy et al. 1995).  The
increase in stability associated with AGG interruptions has a defined polarity.  Interruptions at
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the 5' end of the repeat tract, that leave a large number of uninterrupted CGG triplets at the 3’
end, are not associated with increased stability (Eichler et al. 1996).  However, interruptions
closer to the 3' end of the repeat tract, that leave a small number of uninterrupted CGG triplets at
the 3’ end, are associated with increased stability.  It is in the 3’ region of the repeat tract that
large size changes have been documented.  The polarity of repeat expansion has led investigators
to propose models of expansion that involve errors in DNA replication as the replication fork
passes through the repetitive region (Gordenin et al. 1997).
While the predominant size changes seen during inheritance of the CGG repeat tract are
expansions, contractions in repeat size have also been documented.  Premutation alleles carried
in the female germ line have occasionally been shown to revert to the normal size range in some
offspring (Brown et al. 1996).  Similarly, daughters of premutation carrier males have been
shown to contain smaller CGG repeat tracts than their fathers (Fisch et al. 1995).  One study,
analyzing 191 families, concluded that reverse mutations from father to daughter occurred 22 %
of the time (Nolin et al. 1996).  These data indicate that the CGG repeat tract is unstable in both
directions.
There is considerable debate over the timing of repeat expansion during development.
Several factors of repeat expansion point to it being a germ line event.  Germ line specific
expansion is suggested by the fact that the CGG repeat only expands when inherited from the
female parent.  In addition, the presence of a single size CGG repeat tract in a fragile X patient
suggests that a single expansion event occurs very early in development, either in the germ line
or immediately following fertilization (Tassone et al. 1999; Reyniers et al. 1999).  However,
certain lines of evidence support the notion that CGG repeat expansion also occurs in the mitotic
divisions following fertilization.  Carriers of premutation alleles and expanded alleles
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occasionally show variability in CGG repeat tract length in somatic tissues (Fu et al. 1991;
Taylor et al. 1999).  Also, monozygotic twins have been shown to have different numbers of
CGG repeats at the FMR1 locus, leading to differences in their expression of the fragile X
phenotype (Kruyer et al. 1994).  However, mitotic instability of the repeat tract does not exclude
the possibility that CGG repeat expansion involves events triggered in the germ line.
1.8. Characterization of the imprinted RSVIgmyc transgene
The RSVIgmyc transgene was originally designed to express the c-myc oncogene in the
mouse.  It is composed of a variety of sequence elements including pBR322 vector sequences,
Rous Sarcoma Virus (RSV) Long Terminal Repeat (LTR) sequences, and a fusion gene from the
S107 mouse plasmacytoma cell line (translocation of the c-myc gene into the Immunoglobulin
locus (Ig)) (Figure 11A) (Swain et al. 1997).  The c-myc/Ig sequences within the transgene are
organized so that the a constant and switch regions of the Ig locus are immediately followed by
the c-myc gene with a truncated exon 1.  The original RSVIgmyc transgene construct was injected
into FVB/N fertilized eggs to generate a transgenic mouse line in which over 700 descendents
were analyzed.  Transgene carriers expressed a transgene-specific c-myc transcript only in the
myocardium; however, this expression did not lead to an increase in tumor incidence.
Interestingly, expression of the transgene-specific c-myc transcript was always observed
when RSVIgmyc was inherited through the paternal germ line, but never when RSVIgmyc was
inherited through the maternal germ line.  The expressed paternal allele was associated with
transgene hypomethylation (a low level of CpG methylation), while the silent maternal allele was
associated with transgene hypermethylation (a high level of CpG methylation) in every animal
examined.  These methylation patterns always correlated with the sex of the transmitting parent
and did not vary with the sex of carrier offspring.  The methylation patterns remained consistent
both in expressing and in non-expressing tissues in each carrier animal, suggesting that they are
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the cause of the mono-allelic expression and not a consequence.  Differential methylation was
subsequently seen in different mouse lines generated with the same transgene construct.  Five out
of six transgenic lines were maternally hypermethylated and paternally hypomethylated (in one
exceptional line ~50% of maternally inherited transgenes showed a paternal pattern of
methylation) (Chaillet et al. 1995).  These experiments demonstrated that the RSVIgmyc
transgene contains all of the sequences necessary to establish an imprint in the maternal germ
line, regardless of the site of integration. The consistent imprinting, and easy manipulation of the
RSVIgmyc transgene make it an excellent model system to investigate the characteristics of
imprinted loci.
1.9. Specific aims
The preceding introduction described the diverse functions of DNA methylation during
mouse development.  The aims of this research project focus on gaining a better understanding of
different aspects of the establishment and maintenance of DNA methylation during development.
The goals of this research project are described in Chapter 3 through Chapter 5.  Chapter 3
focuses on the identification of sequences required to create a DMD at an imprinted locus.
These experiments used derivatives of the RSVIgmyc imprinted mouse transgene as a model
system. Chapter 4 focuses on the characterization of unmethylated IAPs in the mouse genome
during the blastocyst stage of preimplantation development.  Chapter 5 describes a mouse model
system designed to determine the effect of maternal-specific methylation on CGG trinucleotide
repeat tract expansion.  These experiments used a derivative of the RSVIgmyc imprinted mouse
transgene to target methylation to the CGG repeat tract.
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Figure 11. The imprinted  RSVIgmyc transgene
Figure and legend adapted from Chaillet et al. 1995 figure 2. A, Physical characteristics of the
transgene. The horizontally hatched area is the 440-bp PvuII-EcoRI fragment of the LTR of the
Schmidt-Ruppin strain (subgroup D) of RSV.  pBR is the EcoRI-AccI fragment of pBR322
containing AmpR. The large EcoRI fragment of the circularized construct (bisected by the unique
KpnI site) contains the breakpoint region of a Burkitt-like immunoglobulin a/c-myc translocation
from the S107 plasmacytoma in which the 5’ region of the switch recombination sequences of
IgA (Sa) has been translocated into the 5’ region of c-myc.  Exon 1 of c-myc is truncated (and
not shown to scale), leaving 23 bp of the 3’ end intact (corresponds to bp 968-bp 990 of
GenBank locus Muscmyc1).  The arrow represents the approximate start of transcription in Sa of
the IgA/c-myc fusion transcript.  Ca is a 1756-bp EcoRI-XbaI fragment (with an internal XbaI
site) containing intervening sequences and constant region coding exons (corresponds to bp
6374-bp 4620 of GenBank locus Musialpha, excluding internal sequence conflicts). Exons 1-3 of
mouse c-myc.  (B)  Imprinting characteristics of modified versions of the transgene.  For
construct H , the last 206 bp of Ca has been deleted (corresponds to bp 4825-bp 4620 of
Musialpha).  For construct I, the last 355 bp of Ca have been deleted (corresponds to bp 4973-bp
4620 of Musialpha).  Results are described as a difference or equivalence between maternal and
paternal methylation or as expression in the heart.  (-) No detectable expression from either
maternal or paternal transgene alleles.  (M) Maternal; (P) Paternal; (NT) not tested.
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Chapter 2: Methods
2.1. Generation of transgene constructs
Hybrid transgenes generated for this study were derivatives of the RSVIgmyc transgene
(Swain et al. 1997).  A number of modifications were made to the original RSVIgmyc construct.
A unique NotI site was created by insertion of a NotI linker into a unique KpnI site.  The
transgene was linearized at the NotI site and subcloned into the pKS+ plasmid (Stratagene, La
Jolla CA); this was done to facilitate removal of pBR322 vector sequences. The transgene was
digested with EcoRI to remove the pBR322/RSV sequences.  This generated a unique EcoRI site
into which all endogenous mouse sequences were subcloned.  Endogenous mouse sequences
were amplified by polymerase chain reaction (PCR) from genomic DNA with oligonucleotide
primers designed to introduce flanking EcoRI sites (described below).  Transgene's generated by
Mariam Eljanne are described in Reinhart et al. (2002) (Igf2rIgmyc, SnrpnIgmyc, H19SIgmyc,
H19LIgmyc, and IAPIgmyc).  The correct sequence and orientation of all transgene constructs
was confirmed by sequencing with primers on either side of the inserted sequence.  Transgene
constructs were prepared for injection by removing pKS+ plasmid sequence by digestion with
NotI.  Digests were run on a 1% agarose gel (Invitrogen, Carlsbad, CA), and the transgene
constructs were gel purified using the Qiagen fragment isolation kit.  DNA was resuspended in
low EDTA, TE (10 mM Tris-HCl pH 7.5, 0.2 mM EDTA pH 8) to a final concentration of 5
ng/ml.
PCR primers:
SnrpnRIgmyc transgene: mouse Snrpn gene (AF130843, nucleotides [nt] 3796 to 4729)
Forward, GAGAATTCGTGAGCAATCCTTTGG
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Reverse, CTGAATTCCTTGAAGCCACATGAAG
Kcnq1Igmyc transgene: mouse Kcnq1 gene (AF119385, nt 1974 to 2919)
Forward, GGTGAATTCTGGTCCAGTCAGG
Reverse, AAGAATTCCCCTGCTTCTGTAAG
TR2+3SIgmyc transgene: mouse Igf2r gene (L06446, nt 1130 to 1307)
Forward, GCTCACGAATTCCCGCGGAACCCTC
Reverse, AGGAGGGAATTCGGAGGGTTTTAGAGGG
2.2. PCR
All sequences used for transgene construction were amplified from C57BL/6J mouse
genomic DNA.  Each PCR reaction contained: 0.1 mg of mouse genomic DNA, 1X PCR buffer
(Invitrogen, Carlsbad, CA), 1.5 mM MgCl2 (Invitrogen, Carlsbad, CA), 0.2 mM dNTPs , 0.1mM
each primer, and 1.25 U of Taq DNA polymerase (Invitrogen, Carlsbad, CA) in a 50 ml reaction
mixture.  The cycling conditions were as follows: 94º C for 5 min; 30 cycles of 94º°C for 45 sec,
60º C for 45 sec, and 72ºC for 1 min; and a final extension at 72º C for 10 min.  PCR products
were resolved on a 1% agarose gel (Invitrogen, Carlsbad, CA) and PCR fragments were isolated
using the Qiagen DNA isolation kit.  PCR fragments were subcloned into the pCR2.1 vector
(TOPO-TA kit, Invitrogen, Carlsbad, CA) and positive clones were sequenced with the M13
reverse primer.
2.3. Generation of  transgenic mice
All transgenic mice were created in an inbred FVB/N genetic background by pronuclear
injection.  Purified DNA fragments were injected at a concentration of 5 ng/ml. Injected zygotes
were reimplanted into the oviducts of pseudopregnant female Swiss Webster mice and developed
to term.  Mice were genotyped for integration of the transgene construct by PCR, and Southern
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blot.  Transgenic founder animals were crossed to wild type FVB/N animals to establish
transgenic lines. Transgenic lines were maintained in the inbred FVB/N background.
2.4. PCR genotyping
Mice were genotyped using PCR primers designed to amplify transgene sequence (JRC
94, CTATTCCAGCCTAGTCTGCT and JRC 98, AGTCAGAATCTACGGAGCCT).  PCR
reactions were performed using approximately 0.1 mg of mouse genomic tail DNA in a 50 ml
reaction containing, 1X PCR buffer (Invitrogen, Carlsbad, CA), 1.5 mM MgCl2, 0.1 mM of each
primer, 200 mM dNTPs, and 1.25 Units of Taq Polymerase (Invitrogen, Carlsbad, CA).  The
cycling conditions were as follows: 5 minutes at 94º°C, followed by 30 cycles of 45'' at 94º C,
45'' at 58º C, and 45'' at 72º ° C, and a final extension of 10' at 72º C.  PCR reactions were
resolved on a 1% agarose gel and visualized by ethidium bromide staining.
2.5. DNA isolation
Most DNA samples were isolated by proteinase K (Invitrogen, Carlsbad, CA) digestion
(10 mM Tris-HCl pH 7.5, 100 mM NaCl, 10mM EDTA, 0.5% SDS, and 0.2 mg Proteinase K)
followed by phenol-chloroform extraction and ethanol precipitation.  DNA samples were
resuspended in TE (10 mM Tris-HCl pH 7.5, 1mM EDTA pH 8).
2.6. Southern blot analysis
DNA was digested with restriction endonuclease (NEB, Beverly, MA) at the appropriate
temperature for 3 hours to overnight.  Digests were electrophoresed on an agarose gel
(Invitrogen, Carlsbad, CA), and transferred to Genescreen nylon filters (NEN, Boston, MA).
Filters were hybridized at 42º C in 40% formamide and with the appropriate 32P-labeled probe,
and washed in 0.1X SSC (1X SSC is 0.15 M NaCl plus 0.015 M sodium citrate) and 0.1%
sodium dodecyl sulfate at 65º C.  Bands were visualized by autoradiography.  The Ca probe is a
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1.75 kb EcoRI-XbaI fragment of Ca, probe a is a 0.6 kb PstI-BamHI fragment from the 3’ region
of c-myc, probe b is a 1.3 kb PvuII-XhoI fragment of c-myc exon 3, and the RSV probe is a 0.44
kb fragment from the LTR region of RSV.
DNA probes for Southern blots were prepared from gel isolated DNA fragments (Qiagen
gel isolation kit, Valencia, CA) by random prime labeling. DNA (30 ng) was denatured at 95ºC
and annealed with random primers (2.5 mg) on ice.  Synthesis of a-32P-labeled probe was done in
the presence of [a-32P] dCTP (50mCi), and Klenow.  a-32P-labeled probes were purified away
from excess unincorporated nucleotides using ProbeQuant G50 micro columns (Amersham
Biosciences, Piscataway, NJ).
2.7. Collection of preimplantation stage embryos
All preimplantation stage embryos were collected in M2 media (Specialty Media,
Phillipsburg, NJ), washed in M2 medium, washed in 1X phosphate buffered saline pH ~7.3
(PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4•7H2O, 1.4 mM KH2PO4), and stored at -
80º C prior to use. Embryo isolation procedures were done as described (Hogan et al. 1994).
Fertilized eggs, 2- cell, 4-cell and 8-cell stage embryos were collected from the oviducts at 0.5
days post coitum (dpc), 1.5 dpc, or 2.5 dpc respectively.  Blastocyst stage embryos were flushed
from the uterus at 3.5 dpc. Extended culture of embryos was done at 37º°C and 5% CO2 in CZB
medium (Specialty Media, Phillipsburg, NJ).
2.8. Bisulfite genomic sequencing
2.8.1. Large DNA samples
DNAs for bisulfite genomic sequencing were isolated from tissue samples by grinding in
liquid nitrogen prior to proteinase K digestion.  DNAs were digested overnight at 37º C with
HindIII, phenol/chloroform extracted, and ethanol precipitated. DNA was resuspended in TE (10
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mM Tris-HCl pH 7.5, 1mM EDTA pH 8) and denatured at a final concentration of 0.3 M NaOH
at 42º C for 30 minutes.  Denatured DNA was treated with sodium bisulfite (Sigma, St. Louis
MO) at a final concentration of 3.06 M and hydroquinone (Sigma, St. Louis MO) at a final
concentration of 0.05 mM in the dark at 55º C for 15 to 18 hours.  DNA was purified using the
geneclean II kit (Qbiogene, Carlsbad, CA) and resuspended in TE.  Treated DNA was
desulphonated for 15 minutes at 37º C at a final concentration of 0.3 M NaOH, neutralized with
3M NH4OAc at a final concentration of 0.3 M, and ethanol precipitated.  DNA was resuspended
in 100 ml TE and used for PCR analysis.  DNA was stored in the dark at -20º C for up to two
weeks.  Two rounds of PCR were performed.  The first reaction contained 1-4 ml of treated DNA
in a 25 ml reaction containing, 1X PCR buffer (Invitrogen, Carlsbad, CA), 1.5 mM MgCl2, 0.4
mM of each primer, 200 mM dNTPs, and 0.50 Units of Taq Polymerase (Invitrogen, Carlsbad,
CA).  Cycling conditions for the first round of PCR were: 2 cycles of 94º C for 4 minutes, 55º C
for 2 minutes, and 72º C for 2 minutes, followed by 35 cycles of 94º°C for 1 minute, 55º C for 2
minutes, and 72º C for 2 minutes, with a final extension of 72ºC for 10 minutes. The nested
round of PCR was performed with the same reaction conditions and contained 2 - 5 ml of the first
reaction product.  Cycling conditions were as follows:  5 minutes at 94º followed by 35 cycles of
94º C for 1 minute, 55º°C for 2 minutes, and 72º°C for 2 minutes, with a final extension of 72ºC
for 10 minutes.  PCR products were electrophoresed on a 1% agarose gel and isolated using the
Qiagen fragment isolation kit (Qiagen, Valencia, CA).  PCR fragments were subcloned into the
TOPO-TA pCR2.1 vector (Invitrogen, Carlsbad, CA) and sequenced using the M13 reverse
primer.
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2.8.2. Preimplantation embryos
The bisulfite genomic sequencing technique for preimplantation stage embryos was
conducted as described in Schoenherr et al. (2003).  Preimplantation stage embryos were stored
in 1X PBS at -80°C and thawed at room temperature immediately prior to use.  Embryos were
briefly centrifuged and embedded in low melting point agarose at a final concentration of 1 to
1.6% [SeaPlaque GTG low melting temperature agarose (Cambrex, Rockland, MD)] Agarose
embedded embryos were incubated on ice and covered with cold mineral oil to solidify the bead.
DNA was extracted by Proteinase K digestion overnight at 50º C (10 mM Tris-HCl pH 7.5, 10
mM EDTA, 1% SDS, and 50 mg Proteinase K).  The agarose bead was washed three times in 1
ml TE and DNA was denatured with 500 ml of 0.3 M NaOH (two incubations for 15 minutes at
room temperature), followed by 0.1 M NaOH (500 ml for 10 minutes at room temperature).  The
DNA was treated with sodium bisulfite for 5 hours in the dark at 50º C [sodium bisulfite (Sigma,
St. Louis, MO) at a final concentration of 3.06 M and hydroquinone (Sigma, St. Louis, MO) at a
final concentration of 0.05 mM].  The agarose bead containing treated DNA was washed briefly
with water and incubated 5 times for 15 minutes with 1 ml TE.  DNA was desulphonated by
incubating the agarose bead in 500 ml of 0.2 M NaOH for 15 minutes at room temperature and
then at 37°C for 15 minutes, the pH was then neutralized by adding 100 ml of 1 M HCl.  The
bead was washed briefly in TE, followed by 2 washes for 15 minutes with water.  The agarose
bead was prepared for PCR by adding water to bring the volume to 50 ml and melting at 65º C
for 5 minutes, resuspending the bead and heating to 80º C for 5 minutes.  The heated bead was
divided into PCR reactions immediately (amount varied for each reaction).  Two rounds of PCR
were performed.  The first PCR reaction conditions were identical to those described for large
DNA samples, except the amount of template DNA varied. Prior to the nested PCR reaction the
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primary reaction was heated to 80º C for 5 minutes.  The nested PCR reaction contained 5 ml of
the first reaction product and was performed as described for the large DNA sample.  PCR
products were electrophoresed on a 1% agarose gel and isolated using the Qiagen fragment
isolation kit.  PCR fragments were subcloned into the TOPO-TA pCR2.1 vector and sequenced
using the M13 reverse primer.
2.8.3. PCR Primers
Primer pairs for endogenous imprinted gene sequences are described in Table 3; primer
pairs for transgene constructs are described in Table 4; and primer pairs for IAP elements are
described in Table 5. Bisulfite genomic sequencing of endogenous genes was done in embryos
obtained from FVB/N mice crossed to B6(CAST7) mice (Mann et al. 2003) and single
nucleotide polymorphisms (SNPs) between the two strains of mice were used to distinguish
parental alleles.  The H19 region includes a G:A (FVB:Cast) polymorphism at nt position 1566.
The Snprn promoter region includes a G:T polymorphism at nt position 2348. The Snrpn repeat
region includes a A:G polymorphism at nt position 4097.
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Table 3. Bisulfite genomic sequencing PCR primers for endogenous imprinted loci
A and D primers were used for primary reactions and B and C primers were used for secondary
reactions.  DNA sequences amplified: H19, U19616 nt 1301-1732; Snrpn promoter, AF081460
nt 2151-2562; Snrpn repeats, AF130843 nt 3900-4225.
79
Endogenous Gene        Primer name                              Sequence
H19
H19 A GAGTATTTAAGGAGGTATAAGAATT
H19 B GTAAGGAGATTATGTTTATTTTTGG
H19 C CCTCATAAAACCCATAACTAT
H19 D ATCAAAAGTAACATAAAGGGGT
Snrpn promoter
Snrpn A TATGTAATATGATATAGTTTAGAAATTAG
Snrpn B AATTTGTGTGATGTTTGTAATTATTTGG
Snrpn C ATAAAATACACTTCACTACTAAAATCC
Snrpn D AATAAACCCAAATCTAAAATATTTTAATC
Snrpn repeats
SnrpnR A TGGTGGTTTGAGGTTGAGATTGG
SnrpnR B GATTTTGGATGTAAGAGTTGTGTTG
SnrpnR C ATCCACCCAACCCCATAACCCAC
SnrpnR D CATCAACAAAACCACAACCTTAAAC
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Table 4. Bisulfite genomic sequencing PCR primers for transgene loci
A and D primers were used for primary reactions and B and C primers were used for secondary
reactions.  The SnrpnRIgmyc DMD is over 900 bp in size and was PCR amplified with two
separate sets of PCR primers.  SnrpnRIgmyc A-1, SnrpnRIgmyc B-1, SnrpnRIgmyc C-2, and
SnrpnRIgmyc D-2 PCR primers are specific for the DMD region of the hybrid transgene.  These
primers were also used to amplify the TR2+3SIgmyc transgene DMD.  The SnrpnRIgmyc C-1,
SnrpnRIgmyc D-1, SnrpnRIgmyc A-2, and SnrpnRIgmyc B-2 are specific for the SnrpnRIgmyc
DMD.
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Transgene               Primer name                                     Sequence
SnrpnRIgmyc
region 1
SnrpnRIgmyc A-1 GTATTGAAATTGAGTTTGAAGTGG
SnrpnRIgmyc B-1 TTGAAGTTATATGAAGTAGTAATAGAG
SnrpnRIgmyc C-1 CTCTATTAATACAACCAATAAACTAC
SnrpnRIgmyc D-1 CACTCTAGGATCAAAACTATAACTC
SnrpnRIgmyc
region 2
SnrpnRIgmyc A-2 ATTGGTTGTATTAATAGAGTTATAG
SnrpnRIgmyc B-2 TTTGGATAATAGAGTGTTTATTTAG
SnrpnRIgmyc C-2 TATCTTCACCTAAAAACCCTCCAC
SnrpnRIgmyc D-2 ATACTCTAAATAACCTAAAAAATCC
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Table 5. Bisulfite genomic sequencing PCR primers for IAP element LTRs
A and D primers were used for primary reactions and B and C primers were used for secondary
reactions. Bisulfite genomic sequencing of IAP 30, IAP 31, IAP 32, IAP 33, IAP 36, IAP 37,
IAP 39, and IAP 40 were done using A and B primers specific to each IAP and common IAP C
and IAP D primers.
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IAP Element                      Primer name                                  Sequence
IAP 23
IAP 23 A TTAGTGTGTGGGTAGATGTTTG
IAP 23 B ATGTAAAAAAGTTTGATTAGAGG
IAP 23 C TCCCTCTCCAATATTTTAATAAC
IAP 23 D CATTTCTCAAATAATATCTTTAC
IAP 7
IAP 7 A GTTTGTTTTATGGGAATTTTTATTA
IAP 7 B GTAGTTTTGGTTTTGGAATGAGG
IAP 7 C TACCTAACCTTATAATCACATAAT
IAP 7 D AATACTACAATATCCAATACATAC
IAP 29
IAP 29 A TTTTTAAGGGTTTGTTATTTTTTTG
IAP 29 B AAGGGTTAATTTTTTGTTTTGTTTA
IAP 29 C CAAAAATTAATAACACAATAACAAC
IAP 29 D AAAAATATACCAAACCTCAAACC
IAP 35
IAP 35 A GAGTTTTGGGTTATAATATAATGG
IAP 35 B TAATTATTAGGTTGAAATGTG
IAP 35 C TTTACAACTTCTTACCATTTAAAC
IAP 35 D CCTCTTCTCTAAAAAACCTATC
Common
IAP C AACCAAAAAAAACACAACAACCCommon primers
used with primers
below IAP D CAATTAAATCCTTCTCAACAATC
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IAP Element                      Primer name                                  Sequence
IAP 30
IAP 30 A TGTGGGAGGGTTTAGTTTATTG
IAP 30 B GGGAGATGTTATTTTTTGGAGAG
IAP 31
IAP 31 A GAGGGTATAGGGAATTTTTAGG
IAP 31 B TAGTATTTGAAATGTAAATAAAG
IAP 32
IAP 32 A TAATATGGAGGTTAGGAAATTGG
IAP 32 B TGAATTATGGAGGGGATGATAAG
IAP 33
IAP 33 A GTAAGAGGAGATAGAGGAAGAG
IAP 33 B TGGAATAAGATGTAGTAGAATTG
 IAP 36
IAP 36 A GTTTATTGGATAGGTAGTTGTTG
IAP 36 B ATTAAGTGTAAATAGAAAGATTTG
IAP 37
IAP 37 A TTTTTGTGAAGAATGGTTAATTG
IAP 37 B AAAATGAGGAAGAGTTGTGTG
 IAP 39
IAP 39 A TGTAATAAAGGTTGTTGAGAAG
IAP 39 B TTTATTTTTTAAATTGAAATTTAGG
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2.9. DNA sequence analysis
All DNA sequencing was performed on the ABI 3700 DNA Analyzer or the ABI 3100
DNA Analyzer (Applied Biosystems, Foster City, CA).  Sequences were viewed using Edit View
v1.0.1 software (Applied Biosystems, Foster City, CA).  All subsequent DNA sequence analysis
was performed using MacVector 6.5 software (Oxford Molecular, Atlanta, GA).  Pustell DNA
matrix comparison was used to find repeat sequences (window size of 20, minimum score 65%).
AssemblyLIGN Software was used for DNA sequence alignments (Oxford Molecular, Atlanta,
GA).
2.10. Sequencing of CGG repeat tracts
PCR products for sequencing were purified away from primers with the Qiaquick PCR
purification kit (Qiagen, Valencia, CA).  Template PCR products were denatured for 5 minutes
with NaOH at a final concentration of 180 mM NaOH and 9 mM EDTA.  Denatured DNA was
precipitated with 40 mg mussel glycogen as a carrier and washed with 95% ethanol.  Sequencing
reactions were performed using the Sequenase 7-deaza-dGTP Sequencing Kit (USB, Cleveland,
OH).  Reactions were run on a 6% denaturing acrylamide gel in 1X TBE (890 mM Tris base,
20 mM EDTA, 890 mM boric acid).
 2.11. Blastocyst lambda library preparation
The IAP library screen was performed using FVB/N blastocyst DNA collected from 30 to
60 blastocysts by proteinase K digestion.  DNA was digested with HpaII, ligated to adaptor
oligos containing EcoRI sites, and PCR amplified with an adaptor specific primer and an IAP
LTR specific primer containing an XhoI site. PCR products were digested with EcoRI and XhoI
and ligated into a predigested ZAP Express vector (Stratagene, La Jolla, CA).  Ligation reactions
were packaged and plated, and screened as described (Stratagene, La Jolla, CA, Gigapack III
Gold Packaging Extract).
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Chapter 3: Identification of sequences required to create a differentially methylated
domain
3.1. Introduction
3.1.1. Mouse model transgenes for the study of genomic imprinting
As outlined previously, targeted deletion studies in the mouse have clearly illustrated that
DMD sequences are required to establish imprinted gene expression.  From these studies it is
apparent that transcription regulatory sequences are included within the DMD, and that
methylation of these sequences on one allele is critical for imprinted expression.  However, it is
not easy to use deletion analysis to closely define what sequences are required to direct parent-
specific methylation in the gamete, and maintain that methylation during development.  Large
deletions eliminate the target of the methylation, and a fine scale analysis is not easily
accomplished by targeted mutagenesis.  Because of these limitations, mouse transgenes have
been utilized to determine the minimal sequence elements needed to generate an imprint.
Many transgenes have been created that contain sequences from either the Igf2r locus or
the H19 locus.  Small transgenes composed of the H19 DMD and 4 kb of genomic flanking
sequence were not capable of creating an imprint (Cranston et al. 2001).  H19 transgenes
containing 14 kb to 16 kb of genomic sequence, including the DMD, were not consistently
imprinted, suggesting that they contained some, but not all of the required imprinting elements
(Cranston et al. 2001; Elson and Bartolomei 1997).  Only large transgenes comprised of 150 kb
of genomic sequence surrounding the H19 DMD were consistently imprinted (Ainscough et al.
1997). Similar results were obtained from transgenes containing the Igf2r DMD.  The Igf2r
DMD alone was not imprinted (Wutz et al. 1997).  However, a 130 kb transgene containing the
DMD was imprinted.  Imprinting of this transgene was abolished when the DMD was removed
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(Wutz et al. 1997). These data suggest that the cis-acting sequences required to imprint a
transgene are spread over a large distance at the genomic locus.   Thus, while transgene studies
have confirmed that the DMD is essential for establishing an imprint, the inability to generate
small, consistently imprinted transgenes makes these analyses difficult to interpret.
While transgene studies using endogenous gene sequences have been challenging and
often hard to interpret, a number of experiments using transgene model systems have contributed
valuable information to the field of imprinting.  Work over the last 15 years using the RSVIgmyc
transgene has provided information critical to our understanding of the epigenetic regulation of
genomic imprinting.  RSVIgmyc was one of the first genes identified that exhibited the
characteristics of an imprinted locus (Swain et al. 1987). RSVIgmyc expresses the c-myc gene
exclusively from the paternal allele.  Correspondingly, RSVIgmyc is always highly methylated
when inherited through the maternal germ line, and always undermethylated when inherited
through the paternal germ line (Chaillet et al. 1995).  Parent-specific expression and methylation
of the transgene are observed at all sights of integration (Chaillet et al. 1995).  The consistent
imprinting of the transgene illustrates that its imprinting is controlled by sequence elements
contained within the transgene itself, and does not rely on flanking genomic sequence.  In
essence, the transgene is a portable imprinted locus.
The above data suggest that removal of specific sequence elements from the transgene
would abolish imprinting.  However, the results obtained from transgenic lines carrying deletion
constructs did not provide a clear answer (Figure 11B) (Chaillet et al. 1995).  Transgenes
identical to RSVIgmyc, but lacking the pBR322 sequences, were still maternally methylated and
paternally expressed (construct C).  Similarly, transgenes carrying a deletion of the RSV LTR
sequences showed maternal specific methylation (construct B).  The RSV LTR contains
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necessary enhancer sequences and transgenes lacking these sequences were not expressed.
Deletion of the Ca region alone also had no effect on transgene methylation; maternal alleles
were highly methylated and paternal alleles were undermethylated (construct D).  Likewise,
deletion of c-myc and Sa together did not have an effect on transgene methylation (construct F)
(removal of the Sa region eliminates a cryptic promoter and completely eliminates transgene
expression).  Only when a 206 base pair region at the junction of the Ca and Sa regions was
removed from a minimal, imprinted transgene construct was an effect on transgene imprinting
seen (construct H compared to construct F).  Equivalent, high levels of methylation were found
on both alleles of this transgene.  Smaller transgene constructs, also eliminating this sequence,
were not imprinted (constructs I and J).
The above series of experiments would suggest that the 206 base pair region is essential
for establishing an imprint.  However, a transgene containing this 206 bp sequence and its
immediate surrounding sequence, fused to a LacZ reporter construct, was not imprinted
(construct K). Moreover, the Ig locus itself is not differentially methylated or expressed.  The
local environment of the 206 base pair sequence must also affect differential transgene
methylation.  In summary, it seems that the unique combination of sequences within the
RSVIgmyc transgene is required to establish an imprint, and not one easily definable element.
3.1.2. Aims of these studies
Little is known about what attracts methylation to DMD sequences in just one germ line,
or how this parent specific methylation is maintained.  It is assumed that the differential
methylation present at imprinted gene DMDs in the germ line is maintained at all stages of
development; however, imprinted gene methylation has not been analyzed at all stages of
development, for any individual imprinted gene. We would therefore like to develop a model
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system to identify sequences in a DMD that are required to establish and maintain parent-specific
methylation.  We would also like to determine if the methylation on these sequences is
maintained during each stage of preimplantation development.  In order to attain these goals we
have used the RSVIgmyc imprinted mouse transgene as a basis to develop a model system.
The first goal of this set of experiments was to define the differentially methylated
domain of RSVIgmyc (Reinhart et al. 2002). This was done by comparing the methylation of
CpG dinucleotides within different regions of the transgene after either maternal or paternal
inheritance.  The requirement of this DMD for transgene imprinting was demonstrated by
Mariam Eljanne.  The non-imprinted transgene (lacking the DMD) was then used to identify
sequences within endogenous imprinted gene DMDs that are required to establish a differentially
methylated domain.  Lastly, this transgene system was used to analyze the methylation of
imprinted gene DMD sequences during preimplantation development.
3.2. Identification of the RSVIgmyc transgene DMD
Methylation of the transgene has previously been characterized by Southern blot analysis
using a variety of probes and methylation sensitive restriction endonucleases.  Methylation
sensitive restriction endonucleases are unable to cleave methylated DNA, but are able to cleave
unmethylated DNA.  In this way, the methylation of specific CpG sites can be assessed.
Southern blot analysis was performed using the methylation sensitive restriction endonuclease
HpaII (recognition site CCGG) to compare the methylation of the maternal and paternal
transgene alleles.  DNAs were collected from hemizygous carriers of the transgene after maternal
or paternal inheritance, digested with HpaII and hybridized with a probe to the Ca region of the
transgene (Chaillet et al. 1995).  The RSVIgmyc transgene has a high level of methylation after
maternal inheritance. A high level of methylation is indicated by an intense, high molecular
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weight band of uncut DNA.  In contrast, the transgene has a low level of methylation after
paternal inheritance, indicated by a pattern of low molecular weight bands.
One key feature of many known endogenous imprinted genes, and the RSVIgmyc
transgene, is their ability to establish and maintain maternal-specific methylation throughout
development.   In order to determine if the RSVIgmyc transgene contains a region homologous to
an endogenous imprinted gene DMD, the methylation at various regions of the transgene was
examined by Southern blot analysis.  DNA samples were cleaved with methylation insensitive
restriction endonucleases to target specific regions of the transgene and methylation sensitive
restriction endonucleases to analyze CpG methylation.  Southern blots were hybridized with
DNA probes corresponding to the region of interest.
Southern blot analyses were performed on the RSVIgmyc DNA samples described above.
The pBR322 and RSV sequences of the transgene comprise a 2.5 kb region (pBR/RSV) that is
flanked by EcoRI sites (Figure 12A).  To examine the methylation in the pBR/RSV region of the
transgene, DNAs were first digested with EcoRI, and then digested with the methylation
sensitive enzymes HpaII, HhaI, or BstUI (recognition sequences CCGG, GCGC, and CGCG,
respectively) (Figure 12B) (Reinhart et al. 2002).  Resulting DNAs were hybridized with the
RSV probe.  Following maternal inheritance of RSVIgmyc the pBR322/RSV sequences were
methylated at each CpG site tested.  In contrast, the same region of the transgene was
unmethylated following paternal inheritance.  These data clearly illustrate that the pBR/RSV
region of the transgene is differentially methylated.
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Figure 12. The DMD of RSVIgmyc
A, Schematic of the RSVIgmyc transgene linearized at the unique KpnI restriction site. The myc
designates exons 1, 2, and 3 of the c-myc endogenous locus and  the 3' noncoding genomic
sequence of c-myc.  pBR/RSV refers to pBR322 vector sequences and RSV long terminal repeat
sequences.   Ig  indicates  coding sequences and  switch recombination sequences of Ig.  EcoRI
(E), BglII (B), XbaI (X).  B, Southern blot of DNA samples from maternal (M) and paternal (P)
hemizygous carriers hybridized with the RSV probe.  DNA samples were digested with EcoRI to
isolate the pBR/RSV region, followed by digestion with either HpaII, HhaI, BstUI, or MspI. The
2.5 kb EcoRI fragment is enlarged below and MspI, HhaI, and BstUI methylation-sensitive
restriction sites are shown as vertical lines of different sizes.  C, Southern blot of DNA samples
from maternal (M) and paternal (P) hemizygous carriers hybridized with the Ca probe. DNAs
were digested with EcoRI and BglII to isolate the IgA region immediately adjacent to the
pBR/RSV region, followed by digestion with either HpaII, HhaI, BstUI, or MspI.  The 3.3 kb
EcoRI/BglII transgene fragment is enlarged below and MspI, HhaI, and BstUI methylation-
sensitive restriction sites are shown as vertical lines of different sizes.  The Ca probe recognizes
a 3.3 kb transgene fragment and an 8 kb endogenous band.  All DNA samples were obtained
from tail biopsies performed at the time of weaning (3 to 4 weeks). Figure legend adapted from
Reinhart et al. (2002).
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The Ig region of the transgene is immediately adjacent to the pBR/RSV region, and
includes the Ca and Sa regions from the Ig locus (Figure 12A). The methylation within this
region was examined using the same DNA samples and methylation sensitive restriction
endonucleases described above(Reinhart et al. 2002).  A 3.3 kb region was isolated using the
EcoRI site adjacent to Ca and the BglII site within Sa.  DNAs were then digested with the
methylation sensitive enzymes HpaII, HhaI, or BstUI and hybridized with the Ca probe (Figure
12C).  After both maternal and paternal inheritance of the RSVIgmyc transgene, the predominant
band seen on the Southern blot was the uncut, 3.3 kb band.  Only minor differences in
methylation were observed at HpaII and HhaI sites, indicated by the appearance of faint, low
molecular weight bands only after paternal inheritance. These data illustrate that the Ig region of
the transgene is not differentially methylated.  It was previously shown that the CpG island
located in intron 1 of c-myc is not differentially methylated (Howell et al. 1998).
The above data demonstrate that the pBR/RSV region of the RSVIgmyc transgene is its
differentially methylated domain.  Only the pBR/RSV sequences within the transgene are
differentially methylated.  The sequences surrounding pBR/RSV have equivalent levels of
methylation on both parental alleles.  The presence of a well-defined DMD within the transgene
locus is similar to what is seen at an endogenous imprinted locus.
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Figure 13. Requirement of the RSVIgmyc DMD for transgene imprinting
A, Schematic of transgenes derived from the RSVIgmyc sequence.  Black lines indicate the
probes used in the Southern blots below.  Ig/myc retains all of the RSVIgmyc transgene sequence,
except the pBR/RSV region between the two EcoRI (E) sites.  pBR/RSV is composed entirely of
the sequence delineated by the two EcoRI sites.  B, Southern blots of DNAs from maternal (M)
or paternal (P) hemizygous carriers of the Ig/myc transgene digested with either HpaII, HhaI,
BstUI, or MspI and hybridized with the Ca probe.  C, The Southern blot was performed as
described above and hybridized with a probe to the RSV region of the transgene. All DNA
samples were obtained from tail biopsies performed at the time of weaning (3 to 4 weeks).
Figure legend adapted from Reinhart et al. (2002).
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Table 6. Summary of pBR/RSV and Ig/myc transgenes
Two additional non-imprinted pBR/RSV lines were previously analyzed (Chaillet et al. 1995).
The number of transgene copies per diploid genome was estimated by comparing the intensity of
the transgene hybridization band to the intensity of the hybridization band from the endogenous
Immunoglobulin heavy chain locus on a Southern blot hybridized with the Ca probe.  Transgene
methylation was determined by comparison of the methylation patterns of maternal and paternal
alleles from Southern blots.  Results are described as a difference or equivalence between
maternal and paternal methylation.
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MethylationNumber of transgene copies
Transgenic 
Line
pBR/RSV C Maternal = Paternal10
pBR/RSV A 10 Maternal = Paternal
Ig/myc D 15 Maternal = Paternal
Ig/myc C 10 Maternal = Paternal
Ig/myc B 10 Maternal = Paternal
Ig/myc A 12 Maternal = Paternal
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3.3. Deletion of the RSVIgmyc DMD abolishes imprinting
At many endogenous imprinted loci deletion of the DMD abolished imprinting
(Thorvaldsen et al. 1997; Zwart et al. 2001; Fitzpatrick et al. 2002). Also, for several endogenous
imprinted genes the DMD alone, when used as a transgene, was not imprinted (Wutz et al. 1997;
Cranston et al. 2001).  As described above, transgenes that lacked the pBR322 sequences were
maternally methylated and paternally undermethylated.  Similarly, transgenes that lacked the
RSV LTR sequences were maternally methylated and paternally undermethylated (Chaillet et al.
1995). Thus, neither the RSV LTR sequence alone, nor the pBR322 sequence alone were
required for transgene imprinting.  However, we have now established that both regions are
included within the transgene's DMD.  To determine if the entire DMD is required to generate an
imprint, the pBR/RSV region of the transgene was removed using flanking EcoRI restriction
sites.  This generated two DNA fragments, pBR/RSV and Ig/myc, that were used as transgene
constructs for the following analysis (Figure 13A).  These experiments were performed by
Mariam Eljanne.
The Ig/myc transgene was tested for its ability to create an imprinted locus. Four
independent transgenic lines were generated and the methylation on maternal and paternal
Ig/myc alleles was compared by Southern blot analysis.  DNAs from hemizygous carriers of the
Ig/myc transgene were digested with HpaII, HhaI, or BstUI and hybridized with the Ca, probe
(Reinhart et al. 2002) (Figure 13A).  Equivalent levels of methylation were present on both
parental alleles of the transgene (Figure 13B).  The same result was observed in four independent
transgenic lines (Table 6).  Therefore, the DMD of RSVIgmyc is required for imprinting.
The ability of the pBR/RSV region of the transgene to create an imprint was addressed by
a previous RSVIgmyc deletion construct (Chaillet et al. 1995, and Figure 11, construct J).  The
pBR/RSV transgene was not imprinted in two transgenic lines.  Maternal and paternal transgene
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alleles showed equivalent levels of methylation.  These results were confirmed by two additional
transgenic lines (Reinhart et al. 2002) (Figure 13C and Table 6).  The maternal and paternal
transgene alleles of the pBR/RSV transgene were compared by Southern blot analysis.  A high
molecular weight band was observed for both the maternal and paternal transgene alleles.  Thus,
the pBR/RSV transgene was not differentially methylated.
The above data demonstrate that the pBR/RSV sequences comprise the DMD of the
RSVIgmyc transgene. The pBR/RSV DMD sequences are required for RSVIgmyc imprinting.
Removal of these sequences leads to a loss of differential methylation.  However, the DMD is
not sufficient to generate an imprinted locus alone.  The pBR/RSV transgene alone is not
imprinted.  Therefore, the combination of the Ig/myc and pBR/RSV sequences is necessary to
establish an imprint.
3.4. Use of the RSVIgmyc transgene as a model to assess DMD sequence function
The DMD of a typical imprinted gene includes a small, well-defined region of the gene.
Removal of an imprinted gene’s DMD leads to a loss of imprinting.  Furthermore, DMDs alone
are not able to generate an imprinted transgene locus.  These similarities suggest that all DMDs
share a common, essential imprinting function.  Assuming that all maternally methylated DMDs
share a common function, it is reasonable to propose that this function is interchangeable.  The
RSVIgmyc transgene was used as a model system to test this hypothesis.
As described above, EcoRI sites delineate the DMD of the RSVIgmyc transgene.
Removal of the DMD (Ig/myc transgene) leads to a loss of imprinting.  The assumption that all
DMDs share a common function was tested by replacing the RSVIgmyc DMD with sequences
from other endogenous imprinted gene DMDs.  If DMDs do share a common function,
exchanging DMD sequences should restore Ig/myc imprinting.  Hybrid transgenes were
constructed by first removing the pBR/RSV region of RSVIgmyc with the flanking EcoRI
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restriction sites.  Specific imprinted gene sequences were PCR amplified from genomic DNA
with PCR primers designed to introduce flanking EcoRI sites.  Resulting EcoRI fragments were
introduced into the unique EcoRI site of the Ig/myc transgene.  Hybrid transgene constructs were
used to generate transgenic mice.  The ability of a transgene to generate an imprint was evaluated
by the presence of parent-specific methylation.  Expression from the transgene was eliminated by
removal of the RSV sequence and could not be assessed.
Sequences from the Igf2r, Snrpn, and H19 imprinted gene DMDs, as well as the long
terminal repeat (LTR) region of an IAP element, were used to replace the DMD of RSVIgmyc
(Figure 14).  All hybrid transgenes were analyzed for parent-specific methylation by Southern
blot analysis (Reinhart et al. 2002).  Tail DNAs from hemizygous carriers of a maternally or
paternally inherited transgene were collected at the time of weaning (3-4 weeks).  DNAs were
digested with the methylation sensitive restriction endonuclease HpaII, and Southern blots were
hybridized with the Ca probe.  A high level of methylation was detected as a high molecular
weight, uncut band on a Southern blot.  A low level of methylation appeared as a series of low
molecular weight HpaII restriction fragments.
3.4.1. Igf2r DMD sequences functionally replace the RSVIgmyc DMD
The Igf2r gene is located within an imprinted gene cluster on chromosome 17 (Figure 6).
A maternally methylated DMD is located within the second intron of Igf2r (DMD2).  The DMD
is approximately 3 kb in size, and contains the promoter for a paternally expressed, untranslated
RNA (Air) (Figure 14).  The sequence chosen for this analysis is 667 bp in size and includes
tandem repeats located downstream of the Air promoter (Figure 15A).  The sequence was
subcloned into the Ig/myc transgene to generate the Igf2rIgmyc transgene.  By Southern blot
analysis all maternally inherited Igf2rIgmyc transgene alleles were highly methylated, and all
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paternally inherited alleles were undermethylated (Reinhart et al. 2002) (Figure 15B).  The same
result was observed in three independent transgenic lines (Table 7).  This pattern of methylation
is similar to what is seen with the RSVIgmyc transgene.  Therefore, the hybrid Igf2rIgmyc
transgene is imprinted.
The Igf2rIgmyc transgenic lines were generated in an inbred FVB/N genetic background.
The imprinted characteristics of the RSVIgmyc transgene were consistent when maintained in this
background.  However, imprinting of the RSVIgmyc transgene was affected by differences in
mouse strain background.  When the RSVIgmyc transgene was crossed into the C57BL/6J genetic
background paternal alleles acquired a high level of methylation, similar to that seen on the
maternal allele (Chaillet et al. 1995).  Endogenous imprinted gene methylation and expression
are typically not affected by alterations in strain background.
The Igf2rIgmyc transgene showed characteristic differential methylation in an inbred
FVB/N background.  The Igf2rIgmyc transgene was also analyzed in an inbred C57BL/6J genetic
background.  Mice hemizygous for the Igf2rIgmyc transgene locus were back-crossed for three
generations to inbred C57BL/6J mice (Taconic, Germantown, NY).  The methylation of the
transgene after maternal and paternal inheritance was compared by Southern blot analysis (data
not shown, Reinhart et al. 2002).  Unlike the original RSVIgmyc transgene, the Igf2rIgmyc
transgene maintained its imprinting in the C57BL/6J genetic background.  Maternal alleles
contained a high level of methylation and paternal alleles contained a low level of methylation.
These data demonstrate that Igf2rIgmyc imprinting is not affected by genetic background.
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Figure 14. Design of hybrid transgenes
A, Simplified schematic of the RSVIgmyc transgene described in Figure 12A.  The black
rectangle represents the DMD of RSVIgmyc (pBR/RSV) flanked by EcoRI sites (E).  B,
Schematics of the Igf2r, H19, and Snrpn imprinted loci, and the Aiapy IAP element insertion at the
agouti locus (drawings not to scale).  Black boxes represent the DMDs of each locus (or the IAP
LTR), and arrows indicate transcription start sites. White portions of each DMD represent the
sequences used to create hybrid transgene constructs. C,  Schematic of the hybrid transgene
constructs created by replacement of the pBR/RSV region of the RSVIgmyc transgene with the
shaded portions of the DMDs illustrated in panel B.  The following sequences were used:  H19,
U19619 nt 1434-1726; Igf2r, L06446 nt 741-1408; Snrpn, AF130843 nt 3237-3745; IAP
reference Michaud et al. 1994 figure 2).
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Figure 15. Restoration of transgene imprinting
A, Schematic of the Igf2r DMD used to generate the Igf2rIgmyc, TR2+3Igmyc and TR1Igmyc
transgenes.  Data for the Igf2rIgmyc and TR2+3Igmyc transgenes are shown. The Igf2r DMD
sequence is shown by a white rectangle.  Transcription start site for the untranslated Air RNA is
shown as a bent arrow.  Arrows within the DMD represent tandem repeats described in Neumann
et al. (1995); arrowheads (TR1 repeats), long arrows (TR2+3 repeats), short arrows (TR2+4
repeats).  Asterisks mark the location of HpaII sites. Thick black lines below the DMD indicate
sequences used to generate each transgene.  Names of each transgene construct are shown to the
right.  B, Southern blot analysis of the Igf2rIgmyc and TR2+3Igmyc transgenic lines.  DNAs
from maternal (M) or paternal (P) hemizygous transgenic carriers were digested with the
methylation sensitive enzyme HpaII.  DNAs were probed with the Ca probe. All DNAs were
obtained from tail biopsies at the time of weaning (3 to 4 weeks).  DNA sizes shown in kilobases
(kb).
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The Igf2r DMD contains three sets of tandem repeats classified as TR1, TR2+3, and
TR2+4 (Neumann et al 1995).  The Igf2r sequence within the Igf2rIgmyc transgene includes
three unit copies of the 30 bp TR1 repeat and two and a half unit copies of the 175 bp TR2+3
repeat (Figure 15A).  To determine if either set of tandem repeats alone could restore imprinting
to the Ig/myc transgene they were independently PCR amplified and introduced into the Ig/myc
transgene (Reinhart et al. 2002).  The TR2+3Igmyc transgene contains approximately 2.5 unit
copies of the TR2+3 repeat.  The TR2+3Igmyc transgene was used to generate one transgenic
line.  Southern blot analysis showed that maternal alleles of the TR2+3Igmyc transgene were
methylated, and paternal alleles were undermethylated (Figure 15B).  The TR1Igmyc transgene
contains three unit copies of the TR1 repeat.  The TR1Igmyc transgene was used to generate one
transgenic line.  Southern blot analysis showed that both parental alleles of this transgene
acquired an equivalent level of methylation (data not shown).  Therefore the TR2+3 repeats, but
not the TR1 repeats, are able to restore imprinting to the Ig/myc transgene.
The ability of Igf2r DMD sequences to functionally replace the DMD of the RSVIgmyc
transgene suggests that maternally methylated DMD sequences share a common imprinting
function. Furthermore, the imprinting of the hybrid TR2+3Igmyc transgene illustrates the
capability of the hybrid transgene model system to evaluate the function of specific DMD
sequences.  The Igf2rIgmyc transgene also maintains its imprinting in the C56BL/6 genetic
background.  These data indicate that hybrid transgenes, composed entirely of mouse genomic
sequences, are a good model for an endogenous imprinted gene.
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3.4.2. Not all DMD sequences are able to functionally replace the RSVIgmyc DMD
The H19 gene is paternally methylated and maternally expressed.  The DMD required for
H19 imprinting is 2 kb in size and is located 2 kb upstream of the H19 transcription start site
(Figure 14).  A 292 bp region from the 5’ end of the H19 DMD was introduced into the Ig/myc
transgene.  This sequence is consistently differentially methylated in the gametes, in blastocysts,
and in adult tissues (Tremblay et al. 1997; Lucifero et al. 2002).  The resulting H19SIgmyc
transgene was tested for its ability to generate an imprint (Reinhart et al. 2002).  The methylation
on the maternal and paternal H19SIgmyc transgene alleles was compared by Southern blot.  Both
the maternal and paternal transgene alleles acquired an equivalent pattern of methylation (Figure
16).  The same result was obtained from two independent transgenic lines (Table 7).  These data
demonstrate that this H19 DMD sequence was not able to restore Ig/myc imprinting.
The Snrpn gene is located in an imprinted gene cluster on chromosome 7 (Figure 6).  The
maternally methylated DMD of the Snrpn gene is 6 kb in size and includes the promoter, first
exon, and first intron of the Snrpn gene (Figure 14).  A 508 bp region that includes the promoter
and first exon of the Snrpn gene was introduced into the Ig/myc transgene (SnrpnIgmyc
transgene).  This region is consistently differentially methylated in gametes and in adult tissues
(Lucifero et al. 2002;  Shemer et al. 1997).  Southern blot analysis showed that the maternal and
paternal alleles of the SnrpnIgmyc transgene contained equivalent, low levels of methylation
(Figure 16) (Reinhart et al. 2002).  The same result was observed in two independent transgenic
lines (Table 7).  Therefore, the Snrpn promoter region is unable to restore imprinting to the
Ig/myc transgene.
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Figure 16. Non-imprinted hybrid transgenes
Southern blot analysis of the H19SIgmyc and SnrpnIgmyc transgenic lines.  DNAs from maternal
(M) or paternal (P) hemizygous transgenic carriers were digested with the methylation sensitive
enzyme HpaII and probed with the Ca probe.  All DNAs were obtained from tail biopsies at the
time of weaning (3 to 4 weeks).  DNA sizes shown in kilobases (kb).
109
12
2.7
1.6
0.7
kb
12
2.7
1.6
0.7
kb
H19SIgmyc SnrpnIgmyc
M M PP
110
Table 7. Summary of hybrid transgenes
The number of transgene copies per diploid genome was estimated by comparing the intensity of
the transgene hybridization band to the intensity of the hybridization band from the endogenous
Immunoglobulin heavy chain locus on a Southern blot hybridized with the Ca probe.  Transgene
methylation was determined by comparison of the methylation patterns of maternal and paternal
alleles from Southern blots.  Results are described as a difference or equivalence between
maternal and paternal methylation.
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MethylationNumber of transgene copies
Transgenic 
Line
Igf2rIgmyc A Maternal > Paternal5
Igf2rIgmyc B Maternal > Paternal3
Igf2rIgmyc C Maternal > Paternal10
TR2+3Igmyc Maternal > Paternal20
TR1Igmyc Maternal = Paternal10
H19SIgmyc B 10 Maternal = Paternal
H19SIgmyc A 10 Maternal = Paternal
SnrpnIgmyc A 20 Maternal = Paternal
SnrpnIgmyc B 10 Maternal = Paternal
IAPIgmyc F 10 Maternal = Paternal
IAPIgmyc E 15 Maternal = Paternal
IAPIgmyc D 15 Maternal = Paternal
IAPIgmyc A 3 Maternal = Paternal
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IAP element LTRs are highly methylated on both parental alleles during early
development and in somatic tissues.  The establishment and maintenance of methylation at IAP
LTRs is similar to that of an imprinted gene DMD.  A hybrid transgene was generated using the
5’ LTR sequence from the agouti Aiapy allele (Figure 14 and Michaud et al. 1994, figure 2B).
The entire 5’ LTR sequence was introduced into the Ig/myc transgene to generate the IAPIgmyc
transgene (Reinhart et al. 2002).  The IAPIgmyc transgene was not imprinted; both parental
alleles acquired an identical pattern of methylation, as demonstrated by Southern blot analysis
(data not shown).  The same result was obtained for four transgenic lines tested (Table 7).
Therefore, the IAP element LTR was also not able to restore differential methylation to the
Ig/myc transgene.
A 292 bp region of the H19 DMD was not able to establish differential methylation in the
H19SIgmyc transgene.  This could be due to an inability of the small sequence alone to create an
imprint.  Alternatively, the negative result could indicate that the maternal and paternal germ
lines employ different mechanisms to target imprinted genes for methylation.  The H19 gene and
the RSVIgmyc transgene are normally methylated in opposite germ lines.
Similar to RSVIgmyc and Igf2r, the Snrpn gene is maternally methylated.  However, the
Snrpn promoter sequences in the SnrpnIgmyc transgene were not able to establish a maternal
imprint.  This could have resulted because the Snrpn DMD is 6 kb in size and the 508 bp region
analyzed was not sufficient to generate an imprint.  A larger sequence, or a different sequence
may be required.  The ability of the Igf2r TR2+3 repeat sequences, and not the TR1 repeat
sequences, to function as a DMD suggest that not all DMD sequences are equivalent.  Therefore,
we may be able to identify sequences within the Snrpn DMD that are required to create the
differential methylation mark.
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3.5. The Igf2rIgmyc hybrid transgene as a model to study genomic imprinting
The Igf2rIgmyc transgene closely models many features of endogenous imprinted genes.
It is strictly maternally methylated at all sites of integration, and it contains DMD sequences that
are required for maternal imprinting.  Maternal-specific methylation is seen in both the FVB/N
genetic background and the C57BL/6J genetic background.  The Igf2rIgmyc transgene is a
hemizygous locus, present in approximately 5 to10 copies per haploid mouse genome.  These
characteristics allow us to easily monitor its parent-specific methylation.  These characteristics
should also make Igf2rIgmyc an ideal model to study the effect of mutations on genomic
imprinting.  We tested this prediction by studying the effect of the Dnmt1D1o mutation on the
methylation of the transgene.
The Dnmt1o methyltransferase is synthesized in the oocyte and is specifically localized
in the nucleus of 8-cell stage embryos.  The Dnmt1D1o mutation causes loss of Dnmt1o
expression from the mutant allele (Howell et al. 2001).  Oocytes and preimplantation embryos
from homozygous Dnmt1D1o/D1o female mice contain no Dnmt1o protein. Embryos derived from
Dnmt1o-deficient oocytes typically die during the last third of gestation with variable phenotypes
and the occasional surviving mouse.  Heterozygous embryos generated from Dnmt1o-deficient
oocytes show a specific loss of methylation at imprinted loci.  Half of the normally methylated
alleles of imprinted genes completely lose methylation.  These data suggest that Dnmt1o is
essential for the maintenance of imprinted gene methylation during the 8-cell stage of
preimplantation development.
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Figure 17. Loss of Dnmt1o activity affects transgene imprinting
Dnmt1D1o females carrying the Igf2rIgmyc transgene in an FVB/N background (A) or wild-type
females carrying the Igf2rIgmyc transgene in an FVB/N background (B) were mated to FVB/N
males.  DNA was extracted from entire transgenic D10.5 embryos, digested with HpaII, and
Southern blots were performed using the Ca probe to the IgA region of the transgene.
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Although methylation of the Igf2r gene was not examined in heterozygous embryos, we
would predict that it would behave as all other imprinted genes tested.  To test the effect of loss
of Dnmt1o activity on Igf2rIgmyc transgene methylation, hemizygous carriers of the transgene in
the FVB/N genetic background were crossed to mice carrying the Dnmt1D1o mutation in the
FVB/N genetic background.  Dnmt1D1o/D1o female mice hemizygous for the transgene locus were
mated to Dnmt1+/+ male mice and embryos were collected at E10.5.  Control Dnmt1+/+ female
mice hemizygous for the transgene locus were mated to Dnmt1+/+ male mice and embryos were
collected at the same stage.
Methylation of the transgene was analyzed by Southern blot analysis (Reinhart et al.
2002).  Transgenic embryos derived from Dnmt1o-deficient oocytes were compared to wild type
transgenic embryos.  DNAs were extracted from entire embryos and digested with the
methylation sensitive enzyme HpaII.  Southern blots were hybridized the Ca probe.  Eight wild
type transgenic embryos were analyzed.  The majority of embryos showed a pattern of
methylation identical to that seen after maternal inheritance of the transgene in adult tail DNA
(Figure 17B).  One exceptional embryo showed a loss of methylation, yielding a methylation
pattern similar to that seen after paternal inheritance of the transgene.  Eight transgenic embryos
from Dnmt1o-deficient oocytes were analyzed (Figure 17A).  Four out of seven embryos showed
extensive methylation loss (2, 3, 5, 7).  The high molecular weight band indicative of a high level
of maternal methylation was completely lost.  The pattern of methylation seen was identical to
that seen after paternal inheritance of the transgene.  The remaining three embryos showed a
partial loss of methylation (1, 4, 6).  This appeared as a combination of the maternal and paternal
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patterns of methylation.  Thus, loss of Dnmt1o activity had a profound effect on transgene
methylation.
3.6. Analysis of DMD sequences from the paternally methylated H19 gene
The H19SIgmyc transgene was not imprinted.  This suggests that the 292 bp sequence
analyzed was not sufficient to establish an imprint, or that the H19 DMD cannot restore
imprinting to the transgene.  To distinguish between these possibilities, a transgene was
constructed that included 2.2 kb of sequence from the H19 locus.  The H19LIgmyc transgene
contains the entire H19 DMD in place of the RSVIgmyc DMD (Figure 18A). Three H19LIgmyc
transgenic lines were generated and the maternal and paternal methylation patterns were
compared via Southern blot analysis (Figure 18B).  The maternal and paternal H19LIgmyc alleles
contained equivalent levels of methylation.  Both parental alleles contained consistent, high
levels of methylation in each transgenic line.  Therefore, the H19 DMD cannot replace the DMD
of the RSVIgmyc transgene.
If sequences from the H19 DMD share a common function with those of the Igf2r DMD
they should be included within the sequences analyzed in the H19LIgmyc transgene.  Not
surprisingly, the presence of normally paternally methylated DMD sequences in the context of
the Ig/myc transgene was not able to restore maternal-specific methylation to the transgene.
These data suggest that the imprinting process is markedly different between the two germ lines.
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Figure 18. Paternally methylated DMD sequences do not restore transgene imprinting
A, Top, Schematic of the H19 locus.  The 2 kb paternally methylated DMD (black box) of the
H19 locus is located 2 kb upstream of the transcription start site (bent arrow).  Bottom, The
hybrid H19Igmyc transgene was generated by replacing the pBR/RSV region of the RSVIgmyc
transgene (described in 13A) with 2.2 kb of DNA sequence from the H19 gene, including the
entire DMD.  B, Southern blot of DNAs from hemizygous carriers of the H19Igmyc transgene.
DNAs were digested with HpaII and hybridized with the Ca probe. (M) Maternal inheritance of
the transgene; (P) Paternal inheritance of the transgene. DNA sizes shown in kilobases (kb).
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Figure 19. Maternally methylated DMD sequence comparison
Comparison of the DMDs located within the Snprn, Igf2r, and Kcnq1 genes.  The white
rectangles represent the entire DMD sequence (the entire Snrpn DMD is 6 kb in size).  The bent
arrows indicate transcription start sites. The Snrpn DMD contains the transcription start site for
the Snrpn gene and the shaded box represents the first exon of the Snrpn gene.  The Igf2r DMD
contains the transcription start site for the untranslated Air RNA, and the Kcnq1 DMD contains
the transcription start site for the Kcnq1ot1 untranslated RNA.  Gray areas depict CpG islands,
and arrows or arrowheads depict the location of tandem repeat sequences (the tandem repeats do
not share sequence similarity among the three DMDs).
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3.7. Design of hybrid transgenes containing maternally methylated DMD sequences
A shared function of DMD sequences would suggest that they share sequence similarity.
However, comparison of the DMDs from various imprinted genes has not revealed any
conserved sequences.  Moreover, while the methylation differences of the DMD are conserved in
the mouse and human there is little sequence conservation.  This would suggest that a simple
sequence element is not involved in targeting differential methylation to the region.  However,
certain imprinted genes do share several general characteristics.  The maternally methylated
DMDs located within the Snrpn, Kcnq1, and Igf2r imprinted genes are compared in Figure 19.
These common characteristics were compared to design new hybrid transgenes.
3.7.1. Comparison of endogenous gene DMDs
One similarity between all three regions is their involvement in the coordinate regulation
of imprinted gene expression in a large gene cluster (Figure 6).  Along with this feature, all three
DMDs have several sequence characteristics in common.  The DMDs of all three genes contain a
CpG island (Shemer et al. 1997; Stoger et al. 1993; Smilinich et al. 2001).  Unlike the majority
of CpGs islands, those in the DMD regions of imprinted genes are hypermethylated on one
parental allele and hypomethylated on the opposite allele.  Each DMD also contains the promoter
for an imprinted locus.  The Snrpn promoter is located within the Snrpn DMD, the promoter for
the Air untranslated RNA is located within the Igf2r DMD, and the promoter for the Kcnq1ot1
untranslated RNA is located within the Kcnq1 DMD (Shemer et al. 1997; Stoger et al. 1993;
Wutz et al. 1997; Smilinich et al. 2001).  Also, the DMDs of all three genes contain tandem
repeats (Neumann et al. 1995; Smilinich et al. 2001; Gabriel et al. 1998).  The repeats within
each DMD are imperfect repeats, and range in size from 20 to 175 base pairs.  They cover
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approximately 800 base pair of sequence, and are located within intron sequences of the Snrpn,
Igf2r, and Kcnq1 genes.
We have shown that the addition of promoter sequences from the Snrpn gene to Ig/myc
did not restore its imprinting.  The maternal and paternal alleles were equally methylated.  In
contrast, addition of tandem repeat sequences from the Igf2r DMD to Ig/myc restored its
imprinting, maternal alleles were methylated and paternal alleles were undermethylated.  These
findings suggest that tandem repeats are required to establish a maternal imprint.  Three
transgenes were generated to test the hypothesis that tandem repeats are required to establish
maternal-specific methylation.  The repeat region from the Snrpn DMD and the repeat region
from the Kcnq1 DMD were incorporated into the Ig/myc transgene.  Also, a single unit copy of
the Igf2r TR2+3 repeat was incorporated into the Ig/myc transgene.  If repeated sequences are a
requirement for maternal-specific methylation, the Snrpn and Kcnq1 sequences should restore
transgene imprinting and the single unit copy of the TR2+3 repeat should not.
3.7.2. Tandem repeats restore imprinting to the Ig/myc transgene
An SnrpnRIgmyc transgene was created that contains 933 bp of the Snrpn DMD
including the entire tandem repeat region and a small amount of flanking sequence (Figure 20A).
Three SnrpnRIgmyc transgenic lines were generated, and the allele-specific methylation patterns
of the transgene were compared by Southern blot analysis (Figure 20B).  Genomic DNAs from
hemizygous carriers of the transgene were digested with the methylation sensitive restriction
endonuclease HpaII and hybridized with the Ca probe (Figure 20C).  The SnrpnRIgmyc
transgene was imprinted in all three lines (Table 8).  Every maternal allele examined was highly
methylated, whereas every paternal allele examined was undermethylated.
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Two Kcnq1Igmyc transgene constructs were created that contain 945 bp of the Kcnq1
DMD, including the entire repeat region and a small amount of surrounding sequence (Figure
20A).  The two constructs contained the repeat region in different orientations with respect to the
Ig/myc sequences (Table 8).   One transgenic line was generated with the Kcnq1 sequence in one
orientation (Kcnq1Igmyc-1), and two transgenic lines were generated with the Kcnq1 sequence in
the opposite orientation (Kcnq1Igmyc-2 and Kcnq1Igmyc-3).  The methylation of the maternal
and paternal transgene alleles was compared by Southern blot (Figure 20B). The Kcnq1Igmyc
transgene was imprinted in each transgenic line tested (Figure 20C) (Table 8). The maternal
alleles were methylated and the paternal alleles were undermethylated.  However, in the
Kcnq1Igmyc-2 transgenic line approximately half of the maternal alleles were undermethylated.
This was not seen for either of the other transgenic lines.
The TR2+3SIgmyc transgene was created that contained one unit copy of the 175 base
pair TR2+3 repeat (Figure 21A).  The central repeat from the three TR2+3 repeats found at the
Igf2r locus was chosen for this analysis (Figure 21B).  Two transgenic lines were generated and
methylation of the transgene after maternal and paternal inheritance was measured by Southern
blot (Figure 21C).  The TR2+3SIgmyc transgene was not differentially methylated.  In each line
tested the maternal and paternal alleles acquired an equivalent level of methylation.  In one
transgenic line slight differences in transgene methylation are indicated by slight variation in the
intensity of bands after Southern blot analysis (line 1, Figure 21C).  This could indicate that the
TR2+3 single unit copy retains a minimal ability to create a maternal-specific methylation
pattern on the transgene.
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Figure 20. Tandem repeats restore transgene imprinting
A, Schematic of the DMDs from the Snrpn and Kcnq1 genes.  Imprinted gene promoters are
shown as arrows above the DMD and tandem repeats are shown as arrows within the DMD.
Rectangles below each DMD indicate sequences tested by incorporation into the Ig/myc
transgene.  The name of each hybrid transgene is indicated to the left (SnrpnRIgmyc, AF130843
nt 3796-4729; Kcnq1Igmyc, AF119385 nt 1974-2919).  Asterisks denote HpaII restriction sites.
B, Schematic of the Ig/myc transgene containing test DMD sequences (black box).  The thick
black line indicates the location of the Ca probe used for Southern blot analysis.  HpaII sites are
shown as vertical lines below the transgene.  C, Southern blot analysis of genomic tail DNAs
digested with the methylation sensitive restriction endonuclease HpaII and hybridized with the
Ca probe.  (M) hemizygous carriers of a maternally inherited transgene.  (P) hemizygous carriers
of a paternally inherited transgene. DNA sizes are indicated in kilobases (kb).
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Figure 21. One unit copy of the TR2+3 repeat is not able to restore transgene imprinting
A, Schematic of the TR2+3SIgmyc transgene.  The TR2+3 DMD sequence is shown as a black
box. The thick black line indicates the location of the Ca probe used for Southern blot analysis.
HpaII sites are shown as vertical lines below the transgene.  B, The white rectangle represents
the portion of the Igf2r DMD that was used to generate the Igf2rIgmyc transgene.  Arrowheads
represent the TR1 repeat and arrows indicate the TR2+3 repeats.  Asterisks show the location of
HpaII sites.  The thick black line below the DMD represents the TR2+3 sequence used to
generate the TR2+3SIgmyc transgene.  C, Southern blot analysis of the two TR2+3SIgmyc
transgenic lines.  Genomic tail DNAs were digested with the methylation sensitive restriction
endonuclease HpaII and hybridized with the Ca probe.  (M) hemizygous carriers of a maternally
inherited transgene.  (P) hemizygous carriers of a paternally inherited transgene.  DNA sizes are
indicated in kilobases (kb).
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Table 8. Characteristics of hybrid transgenes for analysis of tandem repeats
The number of transgene copies per diploid genome was estimated by comparing the intensity of
the transgene hybridization band to the intensity of the hybridization band from the endogenous
Immunoglobulin heavy chain locus on a Southern blot hybridized with the Ca probe. The
orientation of the transgene DMD with respect to the c-myc and Ig (Immunoglobulin) sequences
of the transgene is depicted with an arrow.  The arrow points in the same direction as the arrows
in figure 19.  Transgene methylation was determined by comparison of the methylation patterns
of maternal and paternal alleles from Southern blots.  Results are described as a difference or
equivalence between maternal and paternal methylation.
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Transgenic 
line
Number of 
transgene copies Orientation Methylation
SnrpnRIgmyc-3 Maternal > Paternal30 myc Ig
SnrpnRIgmyc-2 Maternal > Paternal4 myc Ig
SnrpnRIgmyc-1 Maternal > Paternal4 myc Ig
Kcnq1Igmyc-3 Maternal > Paternal15 myc Ig
Kcnq1Igmyc-2 Maternal > Paternal30 myc Ig
Kcnq1Igmyc-1 Maternal > Paternal15 myc Ig
TR2+3SIgmyc-1 Maternal = Paternal30 myc Ig
TR2+3SIgmyc-2 Maternal = Paternal20 myc Ig
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The above data demonstrate that the tandem repeat regions of the Snrpn and Kcnq1
imprinted gene DMDs are able to restore imprinting to the Ig/myc transgene.  This is similar to
the result seen with the Igf2r repeat region.  These data suggested that the ability of the DMD
sequences to restore imprinting to the transgene resides in their tandem repeats.  The previously
described Igf2rIgmyc transgene contained two sets of repeat sequences termed TR1 and TR2+3.
The TR2+3 repeats (TR2+3Igmyc) were able to restore imprinting to the Ig/myc transgene.  The
TR2+3Igmyc transgene contained two complete copies and one partial copy of an imprecise, 175
base pair, repeated sequence.  The above results show that one unit copy of the TR2+3 repeat is
not able to restore imprinting to the Ig/myc transgene.
3.8. Analysis of DMD methylation during development
The data presented in the previous section illustrate the ability to generate hybrid
transgenes, composed of endogenous mouse sequences, which are consistently differentially
methylated.  These transgenes should provide an excellent system to study the methylation of
specific DMD sequences during development.  Ultimately, we would like to use this system to
study the methylation of imprinted genes during preimplantation development.  Methylation
patterns on the DMDs of imprinted genes are thought to be maintained during preimplantation
development, a period when most genomic methylation is lost.  However, the maintenance of
methylation at each preimplantation stage has not been studied for any imprinted gene.  The
DMD of the SnrpnRIgmyc transgene is consistently imprinted in adult tissues from three
transgenic lines.  We would therefore expect it to be differentially methylated during
preimplantation development.
The above data were obtained by Southern blot analysis with a probe adjacent to the
endogenous DMD sequences.  A technique more sensitive than the Southern blot needs to be
132
employed to analyze transgene methylation in preimplantation stage embryos.  To examine the
methylation of DMD sequences in detail the bisulfite genomic sequencing method was
performed. The bisulfite genomic sequencing technique involves treating DNA with sodium
bisulfite, which deaminates cytosine to uracil at a defined rate (Figure 22A).  Unmethylated
cytosines convert more rapidly than methylated cytosines allowing methylated and unmethylated
CpGs to be distinguished.  PCR primers are designed to amplify the DNA sequence of interest.
The PCR products are subcloned and sequenced (Figure 22B).  Each sequenced clone contains
information about a single allele from the population of alleles within the DNA sample.
Bisulfite genomic sequencing has advantages over a Southern blot; it can be performed
on a smaller amount of DNA, and it adds the ability to examine each CpG within the region of
interest.  However, this technique also has a disadvantage when examining small amounts of
DNA.  Small amounts of DNA can lead to bias at the PCR amplification step, possibly leading to
the amplification of only one, or a few alleles.  This problem can be overcome by using
polymorphisms to distinguish the parental alleles of an endogenous gene, and by looking for a
large number of sequences containing a single pattern of methylated CpGs (discussed below).
The differential methylation of the RSVIgmyc transgene resided in the pBR322/RSV
sequences, defining them as its differentially methylated domain.  The ability of endogenous
DMD sequences to restore imprinting to Ig/myc suggests that they are also differentially
methylated.  The SnrpnRIgmyc transgene and the TR2+3SIgmyc transgene were chosen for
detailed methylation analysis.  The imprinted SnrpnRIgmyc transgene is expected to have a
maternal-specific methylation pattern, and the non-imprinted TR2+3SIgmyc transgene is
expected to have equivalent levels of methylation on each allele.
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Figure 22. The bisulfite genomic sequencing technique
A,  Chemical structures of cytosine and uracil.  Unmethylated cytosine is deaminated to form
uracil by treatment with sodium bisulfite (highlighted by red boxes).  B, Diagram of the steps
involved in the bisulfite genomic sequencing technique.  The DNA is shown as a thick black
line.  A methylated cytosine in a CpG dinucleotide is highlighted in red and an unmethylated
cytosine is highlighted in blue.  Sodium bisulfite treatment of DNA leads to the deamination of
unmethylated cytosine to form uracil.  Methylated cytosine is protected from deamination and
forms uracil at a much slower rate.  Treated DNA is amplified with PCR primers designed to the
DNA region of interest.  PCR primers are designed by converting all cytosines (C) to thymines
(T) on one strand and all guanines (G) to adenines (A) on the other strand.  PCR products are
subcloned and sequenced.  Unmethylated cytosines in the sequence are now thymines and
methylated cytosines remain cytosine.
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Figure 23. Snrpn DMD sequences are differentially methylated in the transgene
A, Schematic  of  the region of the  SnrpnRIgmyc  transgene analyzed by  bisulfite genomic
sequencing.  The Snrpn sequences are shown as a thin line and flanking Ig/myc transgene
sequences are shown as incomplete white boxes. CpG dinucleotides within the Snrpn sequence
are shown as filled circles.  The repeats within the Snrpn sequence are shown as thick arrows
(the same orientation as those described in figure 19).  Transgene alleles were PCR amplified
using two sets of primers (thin arrows).  Adult methylation patterns were analyzed using
genomic DNA from the spleen of a hemizygous carrier of a maternally (M) or paternally (P)
inherited SnrpnRIgmyc transgene. Each line indicates a sequenced PCR product.  Filled circles
represent methylated CpGs.  B, Bisulfite genomic sequencing analysis of the TR2+3SIgmyc
transgene was performed as described for the SnrpnRIgmyc transgene with one exception.  Only
one set of PCR primers was needed to span the entire TR2+3 sequence.
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3.8.1. The Snrpn DMD sequences function as SnrpnRIgmyc’s DMD
Methylation of the SnrpnRIgmyc and TR2+3Igmyc trangenes was analyzed in adult
tissues by the bisulfite genomic sequencing technique.  The Snprn sequence in the SnrpnRIgmyc
transgene was PCR amplified with two sets of primers that span the entire sequence (Figure
23A).  The TR2+3 sequence was PCR amplified from the TR2+3SIgmyc transgene with one set
of primers that span the entire sequence (Figure 23B).  Adult methylation patterns were analyzed
in genomic DNA from the spleen of a hemizygous carrier of a maternally or paternally inherited
transgene.  Spleen DNA contains the same methylation pattern as tail DNA and was chosen
because it is of a higher quality than tail DNA.  Each DNA sample was digested with the HindIII
restriction endonuclease to generate small DNA fragments used for the treatment. Digested DNA
was purified and treated with sodium bisulfite.  Bisulfite treated samples were PCR amplified,
subcloned, and sequenced (Figure 23A).  Each maternal SnrpnRIgmyc allele was methylated at
>95% of CpG dinucleotides, and each paternal SnrpnRIgmyc allele was methylated at <22% of
CpGs dinucleotides.  In contrast, the maternal and paternal TR2+3SIgmyc alleles contained
similar levels of methylation (Figure 23B).  These data demonstrate that the Snrpn sequences
within the SnrpnRIgmyc transgene function as its differentially methylated domain.
3.8.2. DMD methylation is maintained during preimplantation development
The methylation of the SnrpnRIgmyc DMD was then analyzed during preimplantation
development.  Female and male mice hemizygous for the transgene locus were mated to wild
type mice, and embryos were collected at different preimplantation stages.  Blastocysts stage
embryos were flushed directly from the uterine horns.  Embryos at the 8-cell stage of
development were obtained by collecting embryos at the 4-cell stage and culturing them in CZB
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medium to the 8-cell stage. Embryos at the 4-cell stage of development were obtained by
collecting 2-cell stage embryos and culturing them in CZB medium to the 4-cell stage.  The in
vitro culture of embryos was done to monitor each embryo and ensure that no embryos went
beyond the stage of interest.  All culture times were kept as short as possible.  Embryos were
pooled and analyzed by bisulfite genomic sequencing.
For each sample the region of the SnrpnRIgmyc DMD closest to the c-myc sequence was
analyzed (Figure 23A).  This region contains 15 CpG dinucleotides.  Ten to twenty blastocyst
stage embryos were pooled for analysis (Figure 24).  Paternal transgene alleles were always
unmethylated with only one allele containing a methylated CpG dinucleotide.  Maternal
transgene alleles were always methylated.  Maternal alleles contained an average of 73%
methylated CpG dinucleotides per allele. Only three of 16 tested alleles contained less than 60%
methylation.  These data clearly illustrate that the SnrpnRIgmyc DMD is maternally methylated
at the blastocyst stage of preimplantation development.
Methylation at the 8-cell stage of preimplantation development was analyzed in pools of
25 to 30 embryos (Figure 24).  Of 11 sequenced paternal alleles eight were completely
unmethylated.  One allele contained three methylated CpG dinucleotides, and two alleles
contained two methylated CpGs.  Each maternal allele sequenced was highly methylated.
However, out of 10 alleles sequenced only two different patterns of methylated CpGs were
detected. There are two possible explanations for the similar patterns of methylated CpGs.  It is
possible that the same CpG dinucleotides are consistently unmethylated from the pool of 8-cell
embryos.  However, because small amounts of DNA are obtained from preimplantation embryos,
it is possible that the PCR reaction preferentially amplified a few alleles.  Regardless of the
possible PCR bias, two different patterns of maternal methylation were observed, in comparison
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to the unmethylated paternal alleles.  These data illustrate that the transgene DMD is
differentially methylated at the 8-cell stage.
Methylation at the 4-cell stage of preimplantation development was analyzed in pools of
30 to 50 embryos (Figure 24).  All maternal transgene alleles were methylated in the 4-cell stage
embryos.  Out of 11 sequenced alleles only two different patterns of methylated CpG
dinucleotides were observed.  Similar to the data obtained for the 8-cell stage sample, this could
indicate a PCR bias for only a few maternal alleles.  However, the two distinct patterns of
methylation still suggest that maternal transgene alleles are methylated at the 4-cell stage.
Unfortunately, no data were obtained for the paternal transgene alleles at the 4-cell stage.  The
PCR was unsuccessful from the pool of 4-cell stage embryos.  However, the methylation of
maternal alleles at the 4-cell stage suggests that differential methylation of the transgene DMD is
maintained at each stage of preimplantation development.
In summary, the SnrpnRIgmyc transgene is differentially methylated at all stages of
development tested.  The Snrpn DMD sequences functionally replace the DMD of RSVIgmyc
and are maternally methylated.  The differential methylation of the transgene DMD is maintained
at the 8-cell and blastocyst stages.  Maternal methylation of the transgene is also seen at the 4-
cell stage of preimplantation development.  Importantly, these data indicate that methylation on
imprinted gene DMDs is maintained during preimplantation development.  This has not been
clearly shown for any maternally methylated imprinted gene.
3.8.3. Methylation of endogenous imprinted genes in the blastocyst
Only certain imprinted gene DMD sequences are able to function as a DMD in hybrid
Ig/myc transgenes. For example, the promoter region of the Snrpn gene is not differentially
methylated in the SnrpnIgmyc transgene.  However, the Snprn repeat sequences are differentially
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methylated in the SnrpnRIgmyc transgene.  This suggests that the ability of DMD sequences to
establish differential methylation is not equivalent.
The preimplantation stage of development is an important period for the maintenance of
genomic imprints.  The above data show that imprinted gene methylation is maintained at this
time.  However, little is known about the methylation of specific DMD sequences during
preimplantation development.  It is likely that only certain DMD sequences are differentially
methylated during preimplantation.  The entire DMD may not be differentially methylated until
later in development.  To test the function of specific DMD sequences during preimplantation
development, the methylation of the promoter and repeat regions of the endogenous Snrpn DMD
were analyzed at the blastocyst stage of development.
The following experiment was performed using the B6(CAST7) substrain of mice (Mann
et al. 2003).  The B6(CAST7) mouse genome is primarily C57BL/6J with chromosome 7 from
the castaneous strain.  The advantage of the B6(CAST7) strain of mice over the castaneous strain
of mice is that they are easier to breed.  Single nucleotide polymorphisms (SNPs) between the
castaneous strain of mice and other inbred strains of mice can be used to distinguish the parental
alleles of genes on chromosome 7.  SNPs between the castaneous strain and any of the mus
domesticus strains were estimated to occur once every 200 bps (Lindblad-Toh et al. 2000).  A
polymorphism in the promoter region of the Snrpn gene has already been identified between the
castaneous and FVB/N strains of mice.  The repeat region of the Snrpn locus was PCR amplified
from the castaneous or FVB/N genomes and sequenced to identify polymorphisms.  One
polymorphism was identified and confirmed by PCR and sequencing from the genomic DNA of
a heterozygous (FVB/N x castaneous) embryo.
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Figure 24. The SnrpnRIgmyc DMD is differentially methylated during preimplantation
Bisulfite treatment was performed on embryos embedded in agarose beads as described by
Schoenherr et al. (2003). Maternal inheritance of the transgene (M) is compared to paternal
inheritance of the transgene (P). For all samples CpG dinucleotides in one half of the
SnrpnRIgmyc DMD were analyzed.  The locations of CpGs are shown as filled circles at the top
of each panel.  Each sequence is represented by a thin line and methylated CpGs are shown as
filled circles.
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Figure 25. The endogenous Snprn gene is differentially methylated in blastocysts
Bisulfite treatment was performed on a pool of 12 blastocysts obtained from a mating of a
FVB/N female mouse to a B6(CAST7) male mouse.  A, The CpGs at the 5’ end of the H19
DMD were analyzed.  The adult methylation patterns on the maternal (M) and paternal (P)
alleles of the H19 gene are shown at the top.  The methylation of the same region in the
blastocyst sample is shown at the bottom.  Methylated CpG dinucleotides are represented by
filled circles.  White circles indicate untested CpG sites.  B, The CpGs in the promoter region of
the Snrpn DMD were analyzed.  The adult methylation patterns on the maternal (M) and paternal
(P) alleles are shown at the top.  The methylation of the same region in the blastocyst sample is
shown at the bottom.  Methylated CpG dinucleotides are represented by filled circles.  C, The
CpGs in the repeat region of the Snrpn DMD were analyzed.  The adult methylation patterns on
the maternal (M) and paternal (P) alleles are shown at the top.  The methylation of the same
region in the blastocyst sample is shown at the bottom. Methylated CpG dinucleotides are
represented by filled circles.
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Blastocysts were collected from wild type FVB/N females crossed to B6(CAST7) males.
Twelve embryos were pooled and subjected to bisulfite treatment.  The resulting DNA was PCR
amplified with primers to the 5’ end of the H19 DMD, the promoter of the Snrpn DMD, and the
repeat region of the Snrpn DMD.  The polymorphisms were used to distinguish the maternal and
paternal alleles in each region.  The H19 DMD has previously been shown to be differentially
methylated at the blastocyst stage and served as a positive control for the technique (Tremblay et
al. 1997). As expected the H19 DMD was paternally methylated (Figure 25A).  Nine out of ten
paternal alleles were methylated at > 80% of CpG dinucleotides.  Two of three maternal alleles
were completely unmethylated, and one allele was methylated at 4 of 15 CpG dinucleotides.
The two regions of the Snrpn DMD yielded different results.  The promoter region of the
Snrpn gene contains 16 CpGs that were analyzed for methylation (Figure 25B).  Of 15 paternal
alleles sequenced, 11 were completely unmethylated.  Three alleles were methylated at one CpG
and one allele was methylated at 11 CpGs.  In contrast, all of the sequenced maternal alleles
were methylated.  All four alleles were methylated at 10 or more CpGs.  The repeat region
contains 12 CpG dinucleotides that were analyzed for methylation (Figure 25C). Twelve of 16
maternal alleles sequenced were completely methylated.  One allele was unmethylated at one
CpG dinucleotide, two alleles were unmethylated at two CpG dinucleotides, and one allele was
unmethylated at five CpG dinucleotides.  Of the two paternal alleles obtained, one allele was
methylated at 11 CpGs, and one allele was methylated at seven CpGs.
These data show that the Snrpn promoter region is differentially methylated during
preimplantation development.  However, differential methylation was not observed for the Snrpn
repeat region.  Paternal and maternal alleles acquired a high level of methylation.  These data
146
suggest that the repeat region of the DMD is not clearly differentially methylated in the
blastocyst. However, more samples need to be analyzed to clarify these results.
3.9. Discussion
3.9.1. The mechanisms of maternal and paternal imprinting are distinct
The ability of the Igf2r DMD sequences to restore imprinting to Ig/myc suggests that
imprinted gene DMD sequences share a common function (Figure 15).  The results obtained
from hybrid transgene containing H19 DMD sequences suggest that this function is specific to
maternally methylated DMD sequences (Figure 16 and Figure 18).  Two different H19 DMD
sequences were not able to restore imprinting to the Ig/myc transgene.  Equivalent levels of high
methylation were established on both parental alleles.  This finding is not surprising.  Imprinted
gene sequences are identical between the two germ lines.  Methylation must be established
specifically on the correct parental allele of an imprinted gene. Separate sets of imprinting
sequences and trans-acting factors in the germ lines would ensure that the imprints are correctly
established.  The inability of other paternally methylated DMD sequences to restore imprinting
to the Ig/myc transgene would support the idea that imprinting in the maternal and paternal germ
lines is performed by different mechanisms.
3.9.2. Analysis of DMD sequence requirements for maternal imprinting
The sequences within a maternally methylated DMD must maintain their parent-specific
methylation throughout development.  This suggests that sequences within the DMD are required
for the establishment of methylation in the oocyte and for the maintenance of methylation during
preimplantation.  Also, sequences within the DMD must protect the paternal allele from
acquiring methylation in the sperm and maintain that protection throughout development.  Along
with carrying the differential methylation at an imprinted locus the DMD is essential for
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imprinted gene expression.  The sequences required for these specific functions may be distinct
or may overlap.  The hybrid transgene analysis described in this chapter examined the
requirement of imprinted gene DMD sequences specifically for the establishment and
maintenance of a maternal-specific methylation pattern.
The ability of Igf2r DMD sequences to functionally replace the DMD of RSVIgmyc
suggested that the DMDs of other maternally methylated imprinted genes may also possess the
same function.  To extend this analysis, the DMD sequences of several maternally methylated
imprinted gene sequences were compared (Figure 19).  The Snrpn and Kcnq1 DMDs, along with
the Igf2r DMD were chosen for analysis.  Each gene is located in an imprinted gene cluster and
contains a maternally methylated DMD.  Each gene’s DMD is required for the imprinted
expression of several other imprinted genes in their cluster.  This was clearly demonstrated by
the results of several deletion experiments (summarized in Figure 6).  At each gene cluster,
inheritance of a DMD deletion on the normally unmethylated, paternal allele abolished mono-
allelic gene expression.  Inheritance of the same deletion on the normally methylated maternal
chromosome had no effect. Gene expression on the deleted paternal chromosome resembled that
of the methylated, maternal chromosome.  These data suggest that maternal methylation of the
DMD is equivalent to its deletion.  A likely role for maternal methylation is to abrogate a gene
regulatory activity of the unmethylated DMD.
Comparison of the DMD deletion studies suggests that these three DMDs are involved in
common mechanisms of gene regulation.  A comparison of the DMD sequences showed that
they share several features (Figure 19).  Each DMD contains the promoter for an imprinted
locus, CpG island sequences, and tandem repeats.  The similarities between the DMDs suggest
that one or more of these sequence elements are required for imprinting.  The promoter
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sequences of the Snrpn DMD were tested and did not restore imprinting to Ig/myc (SnrpnIgmyc,
Figure 16).  These data are consistent with experiments that showed that deletion of the Snrpn
promoter had no effect on the imprinted expression of genes in the Snrpn imprinted gene cluster
(Bressler et al. 2001).  The Igf2r DMD sequences that restored imprinting to the Ig/myc
transgene contained a portion of its tandem repeats (Figure 15A).  This result suggested that
tandem repeats may be involved in creating a differential methylation mark.  In order to test this
hypothesis three transgenes were generated; the SnrpnRIgmyc transgene that contained the entire
repeat region from the Snrpn DMD, the KcnqIgmyc transgene that contained the entire repeat
region from the Kcnq1 DMD, and the TR2+3SIgmyc transgene that contained one unit copy of
the TR2+3 Igf2r repeat (Figures 20A and 21A).
The results from these experiments demonstrated that tandem repeats are required to
establish differential methylation at an imprinted gene DMD.  Three SnrpnRIgmyc transgenic
lines showed maternal-specific methylation (Figure 20C and Table 8).  The maternal specific
methylation of the SnrpnRIgmyc transgene was shown to reside within the Snrpn DMD sequence
(Figure 23).  Therefore, while the Snrpn promoter sequences were unable to imprint the
transgene, sequences 50 bp downstream of the promoter were able to imprint the transgene.  At
the endogenous Snrpn locus both the promoter and the repeats are differentially methylated.
However, this analysis clearly shows that they do not possess equivalent functions.
Three Kcnq1Igmyc transgenic lines also showed maternal-specific methylation (Figure
20C and Table 8).  Two different Kcnq1Igmyc transgene constructs were analyzed that contained
the Kcnq1 DMD sequence in opposite orientations (described in Table 8).  Both orientations of
the Kcnq1 DMD restored imprinting to the Ig/myc transgene.  However, one Kcnq1Igmyc line
was not consistently maternally methylated.  Approximately half of the maternally inherited
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transgene alleles examined showed a low level of methylation.  This could suggest that the
imprinting of the transgene is affected by the orientation of the DMD sequence.  However,
consistent imprinting of a second transgenic line, generated with the DMD sequence in the same
orientation, suggests that the occurrence of undermethylated maternal alleles was not due to the
orientation of the Kcnq1 DMD sequence.  This effect is most likely due to the transgene
integration site and is not a factor of the sequences within the transgene.
Supporting a role for tandem repeats in genomic imprinting the TR2+3SIgmyc transgene
was not imprinted (Figure 21C).  In one transgenic line slight differences in band intensities
between the maternal and paternal alleles suggested that the parental alleles might contain slight
differences in methylation.  However, the overall pattern of bands between the maternal and
paternal alleles was the same, and the differences observed were not clear enough to consider the
transgene imprinted.  These data show that a single unit copy of the TR2+3 tandem repeat is not
able to restore imprinting to Ig/myc.  Still, it is possible that we have merely deleted sequences
from the TR2+3 DMD that are required for imprinting.  Loss of imprinting may not be due to the
loss of repetitiveness.  The minimal TR2+3Igmyc imprinted transgene will be used as a basis to
test the requirement for repetitive sequences in transgene imprinting.  A series of transgene
constructs were designed that each eliminate a different region of the transgene DMD.
Experiments to compare the maternal and paternal methylation patterns of each of these
transgenes are currently underway.
The requirement for repeats in the DMD sequence is also supported by the presence of
tandem repeats in the DMD of the RSVIgmyc transgene.  The pBR322 sequences alone are able
to establish and imprint, and the RSV sequences alone are able to establish an imprint.  Both of
these sequences contain tandem repeats.  All of the sequences that restore imprinting to the
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transgene contain tandem repeats.  However, not all repeated sequences are able to restore
imprinting to the transgene.  The TR1 repeats were not able to establish an imprint in the
TR1Igmyc hybrid transgene.  Moreover, the Ig/myc transgene contains direct repeats in the
switch (Sa) region of the Ig sequence and is not imprinted.  This suggests that only specific
repeat sequences are able to imprint the transgene.
Tandem repeats are also found within the DMDs of other imprinted loci.  The imprinted
gene Impact on chromosome 18 has a repetitive region within its maternally methylated DMD
(Okamura et al. 2000).  The imprinted gene Peg10 was recently identified within an imprinted
gene cluster on chromosome 6.  The maternally methylated DMD at the Peg10 locus also
contains tandem repeats (Ono et al. 2003).  The identification of tandem repeats at these other
gene clusters suggests that the requirement for tandem repeats in genomic imprinting may be
widespread.
These results stress the importance of tandem repeats in the creation of a differentially
methylated domain.  It has been known for a number of years that direct repeats are associated
with imprinted loci.  However, this is the first demonstration of a functional role for direct
repeats in genomic imprinting.  Tandem repeats within DNA sequences are associated with many
epigenetic processes other than genomic imprinting.  Various forms of gene regulation in yeast,
plants, fungi, and mammals have been shown to involve repeated DNA sequences of various
lengths and compositions.  In many of these processes repeats are the target of DNA
methylation, histone modifications, or even point mutations.  Typically these alterations lead to
the repression of gene expression. 
Schizosaccharomyces pombe is subject to gene regulation correlated with the presence of
short tandem repeats (Hall et al. 2002).  The CenH repeat is a 4.3 kb region containing tandem
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repeats similar to the dh centromeric repeats.  The CenH repeat region is required for
maintaining silencing at the mating type loci, and nucleates methylation of histone 3 at lysine 9
(H3-Lys9).  This process involves histone deacetylases (HDACs), Clr4 (H3-Lys9
methyltransferase), and Swi6 (an HP1 homologue).  Interestingly, the centromeric repeats are
also capable of silencing gene transcription.
Repeated regions in the Neurospora and Arabidopsis genomes are also silenced. For
example, multiple copies of a transgene introduced into the Neurospora genome will be targeted
and silenced (Irelan et al. 1994). This process is termed repeat induced point mutation (RIP).
The DNA is targeted for both methylation (CpG and non-CpG methylation) and point mutation,
or point mutation alone.  Several regions of less than 300 bps are capable of acting as
methylation signals; however, not all fragments induce methylation at the same level (Selker et
al. 1993).  Also, repeats alone are not all that is required to trigger de novo methylation in
Neurospora; many repeated transgenes and endogenous duplications are unmethylated (Chang
and Staben 1994).  In Arabidopsis a mechanism similar to RIP, referred to as methylation
induced premeiotically (MIP), silences the transcription by DNA methylation alone.  The
importance of repeated sequences to silencing in this system is illustrated by the fact that if
multicopy transgenes are reduced to a single copy by intrachromosomal deletion, they are
reactivated (Assaad and Signer 1992).
Silencing of repeated transgene sequences is also observed in the petunia (Linn et al.
1990).  In this system, a non-homologous maize gene is expressed when present in a single copy,
but is silenced when present in multiple copies (at the same or different genomic locations).
Silenced transgenes are hypermethylated when compared to single-copy transgenes.  Also, a 1.6
kb repetitive sequence element (RPS) isolated from the petunia genome is able to affect the
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transcription of neighboring genes (Ten Lohuis et al. 1995).  In silenced regions the RPS element
is hypermethylated.
Tandem repeats have recently been shown to correlate with paramutation at the maize b
locus.  Paramutation in maize is an interaction between two alleles where one allele can alter
transcription at the other allele.  Transcriptional changes are associated with changes in DNA
methylation and alterations in chromatin structure (Stam et al. 2002).  This alteration is both
mitotically and meiotically stable.  The paramutagenic B' allele can induce a heritable change in
transcription from the paramutable B-I allele.  The ability of b1 alleles to undergo paramutation
is dependent upon the number of copies of an 853 bp tandem repeat.
The numerous examples of tandem repeats in other epigenetic processes support a role
for tandem repeats in genomic imprinting.  In each of these examples, duplication of a sequence
leads to its methylation and silencing, suggesting that repetitive DNA sequences are targets for
methylation.  Repetitive sequences within the mouse genome are also targets for methylation.
For example, the mouse Aprt gene is targeted for methylation.  The targeting of methylation to
this locus requires two copies of a mouse B1 element (Yates et al. 1999).  Two copies of this
element are more efficient at attracting de novo methylation than a single copy.  Tandem repeats
at imprinted loci may perform a similar function.  Tandem repeats may attract methylation to the
DMD and the maternal-specific pattern of methylation may be achieved in combination with
other gene sequences.
At the SnrpnRIgmyc locus the combination of Ig/myc and Snrpn repeat sequences is
required for imprinting.  The Snrpn repeat sequences may target methylation to the transgene in
the germ line, and the Ig/myc sequences may be involved in establishing the maternal-specific
pattern.  However, merely targeting methylation to the transgene in the germ line is not sufficient
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to generate an imprint.  The LTR of an IAP element is targeted for methylation in the germ line,
and contains a repetitive region.  Hybrid transgenes generated by combining IAP LTR sequences
with Ig/myc had equivalent, high levels of methylation on both the maternal and paternal alleles
(Reinhart et al. 2002).  These data suggest that DMD sequences do not function as nonspecific
targets of methylation, but that certain sequences are required to achieve a maternal-specific
imprint.
3.9.3. Efficiency of transgene imprinting
Maternal alleles of the Igf2rIgmyc transgene were always highly methylated in tail DNAs
collected from mice at the time of weaning.  However, the methylation of maternal Igf2rIgmyc
alleles at E10.5 was not completely efficient (Figure 17B).  One transgenic embryo showed an
unmethylated, paternal-like pattern of methylation.  This would suggest that methylation was
either established and later lost, or was never established.  In either case, these data indicate that
the efficiency of generating a methylation imprint at the transgene locus is not 100%. It is
possible that the minimal DMD sequence present in the Igf2rIgmyc transgene, does not allow for
completely efficient transgene imprinting.
The data from transgenes containing a single unit copy of the TR2+3 repeat and 2.5 unit
copies of the TR2+3 repeat also suggest that efficiency of transgene imprinting is affected by the
sequence that is included within the DMD.  The TR2+3Igmyc transgene (2.5 unit copies of
TR2+3) is imprinted, but the methylated maternal alleles do not reach the high levels of
methylation seen with the Igf2rIgmyc transgene (TR1 repeats plus 2.5 unit copies of TR2+3)
(Figure 15B).  The data obtained with a single TR2+3 unit copy agree with this idea.  Slight
differences in methylation are seen between the two parental alleles, however the transgene is
clearly not imprinted (Figure 21).  These data may demonstrate that multiple copies of the
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tandem repeat are required to increase the efficiency of the imprinting process.  One unit copy
induces minor differences in methylation, 2.5 unit copies restores differential methylation, and
combining the TR1 and TR2+3 repeats establishes a high level of maternal-specific methylation.
Copy number dependence is seen in other processes involving tandem repeats.  The process of
paramutation at the maize b locus is dependent upon the copy number of a tandem repeat.  Also
the ability of B1 repeats to target methylation to the Aprt locus is more efficient when the
sequence is present in two copies (described above).
Decreased efficiency of transgene imprinting was also suggested by the loss of
methylation seen on the Igf2rIgmyc transgene in embryos obtained from Dnmt1o-deficient
oocytes (Section 3.7).  Surprisingly, loss of maintenance Dnmt1o activity had a severe effect on
transgene imprinting.  The transgene lost the majority of its methylation in over half of the
embryos examined (Figure 17).  At endogenous imprinted loci loss of methylation only occurred
at half of the methylated alleles of an imprinted locus, and half of the alleles maintained a wild
type pattern. This difference may be attributed to the difference in efficiency of maintenance
methylation at the transgene locus compared to an endogenous locus in wild type mice.  If
imprinting is not 100% efficient at the transgene locus in wild type mice, it is possible that the
enhanced effect of Dnmt1o loss is due in part to a general decrease in imprinting efficiency.
3.9.4. Imprinted gene methylation during preimplantation development
An important factor in genomic imprinting is the ability to distinguish the parental alleles
of a gene during all stages of development.  It has been clearly shown that differential
methylation at an imprinted gene DMD is established in the gamete.  It has also been well
established that methylation is present in the embryo and in the adult.  The paternally methylated
H19 gene is clearly differentially methylated in blastocysts (Tremblay et al. 1997).  Similarly,
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the RSVIgmyc transgene is clearly differentially methylated in blastocysts (Chaillet et al. 1995).
However, little data exist to describe the methylation of other maternally methylated imprinted
genes in preimplantation embryos.
The SnrpnRIgmyc transgene was used as a model to study the differential methylation of
imprinted gene DMD sequences during preimplantation development. (Figure 24, Section 3.8).
These data clearly demonstrate that the transgene is differentially methylated in the 8-cell stage,
and at the blastocyst stage of preimplantation development.  These data also show that maternal
methylation on the DMD is present at the 4-cell stage.  These data support a methylation
dependent step for imprinting at all stages of early development.  However, transgene
methylation needs to be examined at the 2-cell stage and on the paternal allele at the 4-cell stage
to draw a clear conclusion.
The inability of all DMD sequences to imprint the transgene suggests that not all DMD
sequences possess the same functions.  As described above, the Snprn promoter sequences are
not able to restore imprinting to the Ig/myc transgene, and the Snrpn repeat sequences are.
However, both of these sequences are differentially methylated in the adult.  To test the ability of
both of these sequences to maintain methylation during preimplantation development the
methylation in both regions was examined at the blastocyst stage.  Interestingly, the promoter
sequences of the DMD were clearly differentially methylated at this time.  However, the repeat
sequences of the transgene were not as clearly differentially methylated.  The paternal alleles
contained a higher level of methylation than expected.  This was not the anticipated result for
these experiments. The differential methylation of the Snrpn repeats in the transgene predicted
that they would be differentially methylated at the endogenous locus.  However, these
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experiments do support the fact that not all transgene sequences have equivalent functions with
respect to the maintenance of an imprint during development.
The difference in methylation between the transgene data and the endogenous gene data
may rest in the fact that slightly different regions of the repeats were analyzed in each
experiment.  The 3’ region of the Snprn repeats from the SnrpnRIgmyc transgene was analyzed
in the blastocyst; however, the 5’ region of the repeats was not analyzed.  The repeats analyzed
at the endogenous locus were those in the 5’ region of the repeat.  These results indicate that a
more detailed analysis of methylation at the Snrpn endogenous locus is required to identify the
functional sequences.
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Chapter 4: Characterization of IAP element methylation in the blastocyst
4.1. Introduction
The current data suggest that methylation of the IAP LTR is an important form of
transcriptional regulation.  Data also suggest that LTR methylation is maintained during
preimplantation development.  Maintenance of methylation during preimplantation is exceptional
due to the fact that the majority of genomic methylation is lost by the preimplantation blastocyst
stage.  This indicates that maintaining LTR methylation is critical.  Yet information also suggests
that methylation on IAP LTRs decreases in the preimplantation blastocyst. Southern blot analysis
of blastocyst DNA hybridized with a probe to the IAP LTR suggested that a HpaII site in the
LTR is unmethylated in a small percentage of IAPs at this time (Walsh et al. 1998).  Also,
bisulfite genomic sequencing of the IAP element LTR showed that IAPs retain only 62% of their
methylation in the blastocyst (Lane et al. 2003).  These sequencing data suggested that each IAP
losses a portion of its methylation, and that only a few IAPs are completely unmethylated.  Apart
from these data, little is known about the methylation of IAPs during development.
Loss of methylation in the blastocyst may affect IAPs stochastically, or it may affect
specific IAPs.  One way to determine if specific IAPs are preferentially demethylated in the
blastocyst stage is to directly measure the methylation of individual IAP elements in the
blastocyst.  Characterizing the unmethylated IAPs is of interest because of their ability to escape
the host defense system.  Escape from methylation would allow active transcription and possibly
transposition, ultimately leading to heritable germ line mutations.  Learning the characteristics of
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this population of IAPs will further our understanding of how sequences are targeted for
methylation, and the factors that affect their escape from methylation.
4.2. Methylation of the general IAP element population
Limited data exist to describe the methylation of IAP elements in the blastocyst, and no
information is available concerning the methylation of individual IAPs.  In the following
experiments the bisulfite genomic sequencing technique was performed to examine the
methylation of individual IAP elements in the blastocyst (described in Figure 22).  The
methylation of the general IAP element population in the blastocyst was evaluated first.  This
was done to assess the ability of the bisulfite genomic sequencing technique to analyze the
methylation of IAPs from a small amount of blastocyst DNA.  These data will also confirm the
data obtained by others regarding the methylation state of IAP LTRs at the blastocyst stage.
In this experiment PCR primers were designed within conserved regions of the LTR.
This PCR will amplify representative LTR sequences from the genome.  Blastocysts were
collected from wild type FVB/N females crossed to wild type FVB/N males at 3.5 dpc.  DNA
was collected from blastocysts and treated with sodium bisulfite.  Treated DNA was PCR
amplified, and PCR products were cloned and sequenced.  Each LTR sequence contained nine
CpG dinucleotides that were analyzed for the presence or absence of methylation.  Data from
seven sequenced clones illustrated that the IAP LTR contained a relatively high level of
methylation at the blastocyst stage (Figure 26).  A total of 73% of CpG dinucleotides were
methylated in the blastocyst.  No individual LTR sequence was completely unmethylated.
The methylation of IAP LTRs in blastocyst DNA was compared to their methylation in
sperm DNA.  Sperm DNA is expected to have a higher level of methylation than blastocyst
DNA.  Sperm DNA was isolated from FVB/N mice and treated with sodium bisulfite.  The IAP
LTR was PCR amplified with the same primers used for the blastocyst sample.  PCR products
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Figure 26. IAP element LTRs are methylated in sperm and blastocysts
DNA was collected from a pool of 60 FVB/N blastocysts or from FVB/N sperm by proteinase K
treatment. DNA was bisulfite treated and PCR amplified with primers to the conserved region of
the IAP 5’ LTR (CpGs analyzed within the 5’ LTR are shown as filled circles).  Each sequenced
allele is shown as a thin line and methylated CpGs are shown as filled circles.  The percentage of
methylated CpGs out of the total number of CpGs sequenced is shown below each sample.
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were cloned, and five clones were sequenced.  A total of 87% of the CpG dinucleotides analyzed
were methylated (Figure 26).  Four clones were methylated at eight CpG dinucleotides and one
clone was methylated at seven CpG dinucleotides.
These data illustrate that the LTR is predominantly methylated in the mature male
gamete.  A small amount of LTR methylation is lost by the blastocyst stage of preimplantation
development. From the small number of IAP LTRs sequenced in the blastocyst DNA sample
none were completely unmethylated.  This suggests that the majority of IAP element methylation
is maintained during preimplantation development.
4.3. Identification of unmethylated IAPs in blastocyst stage embryos
4.3.1. Experimental design
The above data confirm that the LTRs of the majority of IAP elements are methylated at
the blastocyst stage.  The goal of these experiments is to identify and characterize unmethylated
IAPs at the blastocyst stage.  How do we separate the unmethylated IAPs from the hundreds of
IAPs present in the mouse genome?  Most genomic DNA is unmethylated at the blastocyst stage
of development.  Therefore, an unmethylated IAP should have an unmethylated LTR in the
context of unmethylated flanking genomic sequence.  In contrast, the majority of IAPs will
contain a methylated LTR in the context of unmethylated flanking sequence.  This distinguishing
feature was used to screen for unmethylated IAPs in blastocyst DNA.
Blastocyst stage embryos were collected from FVB/N mice.  Blastocysts were pooled,
and genomic DNA was collected by proteinase K digestion.  Embryo DNA was digested with the
methylation sensitive restriction endonuclease HpaII.  There is a conserved HpaII site located
within the IAP element LTR (Figure 7).  HpaII digestion will only cut unmethylated IAPs at this
HpaII site, and at the next neighboring unmethylated HpaII site.  This digestion will yield a pool
of small DNA fragments that contain unmethylated IAP element LTRs.  Any methylated LTRs
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will remain uncut and produce larger DNA fragment.  Digested DNA was ligated to adaptor
oligos and PCR amplified.  PCR conditions were designed to amplify small DNA fragments
containing LTR sequence (one primer designed to the LTR).  PCR products were used to
generate a lambda library.  The library was screened with a probe to the IAP LTR (Michaud et
al. 1994).
Thirty clones were selected and sequenced to identify the IAP LTR sequence and
flanking genomic sequence. BLAST searches were performed using the DNA sequence flanking
the LTR.  Clones containing internal IAP genomic sequence were eliminated.  A second group of
IAP element clones were eliminated because they were located within repetitive regions of the
genome.  Only four clones contained unique sequences suitable for further analysis.  These IAP
clones were designated IAP 7, IAP 21, IAP 23, and IAP 29.
Along with analyzing the unmethylated IAPs found in the blastocyst, it is also of interest
to examine the methylation of the general IAP element population in the blastocyst.  This was
previously done on a pool of FVB/N blastocysts using conserved LTR primers (described in
section 4.2).  However, analyzing IAP LTR methylation at specific genomic insertion sites will
offer more valuable information than analyzing LTR methylation using generic LTR sequences.
This analysis was performed by randomly choosing IAP elements from the genome. Sequence
information for the C57BL/6J genome is easily accessed via the UCSC genome browser
(http://genome.ucsc.edu/).  This database estimates that 90-96% of the genome sequence is
known and correct.  This web site offers the ability to perform "BLAT" searches against known
mouse sequences. BLAT searches use query sequences of greater than 40 nucleotides and locate
regions of similarity from the mouse genome sequence.  This feature was used to select IAP
elements at random from the genome.
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Table 9. IAP element characteristics
The IAP elements identified in the blastocyst library screen (IAP 7, IAP 21, IAP 23, and IAP
29), and the IAP elements identified by BLAT search are listed.  The chromosomal locations of
the IAPs and the mouse strains in which they are found (either FVB/N (F) or C57BL/6J (B)) are
provided.  The approximate size of each IAP is also described.  All information was obtained
using the UCSC genome browser (http://genome.ucsc.edu/).
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IAP Element Chromosome
Strain
FVB/N (F);
 C57BL/6J (B)
Size
7 10 B/F 5.25 kb
21 11 B/F 7.1 kb
23 13 F Single LTR
29 13 B/F Single LTR
30 5 B/F 6.8 kb
31 12 B/F 7 kb
32 18 B 7.2 kb
33 3 B 7 kb
35 12 B Single LTR
36 1 B/F 7 kb
37 17 B/F 6.2 kb
39 6 B 4.8 kb
40 15 BF 4.4 kb
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A BLAT search was conducted using the conserved U3 region of an IAP element LTR
(Sequence update February 2003).  Sequence from the 5’ LTR of the IAP insertion at the agouti
locus (Aiapy) was used for the search.  IAPs were chosen from different mouse autosomes, and at
different locations within or near known or predicted genes.  These IAPs were designated IAP 30
through IAP 40.  The UCSC BLAT search was also used to identify the genomic location of the
IAPs identified in the library screen.  The location of each IAP is summarized in Table 9.  The
methylation at the 5’ LTR of each IAP element was analyzed in blastocyst and adult DNA.
4.3.2. Analysis of IAP element methylation
All methylation analyses were performed by the bisulfite genomic sequencing method.
PCR primers were designed within the flanking genomic sequence of each LTR.  Because the
majority of IAP sequences were selected from the C57BL/6J genome, the following analysis was
performed using the C57BL/6J strain, unless otherwise stated.
IAP 23 is a single LTR that is only present in the FVB/N strain of mice.  Bisulfite
genomic sequencing of the IAP 23 LTR was performed on a pool of 40 FVB/N blastocysts.
Every IAP 23 LTR sequenced from blastocyst DNA was completely unmethylated (Figure 27A).
Each sequenced LTR contained eight CpGs.  No methylated CpGs were observed in nine LTRs
sequenced.  The methylation of IAP 23 was then analyzed in sperm and adult DNAs.  Unlike in
the blastocyst DNA, IAP 23 was fully methylated in sperm DNA (data not shown). In adult DNA
the IAP 23 LTR was also highly methylated (Figure 27A).  From 12 sequenced clones only five
CpGs were unmethylated.  Unmethylated CpGs were located at positions scattered throughout
the LTR. No individual LTR contained more than three unmethylated CpGs.  Therefore, IAP 23
is specifically unmethylated in blastocysts.
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Figure 27. Identification of unmethylated IAP elements from blastocysts
A, Bisulfite genomic sequencing of individual IAP LTRs was performed on pools of FVB/N
(IAP 23) or C57BL/6J (IAP 7 and IAP 29) blastocysts.  Bisulfite genomic sequencing of adult
samples was performed using FVB/N or C57BL/6J tail DNAs.  Thin lines represent individual
sequenced alleles and filled circles represent methylated CpGs.  B, Bisulfite genomic sequencing
was performed on FVB/N and C57BL/6J DNAs for IAP 7 and IAP 29.  The data obtained are
summarized in the chart.  The percentage of CpG dinucleotides methylated in each sample is
shown on the y-axis. Data for the FVB/N strain are represented by the gray bar and data for the
C57BL/6J strain are represented by the black bar (x-axis).  The percentage of methylated CpGs
reflects the number of methylated CpGs out of the total number of CpG dinucleotides sequenced.
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Similar to IAP 23, IAP 29 is a single LTR insertion.  Methylation of IAP 29 was
analyzed from a pool of 10 C57BL/6J blastocysts and from adult genomic DNA.  The IAP 29
LTR contains 18 CpGs dinucleotides that were analyzed for methylation by bisulfite genomic
sequencing.  All IAP 29 LTRs examined were unmethylated (Figure 27A). From nine sequenced
alleles only 22 CpGs were methylated (14.3% methylation).  No more than 3 CpGs were
methylated on any one LTR.  In contrast, IAP 29 was completely methylated in C57BL/6J adult
DNA (Figure 27A).  In four sequenced clones no CpG dinucleotides were unmethylated.
Therefore, IAP 29 is also specifically undermethylated in blastocysts.
IAP 7 and IAP 21 are both full length IAP elements.  The methylation of the IAP 7 5’
LTR was analyzed in a pool of 10 C57BL/6J blastocysts and in adult tissue. At the blastocyst
stage only 21.5% of the total CpG dinucleotides analyzed were methylated (Figure 27A).  Thus,
the IAP 7 5’ LTR is relatively unmethylated in blastocysts. In contrast, 97% of the total CpG
dinucleotides sequenced were methylated in adult DNA.  Methylation analysis of the IAP 21 5'
LTR was performed using the same pool of 40 blastocysts that was used to analyze methylation
of the IAP 23 LTR.  Unlike the other three IAPs identified in the library screen IAP 21 was
completely methylated in FVB/N blastocysts (data not shown). These data demonstrated that the
blastocyst library screen selected for unmethylated IAPs.
In order to determine if there was any strain variability in the methylation of these unique
IAPs, the IAP 7 and IAP 29 alleles were analyzed by bisulfite genomic sequencing in C57BL/6J
and FVB/N adult DNAs.  Both LTRs were consistently less methylated in the FVB/N strain of
mice than in the C57BL/6J strain of mice (Figure 27B). The IAP 7 LTR was 92% methylated in
the FVB/N strain and 97% methylated in the C57BL/6J strain.  Likewise, the IAP 29 LTR was
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95% methylated in the FVB/N strain and 100% methylated in the C57BL/6J strain.  In both
strains, each LTR sequence was methylated.  The differences observed between any two LTRs
occurred at CpG dinucleotides scattered throughout the LTR.  These data indicate that there is
little variability in the methylation of IAP LTRs in adult tissues.
The methylation of randomly chosen IAPs was compared to the methylation of those
selected from the library screen.  One single LTR insertion and seven IAPs were chosen from the
C57BL/6J genomic sequence.  The methylation of each IAP was analyzed in blastocyst DNA
and in adult DNA.  Blastocyst methylation analyses were done using two separate pools of 10
C57BL/6J blastocysts.  Adult methylation analyses were done using C57BL/6J DNA and FVB/N
DNA.  Specific primers were designed to amplify the 5’ LTR from each IAP.
The selection of two undermethylated, single LTR insertions from the library screen
suggested that single LTR insertions are preferentially demethylated in the blastocyst.  To test
this notion, the methylation of the IAP 35 single LTR insertion was analyzed in blastocyst DNA
and in adult DNA.  Interestingly, the IAP 35 insertion was undermethylated in both the
blastocyst and adult DNAs (Figure 28).  Only 13% of the CpG dinucleotides sequenced were
methylated on the IAP 35 LTR in blastocyst DNA.  The pattern on methylated CpGs was
different on each LTR, and no LTR was completely methylated. Each IAP 35 LTR sequenced
contained 18 CpGs. In a collection of 10 sequenced LTRs no more than three methylated CpGs
were found per LTR. In adult DNA the IAP 35 LTR was also unmethylated.  Only 7% of the
CpG dinucleotides sequenced were methylated on the IAP 35 LTR.  Again, no sequences were
completely methylated.  Thus, the IAP 35 LTR was undermethylated in both the blastocyst and
in the adult.
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Figure 28. Single IAP LTRs are unmethylated at the blastocyst stage
IAP 35 is a single IAP LTR chosen from the C57BL/6J genome.  Bisulfite genomic sequencing
was performed on the IAP 35 LTR from a pool of 10 C57BL/6J blastocysts and from C57BL/6J
tail DNA.  The filled circles on the top line indicate the positions of CpGs in the IAP 35 LTR.
Thin lines represent sequenced clones and filled circles represent methylated CpGs.
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Figure 29. IAP elements are less methylated in the blastocyst than in the adult
IAP element LTRs were randomly selected from the mouse genome.  The methylation of each
IAP LTR was analyzed by bisulfite genomic sequencing.  Bisulfite genomic sequencing was
performed from a pool of 10 C57BL/6J blastocysts and from C57BL/6J adult genomic DNA.
Certain IAP elements were also analyzed using FVB/N genomic DNA.  The chart summarizes
the bisulfite genomic sequencing data.  The percentage of methylated CpG dinucleotides is
shown on the y-axis.  The data for each IAP element LTR in the FVB/N strain (hatched black
bar), in the C57BL/6J strain (black bar), and in the blastocyst (gray bar) are presented along the
x-axis.  The percentage of methylated CpGs in each sample was calculated from the total number
of methylated CpGs out of the total number of CpG dinucleotides sequenced.
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Six of the seven randomly chosen IAP elements showed a high level of methylation in
both blastocyst and adult tissues (Figure 29).  Blastocyst methylation levels were always 12% to
20% lower than adult methylation levels.  Loss of methylation in the blastocyst was due
exclusively to the loss of one or a few methylated CpGs per IAP LTR.  No IAP LTR sequences
were completely unmethylated at the blastocyst stage.  Little variation was seen in the
methylation patterns of individual IAP LTRs in adult tissues for any of the six IAPs.  Also, little
difference was observed between the FVB/N and C57BL/6J DNAs.  One exceptional IAP, IAP
33, was completely unmethylated in blastocyst DNA.  No methylated CpGs were ever detected.
In contrast, IAP 33 was methylated in adult tissues.  One out of seven IAP LTRs selected from
the mouse genome was completely unmethyated in blastocysts.
In summary, five undermethylated IAP elements were identified in the blastocyst.  Three
were identified in a library screen designed to preferentially amplify unmethylated IAP LTRs
from blastocyst DNA.  Two of these three IAPs were single LTR insertions.  Correspondingly,
one other single LTR insertion was chosen from the mouse genome and was found to be
unmethylated at the blastocyst stage.  The other unmethylated IAP was randomly selected from
the mouse genome.
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Table 10. Description of IAP element methylation and genomic location
The IAP elements identified in the blastocyst library screen (IAP 7, IAP 21, IAP 23, and IAP
29), and the IAP elements identified by BLAT search are listed. The approximate size of each
IAP is described. The location of each IAP element near any known or predicted genes is
described.  All information was obtained using the UCSC genome browser
(http://genome.ucsc.edu/).  The results of methylation analyses for each IAP are summarized; the
presence of > 75% methylated CpGs (Y), or the presence of < 25% methylated CpGs (N).
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                  MethylationIAP
Element
Size Description
Adult (Y/N) Blastocyst (Y/N)
7 5.25 kb 5 kb upstream of Galnt4 Y N
21 7.1 kb 250 kb from Pmp22 Y Y
23
Single
LTR
1 kb upstream of predicted gene
(accession number Al355719)
Y N
29
Single
LTR
150 kb from Foxd1, within SGP
predicted gene chr13_1516.1
Y N
30 6.8 kb
75 kb upstream of Shrm, within
predicted gene chr5_18.114 Y N
31 7 kb within Rad51l-1 Y Y
32 7.2 kb 2.5 kb from Mc2r Y Y
33 7 kb
near no known or predicted
genes Y N
35
Single
LTR 8 kb downstream of Titf1 N N
36 7 kb within Fmo1 Y Y
37 6.2 kb
300 kb from another IAP, 300
kb from Slc8a1
Y Y
39 4.8 kb 40 kb downstream of Snd1 Y Y
40 4.4 kb
Within reference
sequence120000E11Rik
Y Y
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4.3.3. Comparison of unmethylated IAPs
The features of the five unmethylated IAPs were compared to find any similarities. The
sequences of the 5’ LTRs of the full length IAPs and the single LTRs were aligned (Figure 30).
The alignment showed that all five IAPs have a typical LTR structure.  The U3, R, and U5
regions were easily identified by comparison to published LTR sequences (MIARN IAP,
Genbank accession number X01172) (Burt et al. 1984).  The U3 regions and U5 regions of the
IAP LTRs were well conserved with the exception of the IAP 23 LTR and the IAP 29 LTR.  The
IAP 23 LTR contained multiple differences in the 3’ end of the U3 region, and the IAP 29 LTR
contained several differences in the U5 region.  Among all of the IAPs the majority of
differences were seen in their R regions.  This is expected for most IAPs.
The sizes and genomic locations of the IAPs were also compared (Table 10). IAP 7 is
located on chromosome 10 and is 5.25 kb in size.  The 5' LTR of IAP 7 is located 5 kb upstream
of the 5' end of the Galnt4 gene.  IAP 23, IAP 29, and IAP 35 are single LTRs. IAP 23 is located
on chromosome 13, approximately 1 kb from a predicted gene (accession number AL355719).
IAP 29 is located on chromosome 13, 150 kb from the known gene Foxd1 and within the SGP
gene prediction  chr13_1516.1 (predicted using mouse/human homology).  IAP 35 is located on
chromosome 12, approximately 8 kb downstream of Titf1.  IAP 33 is 7 kb in size and is found on
chromosome 3.  However, IAP 33 is not located in the vicinity of any known or predicted genes
in the database.  These data show that the unmethylated IAPs are located on different
chromosomes, and are of different classes based on their size.  The locations of the IAPs near
known or predicted genes was also very different.  Four of the IAPs are located in or near known
genes.  However, many of the methylated IAPs are also located in or near known genes.  These
data do not provide a clear picture of a common feature that selects IAPs for demethylation.
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Figure 30. DNA sequence alignment of unmethylated IAP element LTRs
Alignment of the IAP 7, IAP 33, IAP 23, IAP 29, and IAP 35 LTR sequences.  Boxes separate
the U3, R, and U5 regions of the LTR.  The majority of gaps (.) in the sequence alignment occur
in the R region of the IAP element LTRs.  Sequence alignments were performed using
Assemblylign software.
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TGTGGGAAGCCGCCCCCACATTCGCCGTCACAAGATGGCGCTGACATCCTGTGTTCTAAGTTGGTAAACAAATAATCTGCGCATGAGCCAAGGGTAT.TTACGACTACTTGTACTCTGTTTTTCCCGTGAACGTCAGCTCGGCC.AT
TGTTGGGAGCCGCCCCCACATTCGCCGTTACAAGATGGCGCTGACATCCTGTGTTCTAAG.TGGTAAACAAATAATCTGCGCATGTGCCAAGGGTATCTTATGACTACTTGTGCTCTGCCTTCCCCGTGA.CGTCAACTCGGCCGAT
TGTGGGAAGCCGCCCCCACATTCGCCGTCACAAGATGGCGCTGACATCCTGTGTTCTAAGTTGGTAAACAAATAATCTGCGCATGAGCCAAGGGTAT.TTACGACTACTTGTACTCTGTTTTTCCCGTGAACGTCAGCTCGGCC.AT
TGTAGGAAGCCGCCCTCACATTCGCCGTTGCAAGATGGCGCTGACATCCTGTGTTCTAAG.TGGTAAACAAATAATCTGCGCATGTGCCAAGGGTAGTTTTCCACCCCATGTGCTCTGCGTTCCCCGTGA.CGACAACTCGGCCGAT
TGTGGGGAGCCGCCCTCACATTCGCCGTTGCAAGATGGCGCTGACATCCTGTGTTCTAAG.TGGTAAACAAATAATCTGCGCATGTGCCAAGGGTAGTTCTTCACTCCATGTGCTCTGCCTTCCCCGTGA.CGACAACTCAGCCGAT
IAP 33
IAP 7
IAP 35
IAP 29
IAP 23
GGGCTGCAGCCAATCAGGGAGTGATGCGTCCTAGGCAA.TTGTTGTTCTCTTTAAAGAGGAAAGGGGTTTCGTTTT.CTCTCTCTCTTGCTTCGCTCTCTCTTGCTTCTTACACTCTGGCCCCATAAGATGTAAGCAATAAAGCT.T
GGGCTACAGCCAATCAGGGAGTGACACGTCCGAGGCAAAAGAGAATTCTCCTTAAAAAGGGACGGGGTTTCGTTTT.CTCTCTCTCTTGCTTCTTGCTCTCTTGCTTCTT.....................................
GGGCTGCAGCCAATCAGGGAGTGATGCGCCCTAGGCAATGGTTGTTCTCTTTAAAATAGAAGGG..GTTTCGTTTTTCTCTCTCTCTTGCTTCCCTCTC..TTGCTTCTT.....................................
GGGCTGCAGCCAATCAGGGAGTGACACGTCCTAGGCGGAGGATAATTCTCCTTAAAAGGGACGGGGTTTTGCCATT.CTCTCTCT..TGCT.........CTTGCTCTCTGCTCTCTGGCTCCTGAAGATGTAAGCAATAGAGCTCT
GGGCTGCAGCCAATCAGGGAGTGACACGTCCTAGGCGGAGGATAATTC......................GCCATT.CTCTCTCT..TGCT.......CTCTTGCGCTCTGGC.......TCCTAAAGATGTAAGCAATAGAGCTCT
IAP 33
IAP 7
IAP 35
IAP 29
IAP 23
T............................................................................................................................................GCCGTA
........................................................ACAC...................................GCT............TGCTCCTGAAGATGTAAGAAATAAAGCTTT.GCCGCA
........................................................ACACTCTGGCCCGATAAAGATATAAGCAATAAAGCT.TT..............................................GCCGTA
TG................................................TTCTCTTGCGCTCTGGCTCCTAAAGATATAAGCAATAGAGCTCTTGCTCTATCTCTCT..TGCTCCTAAAGATGTAAGCAATAAAGCTTTTGCCGCA
TGCTCTGGCTCTTGCACTCTTGCTCTGGCTCTTGCTCTCTTGAGCTCTTTCGCTCTTGTGCTCTGGCTCCTAAAGATGTAAGCAATAGAGCTCTTGCTCTCTTGCACTCTTGCTCCTGAAGATGTAAGCAATAAAG.TTTTGCCGCA
IAP 33
IAP 7
IAP 35
IAP 29
IAP 23
GAAGATTCTGGTT.GTTGTGTTCTTCCTGGCCGGTCGTGAGAACGCGTCGAATAACA
GAAGATTCTGGTCTGTGGTGTTCTTCCTGGCCGGTCGTGAGAACGCGTCTAATAACA
GAAGATTCTGGT..GTTGTGTTCTTCCTGGCCGGTCGTGAGAACGCGTCTAATAACA
GAAGATTCCGGTTTGTTGTGTTCTTCCTGGCTGGTCG.G.G.A.GCGTGTAAG
GAAGATTCTGGTTTGTTGCGTTCTTCCTGGCCGGTCGCGCGAACGCGTGTAAGAGGA
IAP 33
IAP 7
IAP 35
IAP 29
IAP 23
U3 
U5 
U3 
U5 
R
R
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4.4. Discussion
4.4.1. Single LTRs are unmethylated at the blastocyst stage
Interestingly, we identified two single LTRs in our blastocyst library screen (IAP 23 and
IAP 29), both of which were located on chromosome 13.  These single LTRs were unmethylated
in the blastocyst and methylated in the adult (Figure 27). This suggested that single LTRs are
preferrentially demethylated at the blastocyst stage.  In support of this notion a single LTR (IAP
35) identified using the UCSC genome database was also unmethylated at the blastocyst stage
(Figure 28).  These data suggest that one source of unmethylated IAPs in the blastocyst is a
population of unmethylated, single IAP LTRs.  Single LTRs are commonly found in the mouse
genome.  They are thought to be due to recombination between two LTRs, leaving a single LTR
in the genome (Kuff and Leuders 1988).  Unmethylated single LTRs may contain active
promoters, and may affect neighboring gene transcription.  However, they are not the sole source
of unmethylated IAPs in the genome.
These data strongly support the idea that methylation at single LTR insertion sites is not
properly maintained during preimplantation.  Furthermore, at the IAP 35 LTR insertion site, the
LTR was not targeted for de novo methylation during post-implantation development.  IAP 35
was almost completely unmethylated in C57BL/6J genomic DNA.  This difference in adult
methylation may be attributed to the genomic context of the IAP element LTR.  IAP 35 is
located on chromosome 12, approximately 8 kb downstream of the gene Titf1.  Several mouse
ESTs and a genescan predicted gene are located within 5 kb of the IAP 35 LTR. Titf1 is a
homeobox transcription factor that is required for thyroid development (Perna et al. 1997).  A
requirement for active Titf1 gene expression, or other nearby genes, may affect IAP 35
methylation levels in adult tissues.
181
4.4.2. A specific population of IAPs is unmethylated at the blastocyst stage
The demethylation of IAPs in the blastocyst could be sporadic or could target specific
IAPs. Sporadic demethylation would be predicted to affect different IAPs in different
blastocysts, and would lead to a mixed population of unmethylated and methylated LTRs in a
pooled sample.  The IAPs examined in these experiments, both methylated and unmethylated,
showed consistent patterns of methylation.  For example, every IAP 29 LTR was unmethylated
in a pool of 10 blastocysts, and every IAP 36 LTR was methylated in the same sample (Figures
27 and 29).  A consistent pattern of methylation on each LTR of an individual IAP should only
be seen if that IAP is always unmethylated or always methylated.  Therefore, our data suggest
that specific IAPs are consistently demethylated at the blastocyst stage.
The presence of a specific group of unmethylated IAPs in the blastocyst indicates that a
population of IAPs are able to escape methylation by the host.  This is also observed in somatic
tissues.  Certain subsets of IAPs are specifically expressed in certain tissue types.  For example,
in mouse thymus tissue a limited group of related IAP elements are active (Meitz et al. 1992).
Evidence indicates that this expressed population of IAP elements in hypomethylated.  Examples
of changes in IAP element methylation and expression are seen at specific IAP insertions in adult
tissues.  At the nocturnin locus a nearby IAP insertion is expressed in a rythmic manner, similar
to that seen for the nocturnin gene (Wang et al. 2001).  The LTR of this IAP is demethylated due
to its location near the nocturnin promoter.  Also, in different tumor cell types, different
subpopulations of IAPs are activated.  This suggests that various changes in the host cell can lead
to alterations in IAP element expression and presumably methylation (Dupressoir and Heidmann
1997).  These examples suggest that certain IAPs are able to escape methylation in adult tissues
as well as in the blastocyst.  This is supported by the data obtained for IAP 35.  IAP 35 is
unmethylated in blastocyst DNA and in adult DNA.
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Chapter 5: Analysis of trinucleotide repeat stability using the RSVIgmyc transgene
5.1. Introduction
Bacterial and yeast model systems, as well as human cell lines, and in vitro systems have
been employed to study the characteristics of trinucleotide repeat expansion.  Work in these
areas has provided valuable information about trinucleotide repeat expansion.  However,
experiments preformed in these systems do not address all of the features of repeat expansion as
it occurs in humans.  Unfortunately, attempts to create a mouse model system to study
trinucleotide repeat expansion have not been successful.  The reason behind the inability to
create a mouse model system is still unclear.
5.1.1. Mouse models of trinucleotide repeat expansion
The FMR1 locus is present in both the mouse and human genomes (Ashley et al. 1993).
The FMR1 proteins share 97% identity, and FMR1-/- mice show phenotypes similar to those seen
in fragile X patients (Dutch-Belgian Fragile X Consortium 1994).  These data suggest that the
two proteins perform similar functions.  Interestingly, at the mouse locus the CGG repeat region
is small, never exceeding nine CGG repeats.  The small number of CGG repeats present at the
mouse FMR1 locus has not been observed to change in size.  Several approaches have been
taken to create a mouse model system to study the mechanism of CGG trinucleotide repeat
expansion.  Unfortunately, experiments using transgenic or knock-in techniques have not been
able to closely model the characteristics of CGG repeat expansion.  When size changes have
been observed they are typically small, resulting in increases or decreases of only a few triplets.
Knock-in experiments were performed to address whether a large CGG repeat tract in the
context of the mouse FMR1 genomic locus would be targeted for expansion.  A (CGG)98 repeat
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tract of human origin was introduced into the endogenous mouse FMR1 locus in place of its
small CGG repeat (Bontekoe et al. 2001).  However, of 121 mice analyzed (80 maternal
transmission and 41 paternal transmissions) only 15 CGG size changes were observed.  The size
changes seen were moderate changes, and the largest expansion documented was an increase of
10 CGG triplets.  This suggests that the mouse genomic locus is not prone to the large repeat
expansions seen at the human locus.
Many transgenic mouse lines have been generated that contain CGG repeat tracts of
various sizes.  A transgene containing a (CGG)22 TGG (CGG)43 TGG (CGG)21 repeat was used
to generate six transgenic mouse lines.  In these lines a total of 342 animals were analyzed for up
to four generations.  However, each animal examined showed an identical repeat length
(Lavedan et al. 1997).  In subsequent experiments a series of transgenes were created that
contained one of three CGG repeat tracts within the 5’ UTR of the human FMR1 locus, and
subcloned upstream of a LacZ reporter.  The human sequence included the first exon of the
FMR1 gene and the upstream CpG island.  The CGG repeat tracts contained 32, 76, or 120
triplets in the organization (CGG)9 AGG (CGG)12 AGG (CGG)x (Lavedan et al. 1998).  The
short and long CGG repeat tracts were stable in 151 transgenic mice analyzed.
Some transgenes have been generated that show moderate instability in transgenic
animals.  A YAC transgene containing the entire FMR1 gene, including 300 kb of upstream
sequence and 100 kb of downstream sequence, was used to generate transgenic animals (Peier
and Nelson 2002).  The transgene included a repeat tract of (CGG)9 AGG (CGG)9 AGG
(CGG)72.  The resulting transgenic lines contained a range of sizes from 20 to 90 CGGs due to
size changes that occurred in generation of the founder animals.  After generation of founder
animals only small size changes of -15 to +4 CGGs were observed.  Thus, even though the entire
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human locus was included in this transgene the parent-specificity and large size changes seen in
human fragile X patients were never duplicated.
The most dramatic size changes documented for a CGG repeat containing transgene have
come from studies done by Baskaran et al. in 2002.  This transgene contained 1057 bp of human
FMR1 sequence, including a (CGG)9 AGG (CGG)6 AGG (CGG)9 CGG repeat tract, downstream
of an SV40 origin of replication.  Repeat size changes in this transgene were analyzed in 95 mice
for four generations.  Again, repeat size changes occurred in the generation of founder animals.
In the mouse line analyzed, the founder animal contained a repeat tract of approximately 196
repeats.  This repeat tract showed further increases in size in the next generation to 279 repeats.
However, the original small repeat tract was seen in all animals tested, even thought the line was
assumed to contain a single transgene copy.  This may suggest that all of the size changes
occurred in somatic tissues and were not due to germ line changes.  Also, the repeat size changes
were observed after both maternal and paternal transmission.  Therefore, even though dynamic
changes in size were seen, they do not model what is seen in human CGG repeat expansion.  The
authors suggest that the presence of the SV40 origin of replication is responsible for the size
changes seen, possibly by providing a nucleosome free region of DNA or by providing a nearby
origin of replication.
5.1.2. Establishing a transgenic mouse model for trinucleotide repeat expansion
The inheritance of fragile X syndrome has several important features that must be
considered when attempting to model CGG repeat expansion.  The CGG repeat expansion
observed in fragile X syndrome is parent-specific, occurring only after passage through the
female germ line.  Also, full mutation CGG repeat tracts are methylated in patients carrying
expanded alleles.  The association between expanded, full mutation CGG repeat tracts and
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methylation suggests that methylation may influence trinucleotide repeat stability.  In order to
test this hypothesis, we designed a transgene that should contain a CGG repeat tract with a high
level of maternal-specific methylation.
In many ways the inheritance of trinucleotide repeat expansion in fragile X syndrome is
similar to the inheritance of a maternal genomic imprint.  At the FMR1 locus and at a maternally
imprinted locus the maternal allele is specifically targeted for modification, while the paternal
allele is protected. In both examples the targeted alleles are subject to DNA methylation changes
that are not seen on the opposite allele.  Also, in each case the effect of the targeting process is an
alteration in gene expression.  One important distinction is that in genomic imprinting the
targeting event occurs normally in the germ line and is necessary for normal development.
However, in the mechanism of CGG repeat expansion the targeting event is abnormal, occurs
infrequently, and leads to a heritable mutation.
 It is possible that like a maternally methylated imprinted gene, the CGG repeat tract at
the FMR1 locus can be targeted for methylation specifically in the female germ line.  Aberrant
targeting of CGG repeats for methylation could affect repeat stability, leading to expanded, fully
methylated alleles in some offspring.  This mechanism would account for the parent-specificity
of the process, due to the placement of a methylation mark in just one gamete.  This mechanism
also correlates with the presence of methylation on all full mutation, fragile X alleles in affected
patients.
As described in Chapter 3, the RSVIgmyc transgene is a well characterized, mouse
transgene that is imprinted at all sites of integration.  RSVIgmyc is always maternally
hypermethylated, and paternally undermethylated.  Therefore, the RSVIgmyc transgene makes an
excellent model system with which to test the effect of methylation on the stability of CGG
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repeats in the mouse genome.  The RSVIgmyc transgene has a well-defined differentially
methylated domain (DMD).  A CGG repeat tract placed in the vicinity of this DMD should also
be specifically maternally methylated.
5.2. Transgene design
Due to the unstable nature of the CGG repeat region, it is subject to size changes during
cloning in both bacterial and yeast vectors (Nichol and Pearson 2002).  Consequently, the CGG
repeat region used for this analysis was synthesized in vitro.  Karen Usdin, a collaborator at the
NIH, did the in vitro synthesis.  The CGG repeat region was synthesized by a technique similar
to that described in Lavedan et al. (1998).  The repeat tract contains 120 total repeats, with 97
uninterrupted CGG repeats at its 3’ end in the organization (CGG)9 AGG (CGG)12 AGG
(CGG)97.  This organization is typical of the CGG repeat tracts found in fragile X patients. The
length of this tract is within the premutation size range, and would be prone to expansion in
humans.  The CGG repeat was subcloned between MluI and NcoI sites in place of a 600 bp
region of RSV and Ca transgene sequence (Figure 31A).  This region is adjacent to the 2.5 kb
DMD of the original transgene and was predicted to be differentially methylated.
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Figure 31. Generation of CGG/Igmyc transgenic mice
A, Schematic of the linear CGG/Igmyc transgene.  The CGG/Igmyc transgene is a derivative of
the RSVIgmyc transgene and was generated in collaboration with Karen Usdin (NIH).  RSVIgmyc
sequences are described in Figure 13A.  Relevant restriction sites for Southern blots are indicated
above the transgene: (P) PstI, (H) HincII, (B) BglII, (A) ApaLI, (M) MluI, (N) NcoI. Probes for
Southern blots are indicated as thick lines above the transgene.  The CGG repeat tract is
represented by a black box.  The sequence of the CGG repeat tract is shown below the transgene.
B,  Southern blot of tail DNAs collected from transgenic founder animals.  DNAs were digested
with BglII and Southern blots were hybridized with the Ca probe.  Lane numbers correlate with
the number of the transgenic line (lines 2 through 7 are shown). DNA sizes indicated in kilobases
(kb). C, Southern blot of the DNAs described in panel B.  DNAs were digested with PstI and
hybridized with the Ca probe.  Lane numbers correlate with the number of the transgenic line
(lines 1, 2, 3, 5, 6, and 7 are shown).  Asterisks indicate the hybridization bands from the
endogenous Ig locus (recognized by the Ca probe).  DNA sizes are indicated in kilobases (kb).
The 1.3 kb and the 2.5 kb bands are from the transgene locus.  The 2.5 kb band contains the
CGG repeat tract. Extra bands are predicted to be due to size changes in the repeat region.
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5.3. The CGG trinucleotide repeat showed instability following injection
The linear CGG/Igmyc transgene construct was injected into the paternal pronucleus of
FVB/N zygotes.  Random integration of the transgene construct in the genome was tested by
Southern blot analysis.  Tail DNAs were collected from mice at the time of weaning (3 to 4
weeks).  DNA from all possible founder mice was digested with the restriction endonuclease
BglII, and Southern blots were hybridized with the Ca probe (Figure 31B).  This digest and
probe should recognize a 6 kb fragment specific to transgenic animals (Figure 31A).  Seven
transgenic founder mice were obtained and mated to wild type FVB/N mice to establish
transgenic mouse lines.
The integrity of the CGG repeat tract was analyzed in founder animals by Southern blots.
Genomic DNA was digested with the restriction endonuclease PstI and Southern blots were
hybridized with the Ca  probe.  This restriction digest and probe should produce two DNA
fragments from the transgene, a 2.5 kb fragment that includes the repeat region, and an adjacent
1.3 kb fragment (Figure 31A).  Two additional bands of 4.5 kb and 0.7 kb from the endogenous
Ig locus should also be present.  Interestingly, this Southern blot yielded different results in each
transgenic animal tested (Figure 31C).  In each animal the 1.3 kb DNA fragment was present, as
was a DNA fragment of approximately 2.5 kb that should include the CGG repeat region.
However, along with the predicted transgene DNA fragments, DNA fragments of slightly
different sizes were also obtained in each founder animal (indicated by arrows, Figure 31C).
These bands migrated close to the CGG repeat containing band, and suggested that size changes
occurred in the CGG repeat region in one or more copies of the transgene.
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Figure 32. Analysis of trinucleotide repeat stability in CGG/Igmyc transgenic lines
Founder animals carrying the CGG/Igmyc transgene were crossed to wild type FVB/N mice and
transgenic lines were established.  Each panel includes representative Southern blots of DNA
samples collected from the founders for each line and their progeny. DNAs were digested with
PstI and hybridized with the Ca probe.  Asterisks indicate the hybridization bands from the
endogenous Ig locus. Extra bands (indicated by arrows) are predicted to be due to size changes in
the repeat region.  DNA sizes are indicated in kilobases (kb).  A, Data from transgenic line 2
(lanes 4-5), transgenic line 5 (lanes 7-13), and transgenic line 7 (lanes 1-3) are shown. Founder
animals for each line are shown in lanes 1, 4, and 7.  B, Data from transgenic line 1 (lanes 1-5)
and transgenic line 6 (lanes 6-12) are shown.  The founder animals for each line are shown in
lanes 1 and 6.  C, Data for transgenic line 3 are shown.  The founder female is shown in lane 1.
This Southern blot includes wild type FVB/N DNA (lane 9).  This lane demonstrates that the two
bands indicated by asterisks are from the endogenous Ig locus.
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Founder animals were mated to wild type FVB/N mice to establish transgenic lines.  Six
of the seven founder animals were fertile and passed the transgene to their offspring.  Five of the
transgenic lines contained unique insertion sites, inherited by all future progeny (Figure 32A and
32B, lines 1, 2, 5, 6, 7).  All of the transgenic progeny of a founder animal contained identical
band patterns by Southern blot analysis of PstI digested DNAs probed with Ca.  However, one
transgenic founder animal (line 3) contained multiple insertion sites that assorted independently
in the founder female's offspring.  This resulted in more than two distinct band patterns by
Southern blot analysis of PstI digested DNAs that were slightly different than the pattern seen in
the founder animal (Figure 32C).  The presence of multiple insertion sites following transgene
injection has been described by others (Tomoko et al. 2002).  Line 3 was subdivided into 2 lines,
CGG/Igmyc-3-1 and CGG/Igmyc-3-2, which were characterized further.
The CGG/Igmyc-3-1 and CGG/Igmyc-3-2 lines were maintained by mating to wild type
FVB/N mice (Figure 33A).  Progeny from both lines yielded consistent patterns of bands by
Southern blot analysis, indicating that they represent unique insertion sites isolated from the
original mosaic founder animal (Figure 33B and 33C).  This was confirmed by Southern blot
analysis using restriction enzymes and probes at each end of the transgene construct (Figure
33D).  The restriction enzyme BglII has one recognition site at the end of the construct and one
recognition site in an unknown region in the genomic flanking DNA.  The intron A probe at the
end of the construct should pick up different bands at each unique insertion site.  The HincII
restriction enzyme and the exon 3 probe were used to examine the opposite end of the construct.
It is clear from the different patterns of bands found in the CGG/Igmyc-3-1 and CGG/Igmyc-3-2
lines with each Southern blot that they represent two different insertion sites.
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Figure 33. Multiple transgene insertion sites in the CGG/Igmyc-3 transgenic line
A, Pedigree for the CGG/Igmyc-3 transgenic line.  The founder female was mated to an FVB/N
male to establish a transgenic line.  Unfilled circles, wild type females; unfilled squares, wild
type males; partially filled circles, hemizygous transgenic females; partially filled squares,
hemizygous transgenic males.  Numbers correspond to the lane numbers in panels B and C. B,
Southern blot of DNA samples collected from carriers of the transgene in the CGG/Igmyc-3
transgenic line. DNAs were digested with PstI and hybridized with the Ca probe.  Asterisks
indicate the hybridization bands from the endogenous Ig locus.  DNA sizes are indicated in
kilobases (kb). A male carrier of the transgene (lane 1) was mated and his progeny are shown in
lanes 2-9.  C, Southern blots performed as described in panel B.  DNA samples were from a male
carrier of the transgene (lane 10) and his progeny (lanes 11-17).  D, Southern blots performed on
the DNA samples from lane 1 in panel B (lanes 1 and 3) and lane 10 in panel B (lanes 2 and 4).
Lanes 1 and 2 show DNAs digested with BglII and hybridized with the intron A probe.  Lanes 3
and 4 show DNAs digested with HincII and hybridized with the exon 3 probe.  DNA sizes are
indicated in kilobases (kb).
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In order to characterize the nature of the size changes seen in generation of the founder
animals, and to interpret any future changes in repeat tract length, it was important to determine
the number of transgene copies present at each insertion site.  A low copy number is preferred, as
a large number of transgene copies will provide a large number of CGG repeat regions to
account for during analysis.  The copy number of each transgenic line was estimated by Southern
blot analysis of genomic tail DNAs digested with the restriction endonuclease PstI, and
hybridized with the Ca probe.  As described above, a PstI digest yields distinct DNA fragments
from the transgene, and from the endogenous Ig locus.  By comparing the intensity of the
endogenous bands (two copies per diploid mouse genome), to the intensity of the transgene
bands, an approximation of transgene copy number was possible.  In three transgenic lines the
transgene was present in greater than three copies (CGG/Igmyc-2, CGG/Igmcy-5, and
CGG/Igmyc-7) (Figure 32A).  In four lines the transgene was present in one or a few copies
(CGG/Igmyc-1, CGG/Igmyc-3-1, CGG/Igmyc-3-2, CGG/Igmyc-6) (Figure 32B and 32C).  The
low copy number transgenes were chosen for subsequent analysis.
5.4. Size changes occurred within the repeat region
5.4.1. Southern blot analysis
Additional Southern blots were performed to determine if the predicted size changes
occur within the CGG repeat tract.  DNA samples from each transgenic line were digested with
ApaLI and NcoI and Southern blots were hybridized with the RSV probe.  The NcoI site is
located at the 3’ end of the repeat region, and the ApaLI site is located 160 bps away from the
CGG repeat region.  This digest isolates the CGG repeat tract and 160 bps of the adjacent RSV
sequence (Figure 31A). Based on the size of the original CGG repeat tract the RSV probe should
recognize a 520 bp band on the Southern blot.  The ApaLI plus NcoI digest includes only 160
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bps of RSV sequence, and any size changes observed most likely occurred within the CGG
repeat region.
To accurately determine the size of the repeat regions in the CGG/Igmyc transgenics,
DNA from a carrier of the RSVIgmyc transgene was digested with ApaLI plus NcoI or ApaLI
plus EcoRI to yield fragments of 790 bp and 465 bp respectively, and these samples were run in
parallel with the CGG/Igmyc genomic DNAs (Figure 34).  For each transgenic line the CGG
repeat tract size changes predicted from the PstI digest are also observed after the ApaLI plus
NcoI digest.  This suggests that the bands seen by both Southern blots represent changes in the
size of the repeat tract.  The size changes seen were predominantly contractions, with the
exception of one expansion.  The result was a variety of band sizes in each transgenic line due to
the multicopy nature of transgene insertions.  These data also demonstrated that the predominant
CGG repeat containing DNA fragment migrates near the 750 bp band on an agarose gel.  The
750 bp band represents the starting size of the repeat tract (120 triplets).  This was demonstrated
by Southern blots of genomic DNAs run in parallel to the injected transgene construct (data not
shown).
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Figure 34. The repeat tract changed in size upon generation of founder animals
Southern blot of DNAs from CGG/Igmyc transgenic animals from line 6 (lanes 1 and 2), line 3-2
(lanes 3 and 4), line 3-1 (lane 5), and line 1 (lane 6). DNAs were digested with ApaLI and NcoI
and run on a 1.2% agarose gel.  The Southern blot was hybridized with the RSV probe. DNA
fragments of known sizes were included in the Southern blot as a size standard.  Lane 7 contains
DNA from a RSVIgmyc transgenic animal digested with ApaLI and NcoI (790 bp band indicated
by an arrow).  Lane 8 contains DNA from a RSVIgmyc transgenic animal digested with EcoRI
and NcoI (465 bp band indicated by an arrow).  DNA ladder sizes are shown in kilobases (kb).
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The ApaLI plus NcoI Southern blots were used to approximate the number of CGG
triplets lost or gained in each transgenic line based on the size of the initial CGG repeat tract. In
the CGG/Igmyc-1 transgenic line the size changes were the most dramatic (Figure 34, lane 6).
The band containing the original repeat tract was absent.  The repeat tract increased in size by
approximately 20 to 30 CGG triplets in at least one transgene copy (820 bp band), and decreased
in size by approximately 40 to 50 CGG triplets in another transgene copy (600 bp band).  In the
CGG/Igmyc-3-1 transgenic line the original repeat tract was present in at least one copy (750 bp
band), and decreased by approximately 80 to 90 repeats in another copy (480 bp band) (Figure
34, lane 5).  A small band that appeared to represent almost a complete loss of the repeat tract
was also seen (350 bp band).  In the CGG/Igmyc-3-2 transgenic line the original repeat tract was
present in at least one copy (750 bp band), and decreased by approximately 50 to 60 repeats in
another copy (600 bp band) (Figure 34, lanes 3 and 4).  Similar results were seen for the
CGG/Igmyc-6 line (Figure 34, lanes 1 and 2), the original repeat size is seen and a band that
represents loss of approximately 65 to 70 triplets (600 bp band).  The approximate size changes
in the CGG repeat tract are summarized in Table 11.
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Table 11. CGG repeat expansions and contractions in CGG/Igmyc transgenic lines
For each transgenic line the number of CGG repeats (number of triplets) is an approximation
based on Southern blot data (ApaLI + NcoI restriction digest and RSV probe).  The number of
transgene copies per diploid genome was estimated by comparing the intensity of the transgene
hybridization bands to the intensity of the hybridization bands from the endogenous
Immunoglobulin heavy chain locus on a Southern blot hybridized with the Ca probe.
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Transgenic line Copy number
Repeat tract length
(number of triplets)
Generations
CGG/Igmyc-1 2 150/ 70 8
CGG/Igmyc-3-1 3 120/ 40/ 0 7
CGG/Igmyc-3-2 2 120/ 70 9
CGG/Igmyc-6 2 120/ 50 8
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 Figure 35. Sequencing of the CGG repeat tract contractions
Summary of results obtained from sequencing the CGG repeat tracts from three transgenic lines
(CGG/Igmyc-3-2, CGG/Igmyc-3-1, CGG/Igmyc-6).  White rectangles indicate the CGG repeat
region. Black bars indicate AGG interruptions.  The top line represents the original repeat size;
the sequence of the repeat is shown above.  The bottom three lines depict the contractions seen in
each transgenic lines; actual sequences are shown to the right.
203
(CGG)9AGG(CGG)12AGG(CGG)97
Original Transgene
CGG/Igmyc-3-2 (CGG)65
CGG/Igmyc-3-1 (CGG)9AGG(CGG)17
CGG/Igmyc-6 (CGG)8AGG(CGG)40
Contractions 
in 
Transgenic 
Mice
204
5.4.2. Direct sequencing of the repeat region
To confirm that the size changes occurred in the repeat region of the transgene, the repeat
region was directly sequenced.  Sequencing of the repeat region was performed for three lines.
Genomic DNA was PCR amplified with primers flanking the repeat tract.  The PCR products
were sequenced with a primer immediately adjacent to the 5’ end of the repeat tract.  Direct
sequencing from the PCR products was performed to avoid size changes upon subcloning the
CGG repeats into bacterial vectors.  Only contractions of the repeat tract were sequenced
because small CGG repeat tracts were preferentially amplified in the PCR reaction.  The
sequencing results are summarized in Figure 35.
The original repeat tract was composed of 120 triplets with AGG interruptions at
positions 10 and 23 ((CGG)9AGG(CGG)12AGG(CGG)97).  The 5’ of the repeat tract in each
sequenced PCR product was intact.  In line 3-2 the first AGG interruption was absent and the
repeat tract consisted of 65 pure CGG triplets.  In line 3-1 the first AGG interruption was
present, and the second AGG interruption was absent.  Following the first AGG interruption the
repeat tract was composed of 17 pure CGGs.  In line 6 the first AGG interruption was present,
however it was shifted by 1 position.  The 3’ end of the repeat tract contained 40 pure CGG
triplets with no second AGG interruption.  For each sample the sequence confirmed that the
changes occurred at the 3’ end of the repeat.  These results demonstrate that the size changes
seen by Southern blot occurred within the repeat tract.  The approximations made by comparing
the band size of the initial repeat, to the band sizes of repeat tract contractions and expansions by
Southern blot were accurate to within 10 to 15 CGG triplets.  These data confirm that Southern
blots are a relatively accurate method to determine the number of CGG triplets gained or lost.
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5.5. The CGG repeat is stable in somatic cells
The CGG repeats found in human fragile X patients often show mitotic instability,
resulting in individuals with different repeat tract lengths in different somatic tissues.  Southern
blots were performed on DNA samples isolated from the heart, liver, kidney, and spleen of the
CGG/Igmyc transgenic animals to identify any size changes in somatic tissues.  Tissue DNA
samples were digested with PstI and Southern blots were hybridized with the Ca probe.  Results
are shown for the CGG/Igmyc3-2 transgenic line (Figure 36).  No obvious differences were seen
in the size of the 2.5 kb repeat containing band in any tissue examined.  Similar results were
obtained for the CGG/Igmyc3-1 and CGG/Igmyc-1 transgenic lines (Data not shown).
5.6. The transgene showed intergeneration stability
The stability of the CGG repeat tracts present within each transgenic line was analyzed
over seven generations in all four transgenic lines (Table 11).  In each generation the transgene
was inherited through either the male or female germ line.  Transgenic animals were analyzed for
changes in repeat size by Southern blots with the ApaLI plus NcoI restriction digest and RSV
probe. A representative Southern blot of each transgenic line is shown (Figure 37).  No changes
in repeat size were observed.  It is possible that small changes in repeat size have gone unnoticed
due to the limits of detection possible by Southern blot analysis.  However, we are interested in
obtaining large changes in repeat size, and the loss or gain of a few repeats is not of great
interest.
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Figure 36. The CGG repeat is stable in somatic tissues
Tissue DNAs were collected from one transgenic carrier of the CGG/Igmyc-3-2 transgenic line.
The Southern blot shows tissue DNAs digested with PstI and probed with Ca.  DNA sizes are
indicated in kilobases (kb).  Asterisks indicate hybridization bands from the endogenous Ig
locus.
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Figure 37. The CGG repeat is stable over successive generations
Southern blot of DNAs from CGG/Igmyc transgenic animals from line 1, line 3-1, line 3-2, and
line 6.  DNA samples are from representative animals over successive generations (the
generation number is indicated at the top of each lane).  DNAs were digested with ApaLI and
NcoI and the Southern blot was hybridized with the RSV probe.  DNA sizes are indicated
kilobases (kb).
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5.7. Maternal methylation of the transgene is not consistent
The CGG/Igmyc  transgene was designed to test the effect of maternal-specific
methylation on the stability of the CGG repeat region.  The CGG repeat tract was positioned
adjacent to the DMD of the original RSVIgmyc transgene, and minimal DMD sequences were
removed.  The methylation of maternal and paternal alleles in each transgenic line was compared
by Southern blot. DNA samples were collected from hemizygous carriers of a maternally or
paternally inherited transgene, and cleaved with the methylation sensitive restriction
endonuclease HpaII (Figure 38).  Southern blots were hybridized with the Ca probe.
In transgenic line 1 the maternal alleles were slightly more methylated than the paternal
alleles.  In transgenic line 3-2 the maternal and paternal alleles showed equivalent levels of
methylation.  In transgenic line 6 the maternal alleles were slightly more methylated than the
paternal alleles.  Finally, in transgenic line 3-1 the maternal alleles were highly methylated and
the paternal alleles were undermethylated. However, in all three lines that showed differential
methylation, the methylation patterns were not consistently observed in each mouse analyzed.
The most distinct differential methylation observed occurred in transgenic line 3-1.  This
was confirmed with the HhaI, Fnu4HI and AciI methylation sensitive restriction enzymes
(recognition sequences GCGC, GCNGC, and GGCG respectively).  The Fnu4HI and AciI
enzymes recognize CpG sites within the CGG repeat tract itself.  Maternal alleles that showed a
high level of methylation at HpaII sites also showed a high level of methylation at sites within
the repeat tract.  Likewise, paternal alleles that were undermethylated at HpaII sites were also
undermethylated at CpG sites within the repeat tract.  These data suggest that the transgene is
capable of establishing differential methylation at the CGG repeat tract.  However, even in mice
that showed maternal-specific methylation the repeat was stable.
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Figure 38. The CGG/Igmyc transgene is inconsistently differentially methylated
Southern blot analysis of genomic tail DNAs digested with the methylation sensitive restriction
endonuclease HpaII and hybridized with the Ca probe.  Hemizygous carriers of the CGG/Igmyc
transgene from transgenic lines 1, 3-2, 6, and 3-1 are shown.  Southern blots were also performed
using the methylation sensitive restriction endonucleases AciI, Fnu4HI and HhaI on the DNAs
from transgenic line 3-1.  DNAs were hybridized with the Ca probe.  (M) Maternal inheritance.
(P) Paternal inheritance. DNA sizes are indicated in kilobases (kb).
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5.8. Discussion
5.8.1. Differences between repeat expansion in the human and mouse
Many unsuccessful attempts have been made to model CGG repeat expansion in the
mouse.  No model to date has been able to reproduce the dynamic instability of the CGG repeat
in fragile X syndrome.  This is also the case with many other trinucleotide repeats.  No mouse
models to date can completely recapitulate the features of trinucleotide repeat expansions seen at
disease loci. The HD and DRPLA loci both contain CAG repeat tracts, and the DMPK locus
contains a CTG repeat (described in Table 2).  At these loci trinucleotide repeat expansions lead
to Huntington disease, dentatorubral-pallidoluysian atrophy, or myotonic dystrophy type I
respectively.  Recent attempts have been moderately successful at generating instability in these
trinucleotide repeat tracts.
Transgenic mice have been generated that contain unstable CAG repeats (Mangiarini et
al. 1997; Sato et al. 1999).  In one model a 1.9 kb region from the 5’ end of the HD gene was
used as a transgene.  The CAG repeat contained 116, 141, or 144 repeats depending upon the
transgenic line.  All three lines showed age-dependent, somatic instability of the repeat region.
In one line, paternal transmission resulted in instability.  The largest size change observed in the
repeat tract was an expansion of 10 CAG triplets.  In another line, a consistent tendency was
observed for paternal increases and maternal decreases in repeat size.  Similarly, a transgene
containing the entire human DRPLA genomic sequence with 78 CAG repeats was used to
generate three mouse lines (containing 76, 77, or 78 repeats).  In one line paternal transmission
led to expansions and contractions ranging between -2 to +1 repeats, and maternal transmission
led to contractions of -1 to -3 repeats.  In this mouse line the mutation rate increased with age,
and somatic mosaicism was seen in carrier animals.
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These results suggest that it is possible to generate mouse models of trinucleotide repeat
instability.  However, unlike CGG repeats, CAG repeats in humans do not normally show large
changes in repeat length (La Spada et al. 1994).  At the Huntington’s disease locus premutation
alleles range from 36 to 39 CAGs with small expansions of 1-4 repeats, and large expansions of
greater than 7 repeats.  These expansions occur primarily through the paternal germ line and
patients show marked somatic mosaicism.  Likewise, dentatorubral-pallidoluysian atrophy
(DRPLA) is caused by expansion of a CAG repeat by an average of 5 triplets, primarily after
paternal transmission.
A CTG repeat at the myotonic dystrophy (DM) locus ranges from 5 to 37 repeats in the
population and can expand to 50 to 1000 repeats in affected patients.  The repeat shows somatic
instability and parent-specific expansion.  These features are similar to the features of CGG
repeat expansion.  Variable results have been obtained with mouse models of CTG repeat
expansion.  A transgene containing 162 CTGs showed size changes of -7 to +2 after maternal
transmission and size changes of -11 to +7 after paternal transmission (Monckton et al. 1997).
Similarly, transgenes containing 45 kb of human genomic sequence with a 55 CTG repeat
showed moderate size changes of -1 to +6 (Gourdon et al. 1997).  However, these moderate size
changes are not typically seen in DM patients.
Recently, a similar transgene, containing 45 kb of human genomic sequence, was
modified to include over 300 CTGs (Seznec et al. 2000).  Different founder lines contained
slightly different repeat numbers, 304, 362, or 362/184/147 in a multicopy transgene.
Expansions were documented in these lines of up to 60 CTGs in one generation with a paternal
bias for repeat expansion.  These lines also showed increased repeat expansion with increased
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age of the transmitting male, and large differences in somatic tissues.  These features more
closely model what is expected of the CTG repeat in human DM patients.
Importantly, these data demonstrate that it is possible to recreate the dynamic changes in
repeat size in a mouse model.  However, these data also point out relevant differences between
the mouse and human systems.  The CTG repeat tract did not expand at 55 CTGs, which is in the
premutation range for CTG repeat expansion.  However, the repeat did expand at 300 CTGs,
well beyond the number of repeats needed to see repeat expansion in humans.  These results may
demonstrate that the threshold for expansion in mice is larger than in humans.  The CGG repeat
tract in the CGG/Igmyc transgene contained 120 triplets, well within the premutation range seen
in humans.  However, based on the above results it is possible that increasing the size of the
CGG repeat tract in the mouse model may increase its tendency to expand.
Also, some successful mouse model systems have employed a large region of genomic
sequence from human disease loci to trigger expansion.  This suggests that unique features of the
human genomic sequence, which are not found in the mouse genome, are required to trigger
expansion.  A human-specific aspect of repeat expansion is suggested by the fact that large
trinucleotide repeats are not observed in the mouse.  The CGG repeat region at the mouse FMR1
locus only contains around 9 CGG repeats.  Experiments replacing the small mouse repeat with a
larger repeat in the context of the mouse FMR1 locus did not trigger repeat expansion (Bontekoe
et al. 2001).  However, including a large amount of human genomic sequence cannot be the only
factor affecting repeat expansion in the mouse.  A YAC transgene containing 400 kb of genomic
DNA surrounding the human FMR1 locus was not unstable in transgenic animals (Peier and
Nelson 2002).
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5.8.2. DNA repair and DNA replication
Trinucleotide repeats are unstable in both yeast and bacteria (Hirst and White 1998).
Similar to what is seen in humans, repeats in these systems show length dependent expansions
and contractions.  Experiments in E. coli have elucidated that DNA replication and DNA repair
affect the stability of trinucleotide repeats (Balakumaran et al. 2000).  For example, mutations
affecting double strand break repair proteins increase the stability of the repeat. The orientation
of the repeat tract relative to the origin of DNA replication also affects the stability of
trinucleotide repeats.  This is observed as an increase in the occurrence of contractions and
expansions when the repeat is in one specific orientation (Hirst and White 1998).  It has also
been shown that E. coli strains carrying mutations in mismatch repair enzymes, nucleotide
excision repair enzymes, Okazaki fragment processing enzymes, and DNA polymerase III show
variations in the number of expansions and contractions seen compared to wild type strains (Iyer
et al. 2000).
Similar studies in the yeast Saccharomyces cerevisiae have shown that certain mutations
in DNA repair proteins, DNA replication proteins, and the orientation of the repeat with respect
to an origin of replication can affect repeat stability (White et al. 1999).  Mutations in
homologues of the human BLM and WRN helicases decrease contractions.  Also, a mutation in
Rad27p, a protein involved in processing Okazaki fragments during DNA replication, increases
the rate of expansions.  The involvement of DNA replication in the process of repeat expansion
in this system is suggested by the orientation dependent expansions of 5 to 40 CGG repeats
observed in yeast.
The above observations in the bacterial and yeast model systems suggest that changes in
DNA replication and the fidelity of DNA repair alter the stability of trinucleotide repeats.  The
effect of mutations in DNA repair proteins has also been observed in the mouse.  Expansion of
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CTG repeats in the transgene containing 45 kb of human genomic sequence and 300 CTGs was
altered in various mutant mouse strains (Savouret et al. 2003).  For example an Msh2 mutation (a
mismatch repair protein) drove the mutability of the repeat from expansions to contractions.  A
mutation in another DNA repair protein, Rad52, decreased the size of expansions observed.
The ability of alterations in the DNA repair and replication processes to increase or
decrease the expansions and contractions seen at trinucleotide repeat tracts suggests that these
processes are involved in the mechanism of repeat expansion.  Many investigators have
suggested that the formation of slipped-strand structures during DNA replication (S-DNA) is
involved in the expansion of trinucleotide repeats.  In support of this, it was shown that the
formation of slipped-strand structures increases in long pure CGG repeat tracts and decreases in
repeat tracts with AGG interruptions (Pearson and Sinden 1998).
These data suggest that mating the CGG/Igmyc transgene into certain mutant mouse
backgrounds may influence the stability of the repeat.  The stability of CGG repeats in mice,
compared to their instability in humans, suggests that there are subtle differences in the DNA
replication and repair processes between the mouse and human systems.  Determining the
specific mutations in the mouse that trigger repeat expansion may clarify what process ultimately
leads to repeat expansion in humans.  For instance, mutations in the Rad27p protein in yeast
increase the rate of repeat expansions.  This protein is involved in processing of Okazaki
fragments during DNA replication.  The formation of slipped strand structures during DNA
replication across a CGG repeat region may interfere with the function of this protein and lead to
expansion.  Therefore, mutations in the mouse homologue of Rad27p, FEN1, that alter its
function may lead to repeat instability in mice.
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5.8.3. Size changes and transgene injections
In many trinucleotide repeat transgenic mouse lines the repeat tracts have increased or
decreased in size following injection into the mouse zygote (Peier and Nelson 2002; Baskaran et
al. 2002).  However, upon establishment of a mouse line the repeats showed no germ line
instability.  This is similar to what we have observed in generation of CGG/Igmyc transgenic
animals.  Each founder animal examined showed size changes of the injected DNA construct.
However, these size changes remained stable in the established mouse line.  This indicates that
the CGG repeat is stabilized following integration into the mouse genome.  The nature of the
instability seen in generation of transgenic animals is not clear.
5.8.4. Methylation and repeat stability
The original intention of these experiments was to investigate the effect of DNA
methylation on the stability of the trinucleotide repeat.  However, in the transgenic lines that
were established the repeat region was not consistently differentially methylated.  The effect of
methylation on repeat stability in a mouse model system is still an important question to address.
Recent experiments in a bacterial model system suggest that methylation of the CGG repeat may
stabilize the repeat (Nichol and Pearson 2003).  In this system a pure repeat of 53 CGGs or an
interrupted repeat with 32 pure CGGs at the 3’ end was stabilized by methylation.  Similarly in a
COS1 primate cell line premethylation of a trinucleotide repeat decreased the occurrence of
contractions following transfection (Nichol and Pearson 2002).
It may be possible to design a different transgene to get at this question.  Perhaps by
moving the CGG repeat within the transgene DMD, or removing less of the DMD when
introducing the CGG repeat tract.  However, these approaches do not guarantee that the CGG
region will be methylated.  It may also be useful to methylate the CGG repeat in vitro prior to
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injecting the construct.  The instability observed in each transgenic consistently occurred upon
injection of the construct.  If methylation increases or decreases repeat stability methylating the
transgene prior to injection, and analyzing the stability of the repeat in founder animals should
give a clear result.  Overall, these experiments have confirmed the results obtained by many
other investigators; trinucleotide repeats are inherently stable in the mouse genome.
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Chapter 6: Summary and Future Directions
The experiments described above were initiated in an attempt to gain a better
understanding of DNA methylation in mammalian species.  Establishing and maintaining proper
DNA methylation is critical for normal mouse development.  This was clearly illustrated by the
embryonic lethality observed with the loss of the Dnmt1 methyltransferase (Li et al. 1992).  The
expression of imprinted genes is altered following loss of methylation, and the expression of IAP
elements is dramatically increased (Li et al. 1993; Walsh et al. 1998).  For both imprinted genes
and IAP elements, methylation is established in the gamete and maintained during
preimplantation development (Tremblay et al. 1997; Lane et al. 2003).  For imprinted genes
methylation is parent-specific, and for IAPs methylation is present on both parental alleles.
These are exceptional sequences, as the bulk of the mouse genome (including a subset of IAP
sequences) loses methylation at this time.  This suggests that these sequences possess specific
features that allow for methylation maintenance during preimplantation development.
Interestingly, it has been shown that loss of the Dnmt1o methyltransferase during
preimplantation development has an effect on imprinted gene methylation and expression
(described in section 1.5.5).  The Dnmt1D1o mutation eliminates the Dnmt1o protein from oocytes
and  preimplantation  embryos  in  homozygous Dnmt1D1o females (Howell et al. 2001).
Embryos do not develop normally and die in the last third of gestation with variable phenotypes.
Experiments examining the methylation of these embryos have clearly shown that methylation is
completely lost from 50% of the normally methylated alleles of imprinted genes by E10.5, while
the methylation on other genomic sequences is largely normal.
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Dnmt1o is localized to the nucleus specifically at the 8-cell stage of preimplantation
development.  The nuclear localization of Dnmt1o only at one preimplantation stage suggests
that it is only active during the 4th S-phase of preimplantation development.  Loss of Dnmt1o
maintenance methylation at the 4th S-phase, and subsequent maintenance methylation [by an
unknown enzyme(s)] would lead to a 50% loss of methylation on imprinted genes.  Notably, the
loss of maintenance methylation activity in Dnmt1o-deficient embryos leads to embryos that are
epigenetic mosaics, with different cells showing loss of methylation at some imprinted genes and
normal methylation at others (Reinhart and Chaillet, unpublished).  This finding is consistent
with loss of maintenance methylation at the 4th S-phase, and suggests that methylation on the
exceptional IAP element and imprinted gene DMD sequences is maintained by Dnmt1o.  The
experiments described in Chapter 3 and Chapter 4 analyzed the methylation of imprinted gene
DMD sequences and IAP element sequences, and provide a novel approach to investigate this
process.
The requirement of sequences from imprinted gene DMDs for the establishment and
maintenance of parent-specific DNA methylation was examined using derivatives of the
RSVIgmyc transgene.  The RSVIgmyc transgene exhibits maternal-specific DMD methylation.
The non-imprinted Ig/myc transgene was generated by removal of the RSVIgmyc transgene
DMD.  Addition of specific sequences from endogenous DMDs to the Ig/myc transgene restored
transgene imprinting.  This suggests that specific DMD sequences, even removed from their
endogenous context, possess the ability to create a DMD.  Importantly, this ability is only
observed in combination with the Ig/myc sequences.  By comparing the sequences that were able
to restore imprinting to Ig/myc, to those that were not able to restore imprinting, we can draw
some initial conclusions about the sequences that are required to create a DMD.
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Using Igf2r DMD sequences (maternally methylated) we have observed that tandem
repeats, specifically the TR2+3 repeats, were able to create a maternally methylated transgene
locus.  Similarly, hybrid transgenes containing the tandem repeats from the Snprn or Kcnq1 loci
(both maternally methylated) were also able to restore maternal-specific transgene methylation.
This suggests a role for tandem repeats in creating an allele-specific methylation mark.
Supporting this idea we have also shown that a transgene containing one unit copy of the TR2+3
repeat is not imprinted.
The ability of multiple, tandem repeat-containing sequences to restore imprinting to
Ig/myc, demonstrates that tandem repeats at endogenous loci are important to the imprinting
process.  How are tandem repeats involved in this process?  As mentioned above, in order to be
an effective imprint, DMD methylation must be specifically established in one gamete,
maintained during preimplantation and throughout embyrogenesis.  Loss of the embryonic
Dnmt1 enzyme leads to loss of all genomic methylation, including methylation at imprinted loci
(Li et al. 193).  This suggests that embyronic maintenance methyltransferase activity is non-
specific.  In contrast, during preimplantation development, methylation is specifically maintained
at imprinted loci, and loss of the Dnmt1o methyltransferase specifically affects imprints.  If
tandem repeats are performing an essential function, they are most likely involved in
establishment of DMD methylation in the oocyte, or maintenance of DMD methylation during
preimplantation.  Analysis of transgene methylation during preimplantation showed that the
transgene is methylated at the 4-cell, 8-cell, and blastocyst stages, supporting a role for repeats in
either/or both processes.
The function of repeats at specific stages of the imprinting process may be addressed by
examining allele-specific methylation on non-imprinted and imprinted transgenes in the gametes
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and during preimplantation development.  For example, the TR2+3 repeat is capable of
imprinting the transgene in 2.5 unit copies, but not in one unit copy.  If the single unit copy
TR2+3 transgene is differentially methylated in the oocyte but eventually loses methylation by
the adult this would demonstrate that repeats are required for maintenance methylation.
However, if the single unit copy TR2+3 transgene is not differentially methylated in the gametes,
than the repeat sequences are also required for methylation establishment in the oocyte.  Most of
the non-imprinted transgenes examined contained a relatively high level of methylation.  This
may suggest that tandem repeats are not only required for maintaining methylation on the
methylated DMD allele, but are required for protecting the paternal allele from acquiring
methylation during development.  Again, this question may be addressed by examining allele-
specific methylation on non-imprinted and imprinted transgenes during preimplantation and
postimplantation development.
The question also arises as to whether the requirement for repeats is specific or non-
specific.  Will any repeat sequence, above a certain size, perform the same function?  This
question has been in part addressed by the fact that some repeats do not imprint the transgene
(including the TR1 and IAP repeats).  However, it would be a better test to generate a “random”
repeated sequence, of a similar size to either the Igf2r or Snrpn repeats.  The inability of a
random repeat to imprint the Ig/myc transgene would support a role for specific repeats in
genomic imprinting.
The entire 2 kb H19 DMD (paternally methylated) was unable to restore imprinting to the
Ig/myc transgene.  The H19 and RSVIgmyc loci are oppositely imprinted, and the H19 DMD
does not contain tandem repeats.  This could suggest that sequences specific to each gamete are
needed to create an imprint, or simply that the H19 DMD sequences could not create an imprint
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in this model system.  This can be further tested by placing sequences from other paternally
methylated, endogenous DMD sequences into the Ig/myc transgene. For example, the Rasgrf1
locus is paternally methylated and contains a tandem repeat in its DMD that is required for
imprinting (41-mer repeated 40 times) (Yoon et al. 2002).  The ability or inability of these
sequences to imprint the transgene could clarify these results.
Like the methylated alleles of imprinted loci, the methylation at IAPs is maintained
during preimplantation development (Lane et al. 2003).  However, data suggest that at the
blastocyst stage a subset of IAP elements lose methylation (described in section 1.6.3).
Examining the methylation of IAP LTRs at unique genomic insertion sites has provided useful
information regarding the features of this methylation loss.  We have shown that the methylation
on the majority of IAPs is maintained at the blastocyst stage, while the methylation of specific
IAPs is lost.  Still, IAPs that are unmethylated in the blastocyst are targeted for de novo
methylation later in development.  The question remains as to how methylation is maintained on
specific IAP element sequences during preimplantation development.
The shared maintenance of imprints and IAPs during preimplantation development
indicates that a similar mechanism regulates their methylation.  As mentioned above, the
Dnmt1o protein may maintain methylation on both imprinted gene DMD sequences and IAP
sequences during preimplantation development. IAP LTR methylation was examined by
Southern blot in E10.5 Dnmt1o-deficient embryos (Howell et al. 2001).  However, IAP elements
may be targets for de novo methylation throughout embryogenesis (suggested by the
remethylation of IAPs found to be unmethylated in the blastocyst), and analysis of methylation
in E10.5 Dnmt1o-deficient embryos may only assess IAPs that are remethylated following
implantation of the blastocyst. Specifically examining the methylation of individual, methylated
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IAP insertions at the blastocyst stage of development, shortly following the activity of Dnmt1o,
will hopefully determine whether common mechanisms are involved in regulating both of these
processes.
We have emphasized the importance of the establishment and maintenance of
methylation during early development for both imprinted gene DMDs and IAP elements.  The
aberrant methylation of certain sequences may also occur at these times. For example, the
expanded trinucleotide repeat tract at the human FMR1 locus is associated with a high level of
DNA methylation (Pieretti et al. 1991) (described in section 1.7). The association between an
expanded CGG repeat tract and methylation suggests that methylation may influence
trinucleotide repeat stability in the gamete or early embryo.  However, little is known about the
timing of repeat expansion and methylation, or the effect of methylation on repeat stability. A
mouse model has not been generated that recreates the dynamic expansions seen at the human
FMR1 locus.  We attempted to create a mouse transgene with maternal-specific methylation at a
CGG repeat tract (similar to the DMD of the Ig/myc hybrid transgenes) to test the involvement of
DNA methylation in trinucleotide repeat expansion. Unfortunately, we did not observe repeat
expansion using this mouse transgene.  However, the transgenic lines generated were not
consistently maternally methylated in adult tissues, suggesting that they may not establish or
maintain methylation in the early embryo.  Generating new transgenic lines, or a different mouse
transgene that is methylated in the gamete and preimplantation embryo may effectively test the
influence of methylation on repeat stability.
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